"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT03268031","Artificial Intelligence-assissted Glaucoma Evaluation","AGE","Recruiting","No Results Available","Artificial Intelligence|Glaucoma","Diagnostic Test: Visual field and OCT tests","Accuracy of diagnosis by artificial intelligence algorithm|Sensitivity of diagnosis by artificial intelligence algorithm|Specificity of diagnosis by artificial intelligence algorithm","Sun Yat-sen University|Chinese Academy of Sciences","All","Child, Adult, Older Adult",,"5000","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","ProjectAGE","August 15, 2017","June 1, 2020","January 1, 2021","August 31, 2017",,"September 25, 2019","Zhongshan Ophthalmic Center, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03268031"
2,"NCT04131530","Automatic Evaluation of Inflammation Activity in Ulcerative Colitis Using pCLE With Artificial Intelligence",,"Recruiting","No Results Available","Ulcerative Colitis|Artificial Intelligence|Confocal Laser Endomicroscopy","Diagnostic Test: The diagnosis of Artificial Intelligence and endoscopist","The diagnosis efficiency of Artificial Intelligence|Contrast the diagnosis efficiency of Artificial Intelligence with endoscopists","Shandong University","All","18 Years to 80 Years   (Adult, Older Adult)",,"60","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2019SDU-QILU-10","October 2019","December 2019","December 2019","October 18, 2019",,"October 18, 2019","Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China",,"https://ClinicalTrials.gov/show/NCT04131530"
3,"NCT03784209","Automatic Real-time Diagnosis of Gastric Mucosal Disease Using pCLE With Artificial Intelligence",,"Recruiting","No Results Available","Gastric Diseases|Artificial Intelligence|Confocal Laser Endomicroscopy","Diagnostic Test: The diagnosis of Artificial Intelligence and endoscopist","The diagnosis efficiency of Artificial Intelligence|Contrast the diagnosis efficiency of Artificial Intelligence with endoscopists","Shandong University","All","18 Years to 80 Years   (Adult, Older Adult)",,"500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2018SDU-QILU-12","July 1, 2018","November 1, 2019","November 1, 2019","December 21, 2018",,"October 18, 2019","Endoscopic unit of Qilu Hospital Shandong University, Jinan, Shandong, China",,"https://ClinicalTrials.gov/show/NCT03784209"
4,"NCT04337229","Evaluation of Comfort Behavior Levels of Newborns With Artificial Intelligence Techniques",,"Not yet recruiting","No Results Available","Newborn|Comfort|Nursing|Artificial Intelligence","Other: Artifical intelligent","Images of the newborn|Artificial intelligence techniques","Eskisehir Osmangazi University","All","up to 28 Days   (Child)","Not Applicable","1000","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","DYIGIT|Ayfer ACIKGOZ","September 2020","December 2020","September 2021","April 7, 2020",,"April 13, 2020",,,"https://ClinicalTrials.gov/show/NCT04337229"
5,"NCT04138771","Validation of an Artificial Intelligence System for Postoperative Management of Cataract Patients",,"Recruiting","No Results Available","Cataract|Postoperative Complications|Artificial Intelligence","Device: An artificial intelligence system for postoperative management of cataract patients","The proportion of accurate, mistaken and miss detection of this artificial intelligence diagnostic system.","Sun Yat-sen University|Ministry of Health, China|Xidian University","All","Child, Adult, Older Adult","Not Applicable","300","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","CCPMOH2019-China-5","January 1, 2013","March 1, 2020","March 1, 2020","October 24, 2019",,"December 3, 2019","Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT04138771"
6,"NCT04126265","Artificial Intelligence-assisted Colonoscopy for Detection of Colon Polyps",,"Recruiting","No Results Available","Artificial Intelligence|Colonoscopy","Device: Artificial intelligence assisted colonoscopy","Detection rate of small polyps (diameter < 6mm)|Number of polyps detected|Polyp size|Polyp morphology","Side Liu|Nanfang Hospital of Southern Medical University","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","560","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","NCT201908-K5-01","September 1, 2019","April 30, 2020","August 31, 2020","October 15, 2019",,"January 2, 2020","Nanfang Hospital, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT04126265"
7,"NCT04442607","Clinical vAliDation of ARTificial Intelligence in POlyp Detection","CAD-ARTIPOD","Not yet recruiting","No Results Available","Polyp of Colon","Device: artificial intelligence image processing","Total polyp detection during single pass colonoscopy by the artificial intelligence tool in comparison to polyp detection by the endoscopist with endoscopic diagnosis as a gold standard|Total polyp detection during single pass colonoscopy by the artificial intelligence tool in comparison to polyp detection by the endoscopist with histological diagnosis as a gold standard.|The number of extra detected polyps by artificial intelligence with the endoscopic diagnosis as a gold standard.|The number of extra detected polyps by artificial intelligence with the histological diagnosis as a gold standard|The endoscopist's polyp miss rate defined as the additional detection of polyps during colonoscopy|The false positive rate during clean withdrawal.","Universitaire Ziekenhuizen Leuven","All","40 Years and older   (Adult, Older Adult)","Not Applicable","1200","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","S64243","September 1, 2020","February 1, 2021","December 31, 2021","June 22, 2020",,"June 22, 2020","University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium",,"https://ClinicalTrials.gov/show/NCT04442607"
8,"NCT04314180","Artificial Intelligence System for Assessing Image Quality of Slit-Lamp Images and Its Effects on Diagnosis",,"Active, not recruiting","No Results Available","Anterior Segment Disorders|Artificial Intelligence","Device: Taking slit-lamp images","Performance of artificial intelligence system for distinguish between good image quality and poor image quality|The comparison of the performance for previous artificial intelligence diagnostic system with slit-lamp images of different image quality","Sun Yat-sen University","All","Child, Adult, Older Adult",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IMAQUA2020-China-02","February 1, 2020","July 1, 2020","July 1, 2020","March 19, 2020",,"March 19, 2020","Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT04314180"
9,"NCT04289064","Artificial Intelligence System for Assessing Image Quality of Fundus Images and Its Effects on Diagnosis",,"Active, not recruiting","No Results Available","Retinal Diseases|Artificial Intelligence","Device: Taking a fundus image","Performance of artificial intelligence system for distinguish between good image quality and poor image quality|The comparison of the performance for previous artificial intelligence diagnostic system with fundus images of different image quality","Sun Yat-sen University","All","Child, Adult, Older Adult",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IMAQUA2020-China-01","February 1, 2020","July 1, 2020","July 1, 2020","February 28, 2020",,"February 28, 2020","Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT04289064"
10,"NCT04186104","Artificial Intelligence in Children's Clinic",,"Recruiting","No Results Available","Artificial Intelligence|Outpatient","Other: Routine diagnostic process|Other: Artificial intelligence assisted diagnosis process","Evaluate the efficiency of the two processes|Evaluate patients' rate of satisfaction for medical processes|Evaluate rate of single visit and rate of return visit|Economic measurements|Work efficiency of doctors|Evaluate the accuracy of examination items prescribed by the AI system and inexperienced physicians","Shanghai Jiao Tong University School of Medicine","All","2 Months to 18 Years   (Child, Adult)","Not Applicable","2000","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","SCMCIRB-K2019020-2","March 21, 2020","June 30, 2020","December 31, 2020","December 4, 2019",,"May 21, 2020","Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China|Shanghai Children's Medical Center, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT04186104"
11,"NCT04425941","Polyp Artificial Intelligence Study",,"Completed","No Results Available","Software Analysis on Polyp Histology Prediction","Other: artificial intelligence diagnosis","Software accuracy of polyp histology prediction","Petz Aladar County Teaching Hospital","All","18 Years to 90 Years   (Adult, Older Adult)",,"373","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","PetzACTHospital","January 5, 2014","May 31, 2020","May 31, 2020","June 11, 2020",,"June 11, 2020",,,"https://ClinicalTrials.gov/show/NCT04425941"
12,"NCT03917017","The Evaluation of Surgical Decisions and Prognosis of the Radiomics and Watson Artificial Intelligence in Patients With Hepatocellular Carcinoma",,"Recruiting","No Results Available","Liver Resection","Device: Radiomics and Watson artificial intelligence","Postoperative survival|Disease-free survival","Zhujiang Hospital","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","201901","January 1, 2019","December 31, 2024","December 31, 2024","April 16, 2019",,"April 16, 2019","Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03917017"
13,"NCT04040114","Improving Skin Cancer Management With Artificial Intelligence (04.17 SMARTI)","SMARTI","Recruiting","No Results Available","Skin Cancer|Melanoma (Skin)","Device: Molemap Skin Cancer Triage Artificial Intelligence Device","Diagnostic accuracy of the device when compared prospectively to a teledermatologist assesment|Diagnostic accuracy of the device when used prospectively as compared to a dermatologist assessment|Diagnostic accuracy of the device compared to teledermatologist, dermatologist and registrar using histopathology as 'gold standard' for any lesions biopsied.|Appropriate selection of lesions by registrar compared to specialist dermatologists|Appropriateness of management by registrar compared to specialist dermatologists and impact AI might have on this.","Melanoma and Skin Cancer Trials Limited|Molemap Australia Pty Ltd|Monash University, Melbourne","All","18 Years and older   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic","04.17","October 1, 2019","October 2020","October 2020","July 31, 2019",,"October 2, 2019","The Alfred- Victorian Melanoma Service, Melbourne, Victoria, Australia|Skin & Cancer Foundation Inc., Melbourne, Victoria, Australia",,"https://ClinicalTrials.gov/show/NCT04040114"
14,"NCT04271657","RadioPathomics Artificial Intelligence Model to Predict nCRT Response in Locally Advanced Rectal Cancer","RPAI-pCR","Recruiting","No Results Available","Rectal Cancer",,"The prediction accuracy of the radiopathomics artificial intelligence model|The specificity of the radiopathomics artificial intelligence model|The sensitivity of the radiopathomics artificial intelligence model|The area under curve (AUC) of Receiver Operating Characteristic (ROC) curves of the radiopathomics artificial intelligence model","Sixth Affiliated Hospital, Sun Yat-sen University|The Third Affiliated Hospital of Kunming Medical College.|Sir Run Run Shaw Hospital","All","18 Years to 75 Years   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Other|Time Perspective: Prospective","RPAI-pCR2020","January 10, 2020","July 2020","December 2020","February 17, 2020",,"February 17, 2020","the Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China|The Third Affiliated Hospital of Kunming Medical College, Kunming, Yunnan, China|Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04271657"
15,"NCT04273451","RadioPathomics Artificial Intelligence Model to Predict Tumor Regression Grading in Locally Advanced Rectal Cancer","RPAI-TRG","Recruiting","No Results Available","Rectal Cancer",,"The prediction accuracy of the radiopathomics artificial intelligence model|The specificity of the radiopathomics artificial intelligence model|The sensitivity of the radiopathomics artificial intelligence model|The F1 score of the radiopathomics artificial intelligence model","Sixth Affiliated Hospital, Sun Yat-sen University|The Third Affiliated Hospital of Kunming Medical College.|Sir Run Run Shaw Hospital","All","18 Years to 75 Years   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Other|Time Perspective: Prospective","RPAI-TRG2020","January 10, 2020","July 2020","December 2020","February 18, 2020",,"February 18, 2020","the Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China|The Third Affiliated Hospital of Kunming Medical College, Kunming, Yunnan, China|Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04273451"
16,"NCT04136236","Automatic Diagnosis of Early Esophageal Squamous Neoplasia Using pCLE With AI",,"Recruiting","No Results Available","Esophageal Neoplasms|Artificial Intelligence|Confocal Laser Endomicroscopy","Diagnostic Test: The diagnosis of Artificial Intelligence and endoscopist","The diagnosis efficiency of Artificial Intelligence|Contrast the diagnosis efficiency of Artificial Intelligence with endoscopists","Shandong University","All","18 Years to 80 Years   (Adult, Older Adult)",,"60","Other","Observational","Observational Model: Cohort|Time Perspective: Other","2019SDU-QILU-66","August 1, 2019","December 1, 2019","December 1, 2019","October 23, 2019",,"October 23, 2019","Qilu Hospital, Shandong University, Jinan, Shandong, China",,"https://ClinicalTrials.gov/show/NCT04136236"
17,"NCT04214782","Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm",,"Not yet recruiting","No Results Available","Ovarian Cancer","Diagnostic Test: Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm","diagnostic accuracy|time cost for Transvaginal Ultrasound image interpretation","Tongji Hospital|Hubei Cancer Hospital|Qilu Hospital of Shandong University|Henan Cancer Hospital|Xiangyang Central Hospital|The First People's Hospital of Jingzhou|First Affiliated Hospital, Sun Yat-Sen University","Female","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","10000","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Diagnostic","2019-TJ-OVAB","January 1, 2020","January 1, 2022","January 1, 2024","January 2, 2020",,"January 2, 2020",,,"https://ClinicalTrials.gov/show/NCT04214782"
18,"NCT04260321","The AID Study 2: Artificial Intelligence for Colorectal Adenoma Detection 2",,"Recruiting","No Results Available","Colon Cancer","Device: AI","Non-inferiority of AI-aided colonoscopy in terms of ADR","Istituto Clinico Humanitas","All","40 Years to 80 Years   (Adult, Older Adult)",,"700","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2363-2","February 19, 2020","December 31, 2020","December 31, 2020","February 7, 2020",,"June 16, 2020","Fondazione Poliambulanza, Brescia, Italia, Italy|Endoscopy Unit, Humanitas Research Hospital, Rozzano, Milano, Italy|Ospedale Valduce, Como, Italy|Digestive Endoscopy Unit, Nuovo Regina Margherita Hospital, Rome, Italy|Ente Ospedaliero Cantonale, Ospedale Italiano, Lugano, Switzerland",,"https://ClinicalTrials.gov/show/NCT04260321"
19,"NCT03700268","Programming Cochlear Implant With Artificial Intelligence","CI_AI","Recruiting","No Results Available","Deafness; Perception","Other: Manual intervention to programme Cochlear Implant electrodes","Evaluate Fox software efficiency","Cliniques universitaires Saint-Luc- Université Catholique de Louvain","All","18 Years and older   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2017/04SEP/427|2017/13OCT/480","September 4, 2017","September 2020","September 2021","October 9, 2018",,"October 9, 2018","Cliniques Universitaires Saint-Luc, Brussels, Belgium",,"https://ClinicalTrials.gov/show/NCT03700268"
20,"NCT04203264","Real-Time Identification System of Magnetically Controlled Capsule Endoscopy Using Artificial Intelligence",,"Recruiting","No Results Available","Capsule Endoscopy","Diagnostic Test: Real-time artificial intelligence identification system","Sensitivity|Delay time|Specificity|Accuracy of anatomic landmarks identification|Completeness of real-time observation with assistance|Accuracy of heat map|Lesion detection yield","Changhai Hospital","All","18 Years to 80 Years   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","20190411A","December 16, 2019","January 1, 2020","January 1, 2020","December 18, 2019",,"December 18, 2019","Changhai Hospital, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT04203264"
21,"NCT04378660","Artificial Intelligence (AI) Validation Study for Polyp Detection",,"Completed","No Results Available","Polyp of Colon","Diagnostic Test: Artificial intelligence for polyp detection","Diagnostic accuracy of the novel AI system compared to endoscopic diagnosis as gold standard|Endoscopist's polyp miss rate as number of extra AI detections","Universitaire Ziekenhuizen Leuven|Nuovo Regina Margherita Hospital, Rome, Italy|Universitäts Medizin, Mainz, Germany","All","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","357","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","s59405","October 30, 2019","April 18, 2020","April 18, 2020","May 7, 2020",,"May 7, 2020","University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/60/NCT04378660/Prot_SAP_000.pdf|""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/60/NCT04378660/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT04378660"
22,"NCT03622281","Quality Improvement Intervention in Colonoscopy Using Artificial Intelligence",,"Completed","No Results Available","Quality Control|Artificial Intelligence|Colonoscopy","Other: quality improvement intervention using artificial intelligence","Adenoma detection rate","Shandong University","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","676","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Health Services Research","2018SDU-QILU-716","October 20, 2018","May 31, 2019","May 31, 2019","August 9, 2018",,"February 12, 2020","Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China",,"https://ClinicalTrials.gov/show/NCT03622281"
23,"NCT04196088","To Compare Artificial Intelligence Software Aided Adenoma Detection in Screening Colonoscopies Versus Standard Colonoscopy Without Artificial Intelligence Software Assistance in Participants Between 50 and 75 Years of Age","AIDA","Recruiting","No Results Available","Colorectal Adenoma|Colorectal Polyp|Colorectal Adenocarcinoma|Colorectal SSA","Device: Ultivision Artificial Intelligence Software|Device: No Artificial Intelligence Software enhancement","Overall adenoma detection using Ultivision AI software in subjects undergoing screening standard high definition white light colonoscopy (SHDWLC) versus screening SHDWLC without AI.|Adenoma detection rate using Ultivision AI software in subjects undergoing screening standard high definition white light colonoscopy (SHDWLC) versus screening SHDWLC without AI.|Adenomas per extraction (APE) ratio using Ultivision AI software in subjects undergoing screening standard high definition white light colonoscopy (SHDWLC) versus screening SHDWLC without AI.","Docbot, Inc.","All","50 Years to 75 Years   (Adult, Older Adult)","Not Applicable","978","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Screening","Docbot AIDA: Ultivision_002","June 11, 2020","November 2020","December 2020","December 12, 2019",,"June 30, 2020","Gastro Health, Birmingham, Alabama, United States|Kansas City Veterans Administration, Kansas City, Kansas, United States|Capital Digestive Care, Chevy Chase, Maryland, United States|Gastrointestinal & Liver Specialists of Tidewater, PLLC, Norfolk, Virginia, United States|Wisconsin GI Associates, Milwaukee, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT04196088"
24,"NCT04071678","A Randomized Controlled Multicenter Study of Artificial Intelligence Assisted Digestive Endoscopy",,"Recruiting","No Results Available","Artificial Intelligence","Behavioral: Careful examination during endoscopic procedures to identify lesions","Changes of detection rate of digestive tract lesions assisted by artificial intelligence gastroenteroscopy|The accuracy of AI-assisted diagnostic model evaluating the intestinal readiness score","Second Affiliated Hospital, School of Medicine, Zhejiang University","All","18 Years and older   (Adult, Older Adult)",,"3600","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","研2019-262","August 1, 2019","August 1, 2021","December 30, 2021","August 28, 2019",,"October 22, 2019","Cai J Ting, Hangzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04071678"
25,"NCT04359355","Computer-aided Detection of Colorectal Polyps",,"Recruiting","No Results Available","Adenoma Colon|Polyp of Colon","Device: Artificial Intelligence System for Detection of colorectal polyps","Feasibility to use the AI System in vivo during colonoscopy|Diagnostic Performance of the AI System for detecting colorectal polyps","University of Erlangen-Nürnberg Medical School","All","18 Years to 85 Years   (Adult, Older Adult)",,"40","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CAID","January 1, 2020","April 30, 2020","May 31, 2020","April 24, 2020",,"April 24, 2020","University Hospital Erlangen, Erlangen, Germany",,"https://ClinicalTrials.gov/show/NCT04359355"
26,"NCT04227795","AI-assisted Detection of Missed Colonic Polyps",,"Completed","No Results Available","Colon Adenoma|Colonic Polyp|Colon Cancer","Device: Artificial intelligence-Assisted real time colonoscopy","Adenoma miss rate|Total number of adenoma missed|Colonic polyp miss rate|Total number of missed polyps","The University of Hong Kong","All","40 Years to 90 Years   (Adult, Older Adult)","Not Applicable","52","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","UW 19-309","January 1, 2020","February 1, 2020","March 1, 2020","January 14, 2020",,"March 4, 2020","Queen Mary Hospital, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT04227795"
27,"NCT04255615","Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes","AI in ART","Suspended","No Results Available","Infertility|in Vitro Fertilization (IVF)|ART","Other: AI to analyze 3 D ultrasound","Number of baseline antral follicle count|Number of retrieved oocytes|Number of mature oocytes|Number of multiple gestation|Number of clinical intrauterine pregnancies IVF|Number of clinical intrauterine pregnancies OI","Weill Medical College of Cornell University","All","18 Years to 48 Years   (Adult)","Not Applicable","2000","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","19-06020306","February 12, 2020","January 31, 2022","January 31, 2023","February 5, 2020",,"April 2, 2020","Weill Cornell Medicine, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT04255615"
28,"NCT03787784","Automatic Classification of Colorectal Polyps Using Probe-based Endomicroscopy With Artificial Intelligence",,"Recruiting","No Results Available","Probe-based Confocal Laser Endomicroscopy|Artificial Intelligence|Colorectal Polyps","Other: AI presentation","The accuracy of classifying colorectal Polyps using Probe-based endomicroscopy with deep neural networks|Contrast the diagnosis efficiency of Artificial Intelligence with endoscopists","Shandong University","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Diagnostic","2018SDU-QILU-8","May 1, 2018","January 30, 2019","March 30, 2019","December 26, 2018",,"December 26, 2018","Endoscopic unit of Qilu Hospital Shandong University, Jinan, Shandong, China",,"https://ClinicalTrials.gov/show/NCT03787784"
29,"NCT04079478","The AID Study: Artificial Intelligence for Colorectal Adenoma Detection","AID","Completed","No Results Available","Colon Cancer","Other: AI","Additional diagnostic yield obtained by AI-aided colonoscopy to the yield obtained by the Standard (high-definition) colonoscopy","Istituto Clinico Humanitas","All","40 Years to 80 Years   (Adult, Older Adult)",,"700","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2363","September 25, 2019","December 31, 2019","December 31, 2019","September 6, 2019",,"February 12, 2020","Endoscopy Unit, Humanitas Research Hospital, Rozzano, Milano, Italy",,"https://ClinicalTrials.gov/show/NCT04079478"
30,"NCT04399590","Comparing the Number of False Activations Between Two Artificial Intelligence CADe Systems: the NOISE Study","NOISE","Not yet recruiting","No Results Available","Artificial Intelligence","Other: Interficial Intelligence","To evaluate the cause of False Positives (FPs) signals, their frequenTocy and time rate, on two different CAD systems: CADe (GI Genius, Medtronic) and CADe/CADx (CAD EYE, Fujifilm) and report a comparison among the two","Istituto Clinico Humanitas","All","18 Years and older   (Adult, Older Adult)",,"40","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2598","June 30, 2020","September 30, 2020","September 30, 2020","May 22, 2020",,"June 22, 2020","Endoscopy Unit, Humanitas Research Hospital, Rozzano, Milano, Italy",,"https://ClinicalTrials.gov/show/NCT04399590"
31,"NCT04275609","The Efficiency of Writing Endoscopic Reports by Artificial Intelligence and Physicians: a Randomized Controlled Trial",,"Not yet recruiting","No Results Available","Gastrointestinal Disease","Other: AI generated report|Other: physicians writing report","The time spent writing reports","Shandong University","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic","2020SDU-QILU-G002","February 20, 2020","March 20, 2020","March 30, 2020","February 19, 2020",,"February 19, 2020",,,"https://ClinicalTrials.gov/show/NCT04275609"
32,"NCT03899623","Multi-modal Imaging and Artificial Intelligence Diagnostic System for Multi-level Clinical Application",,"Recruiting","No Results Available","Diabete Mellitus|Diabetic Retinopathy",,"The diagnostic sensitivity, specificity and ROC curve of the artificial intelligence（AI） system compared with reference standard (ophthalmologist).","Zhongshan Ophthalmic Center, Sun Yat-sen University","All","Child, Adult, Older Adult",,"3000","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","2017KYPJ104","April 23, 2018","December 31, 2019","December 31, 2019","April 2, 2019",,"April 2, 2019","Zhongshan Opthalmic Center, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03899623"
33,"NCT04022018","Study on Adaptive Radiotherapy and Multimodal Information of Cervical Cancer Assisted by Artificial Intelligence","SOARAMIOCC","Recruiting","No Results Available","Cervical Cancer|Radiotherapy Side Effect|Biomarker|Artificial Intelligence","Radiation: Adaptive radiotherapy|Radiation: no adaptive radiotherapy","the difference in grade 3 side effects between the two groups|2-year PFS differences between the two groups|2-year OS differences between the two groups|the correlation between physical dosimetry differences and prognosis|the predictive factors for the response rate of concurrent chemoradiotherapy for cervical cancer|the prognostic factors for the 2-year overall survival rate of patients with cervical cancer after concurrent chemoradiotherapy|the time difference between labor and an artificial intelligence to design radiotherapy plans","The University of Hong Kong-Shenzhen Hospital","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","122","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","hkuszh2019119","December 18, 2019","May 30, 2022","May 30, 2022","July 16, 2019",,"March 27, 2020","HongKong University Shenzhen Hospital, Shenzhen, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT04022018"
34,"NCT04294355","AI-assisted Colonoscopy on Detection of Missed Proximal Lesions",,"Not yet recruiting","No Results Available","Colon Adenoma|Colon Polyp","Device: Artificial intelligence-Assisted colonoscopy|Procedure: Conventional colonoscopy","Proximal adenoma missed rate|Proximal polyp missed rate|Proximal adenoma detection rate|Proximal polyp detection","The University of Hong Kong|Tan Tock Seng Hospital|The University of Hong Kong-Shenzhen Hospital|Chongqing University Cancer Hospital|Hanoi Medical University","All","40 Years and older   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic","UW 19-713","May 1, 2020","April 1, 2021","July 1, 2021","March 4, 2020",,"March 4, 2020",,,"https://ClinicalTrials.gov/show/NCT04294355"
35,"NCT04242043","Feasibility Study for Improving the Relevance of Diagnostic Proposals for an Artificial Intelligence Software in the Elderly Population.","Intel@med-F","Recruiting","No Results Available","Artificial Intelligence|Geriatrics|Diagnostic Proposals Elderly","Diagnostic Test: intel@med-feasibility","AI diagnostic proposals|severity diagnoses|satisfaction survey","University Hospital, Limoges","All","65 Years and older   (Older Adult)",,"50","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","87RI19_0026 (Intel@med-Faisa)","December 21, 2019","March 21, 2020","March 21, 2020","January 27, 2020",,"February 24, 2020","Ehpad Des Bayles, Isle, France|Ehpad Le Roussillon, Limoges, France",,"https://ClinicalTrials.gov/show/NCT04242043"
36,"NCT03936413","Artificial Intelligence in Echocardiography",,"Not yet recruiting","No Results Available","Cardiovascular Diseases","Device: Bay Labs EchoGPS Echcoardiogram|Device: Native Terason Echocardiogram","Echocardiogram image acquisition quality|Educational outcome","New York Presbyterian Hospital|Caption Health, Inc.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","1500","Other|Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","NYPresbyterianH","May 1, 2019","June 30, 2020","June 30, 2020","May 3, 2019",,"May 3, 2019",,,"https://ClinicalTrials.gov/show/NCT03936413"
37,"NCT04441775","Artificial Intelligence for Prostate Cancer Treatment Planning",,"Not yet recruiting","No Results Available","Prostate Cancer|Artificial Intelligence|Radiotherapy","Other: AI-assisted RT modelling","Change (trend) in AI System performance over time","Dartmouth-Hitchcock Medical Center|Oregon Health and Science University|University of Massachusetts, Worcester|Nicolalde R&D, LLC|National Cancer Institute (NCI)|NRG Oncology","Male","21 Years to 90 Years   (Adult, Older Adult)",,"195","Other|NIH","Observational","Observational Model: Cohort|Time Perspective: Other","D20003|75N91019C00054-0-9999-1","June 22, 2020","June 2023","June 2023","June 22, 2020",,"June 22, 2020",,,"https://ClinicalTrials.gov/show/NCT04441775"
38,"NCT03530098","Validation of an Artificial Intelligence-based Algorithm for Skeletal Age Assessment",,"Completed","No Results Available","Bone Age","Device: BoneAgeModel","Paired Difference of Skeletal Age Estimate|Time Saved","Stanford University","All","1 Year to 18 Years   (Child, Adult)","Not Applicable","1903","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","IRB #44764","July 12, 2018","October 1, 2019","November 1, 2019","May 21, 2018",,"February 12, 2020","Stanford University, Stanford, California, United States|Yale New Haven Hospital, New Haven, Connecticut, United States|Boston Children's Hospital, Boston, Massachusetts, United States|New York University, New York, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03530098"
39,"NCT04216901","A Single Center Study on the Effectiveness and Safety of Polyp Classification With Artificial Intelligence",,"Recruiting","No Results Available","Colonic Diseases|Artificial Intelligence","Diagnostic Test: Endoscopists refer to AI for diagnosis","Accuracy of evaluating the feasibility of selective-ESD|Accuracy of Vision location|Consistent of classification among different endoscopists|Consistent of classification between diagnostic system and endoscopists|Consistent of vision positioning between diagnostic system and endoscopists","Renmin Hospital of Wuhan University","All","18 Years and older   (Adult, Older Adult)",,"70","Other","Observational","Observational Model: Other|Time Perspective: Prospective","EA-19-003","December 24, 2019","December 31, 2020","December 31, 2020","January 3, 2020",,"January 6, 2020","Renmin Hospital of Wuhan University, Wuhan, Hubei, China",,"https://ClinicalTrials.gov/show/NCT04216901"
40,"NCT03682783","Artificial Intelligence-assisted Glaucoma Screening (AIAGS)",,"Not yet recruiting","No Results Available","Glaucoma Eye","Diagnostic Test: Fundus Image","The specificity of the algorithm for diagnosing glaucoma|The sensitivity of the algorithm for diagnosing glaucoma","Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","All","Child, Adult, Older Adult",,"8000","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","81300776","October 1, 2018","October 1, 2020","October 30, 2021","September 25, 2018",,"September 25, 2018","Shanghai General Hospital, Shanghai, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT03682783"
41,"NCT04046497","Artificial Intelligence to Measure Adherence to Oral Medication",,"Not yet recruiting","No Results Available","First Episode Psychosis","Other: Smartphone App|Other: Ususal Care","Service Utilization Report Form","Northwell Health|National Institute of Mental Health (NIMH)","All","15 Years to 40 Years   (Child, Adult)","Phase 4","200","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","19-0307-A","July 1, 2020","December 31, 2022","March 15, 2023","August 6, 2019",,"April 17, 2020",,,"https://ClinicalTrials.gov/show/NCT04046497"
42,"NCT03317691","The ALERT-Pilot Study",,"Unknown status","No Results Available","Myocardial Infarction, Acute|Artificial Intelligence|ECG Pattern","Diagnostic Test: electrocardiogram diagnosed by artificial intelligence","the algorithm of artificial intelligent to diagnose myocardial infarction through prior surgery Electrocardiogram|The accuracy of using artificial intelligent to diagnose acute ST-segment elevation myocardial infarction and judge criminal vascular","Shanghai 10th People's Hospital","All","18 Years and older   (Adult, Older Adult)",,"2000","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","2017YFC0111800","October 20, 2017","October 15, 2018","November 1, 2018","October 23, 2017",,"November 14, 2017","Shanghai Tenth People's Hospital, Shanghai, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT03317691"
43,"NCT03623971","Validation of a Universal Cataract Intelligence Platform",,"Completed","No Results Available","Cataract|Artificial Intelligence","Device: Cataract AI agent","Diagnostic accuracy of the cataract AI agent","Sun Yat-sen University|Xidian University","All","Child, Adult, Older Adult","Not Applicable","500","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","CCPMOH2018- China7","January 1, 2013","June 1, 2017","June 1, 2017","August 9, 2018",,"August 9, 2018",,,"https://ClinicalTrials.gov/show/NCT03623971"
44,"NCT04444908","Development and Validation of an Artificial Intelligence-assisted Strategy Selection System for Colonoscopy Cleaning",,"Recruiting","No Results Available","Colorectal Adenoma",,"The adenoma detection rate (ADR)|Cleanliness assessment of different intestinal segment in the artificial intelligence system|The polyp detection rate (PDR)|The mean number of polyps per patient (MNP)|The mean number of adenomas per patient (MAP)|PDR of different sizes|MNP of different sizes|ADR of different sizes|MAP of different sizes|ADR of different location|MAP of different location|Scope-forward time and Withdrawal time|Boston Bowel Preparation Score of endoscopists|Cecal intubation rate","Renmin Hospital of Wuhan University","All","18 Years and older   (Adult, Older Adult)",,"500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","WDRY2019-KK073","May 11, 2020","August 1, 2020","August 31, 2020","June 24, 2020",,"July 7, 2020","Renmin hospital, Wuhan, Hubei, China","""Study Protocol, Statistical Analysis Plan, and Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/08/NCT04444908/Prot_SAP_ICF_000.pdf","https://ClinicalTrials.gov/show/NCT04444908"
45,"NCT03621462","Elucid Labs AIDA™ - Labelled Image Acquisition Protocol",,"Not yet recruiting","No Results Available","Melanoma (Skin)|Basal Cell Carcinoma of the Skin|Squamous Cell Carcinoma of the Skin","Device: Artificial Intelligence Dermatology Assistant (AIDA™)","Sensitivity of in-clinic dermatologist diagnosis using AIDA™ compared to standard dermoscopy and physical examination alone|Specificity of in-clinic dermatologist diagnosis using AIDA™ compared to standard dermoscopy and physical examination alone","Elucid Labs Inc.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","4000","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","AIDA-PRO-001","October 15, 2018","September 1, 2020","October 15, 2020","August 8, 2018",,"August 8, 2018","Total Skincare Centre, Calgary, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT03621462"
46,"NCT04440865","Impact of Artificial Intelligence Genius® System-assisted Colonoscopy vs. Standard Colonoscopy (COLO-GENIUS)","COLO-GENIUS","Not yet recruiting","No Results Available","Colonic Polyp|Colonoscopy|Artificial Intelligence|Colonic Adenoma|Colonic Neoplasms","Other: Genius® System-assisted Colonoscopy|Other: Standard Colonoscopy","Adenoma Detection Rate (ADR)|Advanced Neoplasia Detection Rate (ANDR)|Proximal Serrated Polyp Detection Rate (PSPDR)|Polyp Detection Rate (PDR)|The factors influencing the Adenoma Detection Rate (ADR)|Time to reach caecum (sec)|Caecal intubation rate (%)|Morbidity: perforation rate (%)|Morbidity: bleeding rate (%)","Clinique Paris-Bercy","All","18 Years and older   (Adult, Older Adult)","Not Applicable","2100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","COLO-GENIUS","October 1, 2020","October 7, 2020","October 1, 2021","June 22, 2020",,"June 22, 2020","Clinique Paris-Bercy, Charenton-le-Pont, France",,"https://ClinicalTrials.gov/show/NCT04440865"
47,"NCT03611387","Artificial Intelligence Screening on Patients With Primary Angle Closure Glaucoma","AI","Unknown status","No Results Available","Ophthalmopathy","Device: CASIA 2 OCT","The accuracy of the CASIA 2 OCT|The sensitivity and specificity of the AI","Sun Yat-sen University|University of California","All","18 Years and older   (Adult, Older Adult)",,"1500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CCPMOH2018-China-4","April 1, 2018","December 31, 2019","December 31, 2019","August 2, 2018",,"August 2, 2018","Zhognshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03611387"
48,"NCT04232462","A Multicentric Validation Study on the Accuracy of Artificial Intelligence Assisted System in Clinical Application of Digestive Endoscopy",,"Not yet recruiting","No Results Available","Gastrointestinal Disease|Endoscopy|Artificial Intelligence","Diagnostic Test: Endoscopists refer to AI for diagnosis","Accuracy|Sensitivity|Specificity|Positive Predictive Value (PPV)|Negative Predictive Value (NPV)|Receiver Operating Characteristic (ROC) Curve|Area Under the Curve (AUC)|mean Average Precision (mAP)|Sørensen-Dice coefficient (F1 score)|Recall Rate|Positive Likelihood Ratio|Negative Likelihood Ratio","Renmin Hospital of Wuhan University","All","18 Years and older   (Adult, Older Adult)",,"10000","Other","Observational","Observational Model: Other|Time Perspective: Prospective","EA-19-006","January 12, 2020","May 1, 2020","December 1, 2023","January 18, 2020",,"January 18, 2020",,,"https://ClinicalTrials.gov/show/NCT04232462"
49,"NCT03766737","Validation of the Utility of an Intelligent Visual Acuity Diagnostic System for Children",,"Completed","No Results Available","Ophthalmopathy|Artificial Intelligence","Device: An intelligent visual acuity diagnostic system for children","The proportion of accurate, mistaken and miss detection of the intelligent visual acuity diagnostic system.","Sun Yat-sen University","All","1 Month to 14 Years   (Child)","Not Applicable","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","CCPMOH2018-China-12","May 20, 2018","July 20, 2018","July 20, 2018","December 6, 2018",,"December 6, 2018","Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03766737"
50,"NCT03903042","Comparison of Aurora Fundus Camera With Traditional Camera in Diabetic Retinopathy With Visual Artificial Intelligence",,"Enrolling by invitation","No Results Available","Diabetic Retinopathy",,"Image Quality of Aurora camera|Outcome of gold standard|Image of Aurora camera|Image of traditional camera (Center 1: Canon)|Image of traditional camera (Center 2: Zeiss)|Image of traditional camera (Center 3: Topcon)|Outcome of artificial intelligence algorithm","Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","All","18 Years and older   (Adult, Older Adult)",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Shanghai1stAI","November 1, 2018","May 2019","May 2019","April 4, 2019",,"April 4, 2019","Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT03903042"
51,"NCT04313946","Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays","AI-COVID-Xr","Recruiting","No Results Available","COVID-19|Pneumonia, Viral|Influenza With Pneumonia|Flu Symptom|Flu Like Illness|Pneumonia, Interstitial|Pneumonia, Ventilator-Associated|Pneumonia Atypical","Diagnostic Test: Scanning Chest X-rays and performing AI algorithms on images","COVID-19 positive X-Rays|COVID-19 negative X-Rays","Professor Adrian Covic|Falcon Trading Iasi|Romanian Academy of Medical Sciences|Grigore T. Popa University of Medicine and Pharmacy","All","Child, Adult, Older Adult",,"200","Other","Observational","Observational Model: Ecologic or Community|Time Perspective: Prospective","0110","March 18, 2020","August 16, 2020","August 18, 2020","March 18, 2020",,"April 27, 2020","U.O. Multidisciplinare di Patologia Mammaria e Ricerca Traslazionale; Dipartimento Universitario Clinico di Scienze Mediche, Chirurgiche e della Salute Università degli Studi di Trieste, Cremona, Italy|University of Medicine and Pharmacy Gr T Popa, Iaşi, Romania|Department of Cardiology at Chelsea and Westminster NHS hospital, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04313946"
52,"NCT04040374","Artificial Intelligence Versus Expert Endoscopists for Diagnosis of Gastric Cancer",,"Completed","No Results Available","Gastric Cancer","Diagnostic Test: AI-based diagnosis|Diagnostic Test: The expert endoscopists-based diagnosis","Per patient diagnosis of gastric cancer|Number of images analyzed for diagnosis of gastric cancer|Intersection over union (IOU) of gastric lesions|Diagnosis of advanced gastric cancer|Diagnosis of early gastric cancer|Agreement on image and IOU based diagnosis of gastric cancer between AI and expert endoscopists","Tokyo University","All","20 Years and older   (Adult, Older Adult)","Not Applicable","500","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","11931-(1)","July 1, 2019","October 1, 2019","November 16, 2019","July 31, 2019",,"November 20, 2019","Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan",,"https://ClinicalTrials.gov/show/NCT04040374"
53,"NCT04384575","Study on the Effectiveness of Gastroscope Operation Quality Control Based on Artificial Intelligence Technology",,"Recruiting","No Results Available","Gastric Cancer",,"Accuracy|Sensitivity|Specificity","Peking University","All","18 Years to 75 Years   (Adult, Older Adult)",,"700","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","PX2020047","February 22, 2020","June 2020","July 2020","May 12, 2020",,"May 12, 2020","Beijing Cancer Hospital, Beijing, Haidian, China",,"https://ClinicalTrials.gov/show/NCT04384575"
54,"NCT03572699","Simple, Mobile-based Artificial Intelligence AlgoRithms in the Detection of Diabetic ReTinopathy (SMART) Study","SMART","Recruiting","No Results Available","Diabetic Retinopathy","Other: diabetic retinopathy","Sensitivity and specificity of the AI in detecting any grade of diabetic retinopathy|Sensitivity and specificity of the AI in detecting referable diabetic retinopathy (referable retinopathy defined as moderate non proliferative retinopathy or greater)|Sensitivity and specificity of the AI in detecting sight threatening diabetic retinopathy (referable retinopathy defined as severe non proliferative retinopathy or greater)","Medios Technologies Pte. Ltd|Diacon Hospital","All","18 Years and older   (Adult, Older Adult)",,"900","Industry|Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","SMART1","July 11, 2018","October 2018","October 2018","June 28, 2018",,"October 9, 2018","Diacon Hospital, Bangalore, India",,"https://ClinicalTrials.gov/show/NCT03572699"
55,"NCT04053959","Effect of Artificial Intelligence Assisted Insulin Titration System on Glucose Control in Type 2 Diabetes Mellitus Patients",,"Not yet recruiting","No Results Available","Type 2 Diabetes","Drug: AI assisted insulin system|Drug: Physician based insulin regime","Proportion of time in which the blood glucose level is well controlled|Proportion of time in which the blood glucose level is over 10 mmol/L|Proportion of time in which the blood glucose level is below 3.9 mmol/L|Total insulin dose","Shanghai Zhongshan Hospital","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 4","44","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","INCDSS","August 15, 2019","September 7, 2019","November 15, 2019","August 13, 2019",,"August 13, 2019",,,"https://ClinicalTrials.gov/show/NCT04053959"
56,"NCT04099147","Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.","NASHAI","Not yet recruiting","No Results Available","Non-alcoholic Fatty Liver Disease (NAFLD)","Other: This is an observational study.","Number of subjects diagnosed with NAFLD and NASH in the ETHON cohort after applying Artificial Intelligence algorithms|Percentage of subjects diagnosed with NAFLD and NASH in the ETHON cohort after applying Artificial Intelligence algorithms|Sensitivity in terms of NASH diagnosis of AI algorithms with respect to histologic diagnosis compared with the Hepamet non-invasive score|Specificity in terms of NASH diagnosis of AI algorithms with respect to histologic diagnosis compared with the Hepamet non-invasive score|Positive predictive value in terms of NASH diagnosis of AI algorithms with respect to histologic diagnosis compared with the Hepamet non-invasive score.|Negative predictive Value in terms of NASH diagnosis of AI algorithms with respect to histologic diagnosis compared with the Hepamet non-invasive score.|Kappa coefficient of concordance about NASH diagnosis between AI algorithms and histologic diagnosis.|Kappa coefficient of concordance about NASH diagnosis between AI algorithms and the Hepamet non-invasive score.|ROC curve at various threshold settings obtained through the algorithms for NASH diagnosis and staging","Instituto de Investigación Marqués de Valdecilla|Servicio Cántabro de Salud","All","19 Years to 74 Years   (Adult, Older Adult)",,"14046","Other","Observational","Observational Model: Cohort|Time Perspective: Other","NASHAI","September 30, 2019","September 30, 2020","December 31, 2020","September 23, 2019",,"September 23, 2019",,,"https://ClinicalTrials.gov/show/NCT04099147"
57,"NCT03911323","Real-world Diagnostic Effectiveness of Artificial Intelligence Algorithm in Diabetic Retinopathy Screening",,"Recruiting","No Results Available","Diabetic Retinopathy","Other: diabetic retinopathy","Sensitivity and specificity","Shenzhen Second People's Hospital","All","18 Years and older   (Adult, Older Adult)",,"1000","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","20190401","October 1, 2018","October 1, 2020","October 1, 2020","April 11, 2019",,"April 11, 2019","Shenzhen second peoples's hospital, Shenzhen, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03911323"
58,"NCT04154228","Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI",,"Not yet recruiting","No Results Available","Lymphoma|Non Hodgkin Lymphoma|Follicular Lymphoma","Diagnostic Test: PET/MR scan","Patients that preform 18F-FDG PET/MRI and the routinely PET/CT","Tel-Aviv Sourasky Medical Center","All","18 Years to 120 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","TASMC-19-ES-0556-CTIL","December 10, 2019","January 10, 2020","December 10, 2021","November 6, 2019",,"November 6, 2019",,,"https://ClinicalTrials.gov/show/NCT04154228"
59,"NCT04371744","QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19","QT-Logs","Completed","No Results Available","COVID-19",,"Corrected QT (QTc) interval measurement","Assistance Publique Hopitaux De Marseille","All","18 Years and older   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CIL 2020-52","April 17, 2020","June 4, 2020","June 5, 2020","May 1, 2020",,"June 9, 2020","Assistance Publique Hôpitaux de Marseille, Marseille, France",,"https://ClinicalTrials.gov/show/NCT04371744"
60,"NCT04273477","Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer","MRAI-pCR","Recruiting","No Results Available","Rectal Cancer",,"The prediction accuracy of the radiomics prediction model|The specificity of the radiomics prediction model|The sensitivity of the radiomics prediction model|The area under curve (AUC) of Receiver Operating Characteristic (ROC) curves of the radiomics prediction model","Sixth Affiliated Hospital, Sun Yat-sen University|The Third Affiliated Hospital of Kunming Medical College.|Sir Run Run Shaw Hospital","All","18 Years to 75 Years   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Other|Time Perspective: Prospective","MRILARC-pCR2020","January 10, 2020","July 2020","December 2020","February 18, 2020",,"February 18, 2020","the Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China|The Third Affiliated Hospital of Kunming Medical College, Kunming, Yunnan, China|Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04273477"
61,"NCT03602989","A Multi-center Study on the Artificial Intelligence Enabled Diabetic Retinopathy Screening Based on Fundus Images",,"Active, not recruiting","No Results Available","Diabetic Retinopathy","Device: AI-enabled Diabetic Retinopathy Screening Software","Sensitivity and specificity","Shenzhen SiBright Co., Ltd.|Zhongshan Ophthalmic Center, Sun Yat-sen University|Peking University People's Hospital|The Eye Hospital of Wenzhou Medical University","All","18 Years and older   (Adult, Older Adult)",,"1000","Industry|Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","AIDRScreening","July 5, 2018","November 30, 2018","August 31, 2019","July 27, 2018",,"May 20, 2019","Peking University People's Hospital, Beijing, Beijing, China|Zhongshan Ophthalmic Center, Guangzhou, Guangdong, China|The Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT03602989"
62,"NCT04206098","Chart Review of Patients With COPD, Using Electronic Medical Records and Artificial Intelligence","BigCOPData","Recruiting","No Results Available","Chronic Obstructive Pulmonary Disease","Other: Factors associated with Hospital admission for an Acute Exacerbation Chronic Obstructive Pulmonary Disease (AECOPD)","Number of factors associated with hospital admission of patients with AECOPD|Number of clinical characteristics of COPD hospitalized patients|Number of comorbidities of COPD patients hospitalized per sex|Number of patients with increased eosinophil blood counts|Number of patients with COPD hospitalized with elevated inflammatory parameters|Number of clinical phenotypes identified in COPD patients hospitalized|Number of COPD patients hospitalized do not follow treatment recommendations|Number of Risk on COPD patients hospitalized|Number of biologic biomarkers different to eosinophil count","Sociedad Española de Neumología y Cirugía Torácica|SAVANA|European Commission","All","35 Years to 99 Years   (Adult, Older Adult)",,"2500000","Other","Observational","Observational Model: Other|Time Perspective: Other","H2020","January 8, 2020","October 1, 2020","December 30, 2020","December 20, 2019",,"January 13, 2020","Kepler Universitäts Klinikum, Linz, Austria|Hospital Universitario de Guadalajara, Alcalá De Henares, Spain|Hospital Universitario Príncipe de Asturias, Alcalá De Henares, Spain|Hospital Universitario Vall d'Hebron, Barcelona, Spain|Hospital Universitario La Princesa, Madrid, Spain|Hospital Universitario Son Espases, Palma De Mallorca, Spain|Hospital Universitario Santiago de Compostela, Santiago De Compostela, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Hospital Arnau de Vilanova, Valencia, Spain|HUG, Geneva, Switzerland|Queen Elizabeth Hospital University, Birmingham, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04206098"
63,"NCT04358198","AI in GIM Diagnosis",,"Not yet recruiting","No Results Available","GIM Diagnosis|Artificial Intellegence","Diagnostic Test: Artificial intelligence","Accuracy of AI for GIM diagnosis","King Chulalongkorn Memorial Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","120","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","RP018","May 1, 2020","November 30, 2020","April 30, 2021","April 24, 2020",,"April 24, 2020",,,"https://ClinicalTrials.gov/show/NCT04358198"
64,"NCT03487952","Evaluation of Lung Nodule Detection With Artificial Intelligence Assisted Computed Tomography in North China",,"Not yet recruiting","No Results Available","Solitary Pulmonary Nodule|Multiple Pulmonary Nodules","Other: Questionnaire Administration","Detection rate of lung nodule|Profile of detected lung nodule|Sensitivity in the detection of clinically actionable lung nodules|Growth of lung nodule|Anxiety and depression level|Life quality and health status|Lung cancer detection rate","Peking University People's Hospital|Lu'an Municipal Hospital|North China Petroleum Bureau General Hospital","All","40 Years and older   (Adult, Older Adult)",,"5000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","NCLUNG","April 2018","December 2021","December 2021","April 4, 2018",,"April 4, 2018",,,"https://ClinicalTrials.gov/show/NCT03487952"
65,"NCT04132401","Artificial Intelligence for the Detection of Diabetic Retinopathy in Primary Care",,"Not yet recruiting","No Results Available","Diabetic Retinopathy","Diagnostic Test: algorithm","Sensitivity of the algorithm|Specificity of the algorithm|Accuracy of the algorithm|Area under the receiver operating characteristic curve of the algorithm","Jordi Gol i Gurina Foundation|OPTretina|Institut Català de la Salut|Department of Health, Generalitat de Catalunya","All","Child, Adult, Older Adult","Not Applicable","10","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility","P18/109","January 2, 2020","December 31, 2021","June 30, 2022","October 18, 2019",,"October 18, 2019",,,"https://ClinicalTrials.gov/show/NCT04132401"
66,"NCT03969056","AI Activity Study in Patients With Elevated Blood Pressure",,"Not yet recruiting","No Results Available","Hypertension","Behavioral: Artificial Intelligence (AI) Activity|Behavioral: 10,000 steps","Changes in weekly daily average steps|Duration (minutes) of moderate to vigorous intensity physical activity (MVPA) per day|Changes in Systolic blood pressure (SBP)|Changes in diastolic blood pressure (DBP)|aortic stiffness|sodium intake|Changes in weight|Changes in Body Mass Index (BMI)","University of California, San Francisco","All","18 Years and older   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","18-26452","October 10, 2020","March 2021","June 30, 2021","May 31, 2019",,"September 11, 2019","University of California San Francisco, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT03969056"
67,"NCT03731936","Artificial Intelligence to Assess the Association Between Facial Characteristics and Coronary Artery Diseases",,"Completed","No Results Available","Coronary Artery Disease","Other: No intervention","Sensitivity of diagnostic model|Specificity of diagnostic model|Positive predictive value (PPV)|Negative predictive value (NPV)|Diagnostic accuracy rate","China National Center for Cardiovascular Diseases","All","18 Years and older   (Adult, Older Adult)",,"6864","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","20181104-2017-907","July 10, 2017","August 2, 2019","August 2, 2019","November 6, 2018",,"August 20, 2019","Beijing Anzhen hospital, Beijing, Beijing, China|Fuwai hospital, Beijing, Beijing, China|Guanganmen Hospital, Chinese Academy of Traditional Chinese Medicine, Beijing, Beijing, China|Wuhan union hospital, Wuhan, Hubei, China|Xuzhou third people's hospital, Xuzhou, Jiangsu, China|The first affiliated hospital of Dalian medical university, Dalian, Liangning, China|Shanghai East hospital, Shanghai, Shanghai, China|Shanghai Renji hospital, Shanghai, Shanghai, China|The fisrt affiliated hospital of Wenzhou medical university, Wenzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT03731936"
68,"NCT03759756","Artificial Intelligence for Early Diagnosis of Esophageal Squamous Cell Carcinoma",,"Completed","No Results Available","Artificial Intelligence|Optical Enhancement Endoscopy|Magnifying Endoscopy","Other: AI presentation|Other: no AI presentation","the diagnosis efficiency of the AI model","Shandong University","All","18 Years and older   (Adult, Older Adult)",,"119","Other","Observational","Observational Model: Other|Time Perspective: Retrospective","2018SDU-QILU-2","December 1, 2018","March 1, 2020","April 1, 2020","November 30, 2018",,"April 28, 2020","Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China",,"https://ClinicalTrials.gov/show/NCT03759756"
69,"NCT03849040","The Use of Artificial Intelligence to Predict Cancerous Lymph Nodes for Lung Cancer Staging During Ultrasound Imaging",,"Completed","No Results Available","Lung Diseases|Lung Neoplasm","Procedure: Endobronchial Ultrasound","Development of computer algorithm to identify lymph node ultrasonographic features|Validation of computer algorithm to identify lymph node ultrasonographic features|Accuracy and reliability of the segmentation performed by NeuralSeg|NeuralSeg prediction of lymph node malignancy","St. Joseph's Healthcare Hamilton","All","18 Years and older   (Adult, Older Adult)",,"52","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","StJoes EBUS AI (5636)","April 8, 2019","September 23, 2019","November 20, 2019","February 21, 2019",,"March 11, 2020","St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03849040"
70,"NCT03887598","Application of Ultrasound Artificial Intelligence and Elastography in Differential Diagnosis of Breast Nodules",,"Recruiting","No Results Available","Breast Cancer","Device: Ultrasound diagnosis","Benign or malignant lesions as determined by pathology|Elastic ratio","Xin-Wu Cui|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|Taizhou Hospital|Wuhan Hospital of Traditional Chinese and Western Medicine|Macheng People's Hospital|Huangshi Central Hospital|Affiliated Hospital of Jiangsu University|The First People's Hospital of Yichang|The Second People's Hospital of Yichang|Xiangyang Central Hospital|the Second Affiliated Hospital of Anhui Medical University|Anqing People's Hospital|Huainan People's Hospital|Wenzhou Central Hospital|Xuzhou First People's Hospital|The Central Hospital of Lishui City|Huai'an First People's Hospital|WISCO General Hospital|First People's Hospital of Jiangxia District, Wuhan City|Enshi State Central Hospital|Lianyungang Third People's Hospital|Xiangyang First People's Hospital|Tongji Hospital","Female","18 Years and older   (Adult, Older Adult)",,"2000","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","2019(S073)","January 18, 2019","January 18, 2020","February 18, 2020","March 25, 2019",,"March 26, 2019","Xin-Wu Cui, Wuhan, Hubei, China",,"https://ClinicalTrials.gov/show/NCT03887598"
71,"NCT03887611","Application of Ultrasound Artificial Intelligence and Elastography in Differential Diagnosis of Thyroid Nodules",,"Recruiting","No Results Available","Thyroid Nodule","Device: Ultrasound diagnosis","Benign or malignant lesions as determined by pathology|Elastic ratio","Xin-Wu Cui|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|Wuhan Hospital of Traditional Chinese and Western Medicine|Macheng People's Hospital|Huangshi Central Hospital|Affiliated Hospital of Jiangsu University|The First People's Hospital of Yichang|The Second People's Hospital of Yichang|Xiangyang Central Hospital|the Second Affiliated Hospital of Anhui Medical University|Anqing People's Hospital|Huainan People's Hospital|Taizhou Hospital|Wenzhou Central Hospital|Xuzhou First People's Hospital|The Central Hospital of Lishui City|Huai'an First People's Hospital|WISCO General Hospital|Jiangxia District First People's Hospital|Enshi State Central Hospital|Lianyungang Third People's Hospital|Xiangyang First People's Hospital|Tongji Hospital","All","18 Years and older   (Adult, Older Adult)",,"2000","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","2019(S074)","January 18, 2019","January 18, 2020","March 18, 2020","March 25, 2019",,"March 26, 2019","Xin-Wu Cui, Wuhan, Hubei, China",,"https://ClinicalTrials.gov/show/NCT03887611"
72,"NCT03877614","Artificial Intelligence With Deep Learning and Genes on Cardiovascular Disease",,"Recruiting","No Results Available","Cardiovascular Diseases","Other: ASCVD risk score","Major cardiovascular events|Heart function changes|Lipid profiles|Arrhythmia events|Recurrent acute coronary events","National Cheng-Kung University Hospital","All","18 Years and older   (Adult, Older Adult)",,"5000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","A-ER-107-149","August 28, 2018","December 2021","June 2022","March 15, 2019",,"March 15, 2019","Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan",,"https://ClinicalTrials.gov/show/NCT03877614"
73,"NCT03397524","Tailored Drug Titration Through Artificial Intelligence","ARTERY","Withdrawn","No Results Available","Hypertension","Other: optima4BP","Reduction in systolic BP [SBP] (mmHg) measure in the office|Reduction in systolic BP [SBP] (mmHg) measure remotely [home monitoring]|Incidence of Adverse Events","Optima Integrated Health|University of California, San Francisco","All","21 Years to 80 Years   (Adult, Older Adult)","Not Applicable","0","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","17-21426","October 1, 2018","December 31, 2019","March 31, 2020","January 12, 2018",,"September 20, 2019","University of California San Francisco, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT03397524"
74,"NCT02599259","Using Artificial Intelligence to Measure and Optimize Adherence in Patients on Anticoagulation Therapy.",,"Completed","No Results Available","Stroke","Device: Monitored (M+)","To evaluate acceptability and likability of the platform to patients and providers in providing real-time adherence monitoring.|Improved self-efficacy rates as measured by the SEAMS and BMQ questionnaires, administered at baseline and at the end of the study.|Optimized treatment models based on regular monitoring of INR in desired target range of 2 - 3 and DRVVT in combination with real-time adherence data from the Automated DOT® platform|Optimized treatment models based on regular monitoring of INR and DRVVT in combination with real-time adherence data from the Automated DOT® platform.|Evaluate acceptability and utility through qualitative questionnaires.","AiCure|Montefiore Medical Center","All","18 Years and older   (Adult, Older Adult)","Not Applicable","28","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","AI-007.2","March 2015","April 2016","April 2016","November 6, 2015",,"July 12, 2016","Montefiore Medical Center, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT02599259"
75,"NCT04304742","Radiologist Diagnostic Performance Versus Artificial Intelligence (AI)","RAVIA","Recruiting","No Results Available","Painful Hip|Fonctional Impotence After Minor Trauma (Fall)","Procedure: hip standard radiography/ CT scan/ MRI","Detection rate of femoral neck fracture|Detection rate of other hip fracture","University Hospital, Montpellier","All","60 Years and older   (Adult, Older Adult)",,"1000","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","RECHMPL20_0126","April 1, 2020","April 1, 2021","October 30, 2021","March 11, 2020",,"June 5, 2020","Uhmontpellier, Montpellier, France",,"https://ClinicalTrials.gov/show/NCT04304742"
76,"NCT03761771","Artificial Intelligence Identifying Polyps in Real-world Colonoscopy",,"Completed","No Results Available","Sensitivity of the ADS in Identifying Polyps in Real-world Colonoscopy|Mean Number of Polyps Per Colonoscopy for Colonoscopists and Colonoscopists + ADS","Device: colonoscopy withdrawal with the ADS monitoring","sensitivity of the ADS in identifying polyps|false positves of the ADS per colonoscopy withdrawal","Zhaoshen Li|Changhai Hospital","All","18 Years to 75 Years   (Adult, Older Adult)",,"209","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","AI-1","November 1, 2018","December 10, 2018","December 10, 2018","December 3, 2018",,"December 17, 2018","Changhai Hospital, Second Military Medical University, Shanghai, China|Changhai Hospital, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT03761771"
77,"NCT03912961","The Santa Cruz Diabetic Retinopathy Utilizing Artificial Intelligence Study","SC-DRAI","Completed","No Results Available","Diabetic Retinopathy","Other: Picture of the retina with a handheld retinal camera","Number of subjects where the image readout by retina specialists match the readouts by EyeStar AI system for identifying diabetic eye disease|Number of subjects with gradable images taken by the hand held camera|Number of subjects with ocular diseases other than diabetic retinopathy between the readout by the EyeStar AI system and those by the retina specialists","Retina Global|VisionQuest Biomedical LLC","All","18 Years and older   (Adult, Older Adult)",,"1034","Other|Industry","Observational","Observational Model: Case-Only|Time Perspective: Prospective","2019-BOL-SC-DRAI","January 21, 2019","April 14, 2019","October 15, 2019","April 11, 2019",,"June 5, 2020","Centro Medico Kolping, Santa Cruz de la Sierra, Bolivia|Clinica Incor, Santa Cruz de la Sierra, Bolivia|Hospital Universitario Japones, Santa Cruz de la Sierra, Bolivia",,"https://ClinicalTrials.gov/show/NCT03912961"
78,"NCT03708978","Development of Artificial Intelligence System for Detection and Diagnosis of Breast Lesion Using Mammography",,"Active, not recruiting","No Results Available","Women With Breast Cancer","Diagnostic Test: mammography","benign-malignant diagnosis accuracy|lesion detection accuracy","Beijing Cancer Hospital|Peking University","Female","18 Years and older   (Adult, Older Adult)",,"10000","Other","Observational","Observational Model: Cohort|Time Perspective: Other","BCA-AI","April 5, 2018","June 30, 2020","November 30, 2020","October 17, 2018",,"November 27, 2019","Beijing Cancer Hospital, Beijing, Beijing, China|Beijing Chao Yang Women and Children's Health Hospital, Beijing, Beijing, China|Beijing Da Xing People's Hospital, Beijing, Beijing, China|Beijing Hang Tian Centre Hospital, Beijing, Beijing, China|Beijing Nan Jiao Cancer Hospital, Beijing, Beijing, China|Beijing Shi Jing Shan Hospital, Beijing, Beijing, China|Beijing Shun Yi Qu Hospital, Beijing, Beijing, China|Beijing Shun Yi Woman and Children Health Hospital, Beijing, Beijing, China",,"https://ClinicalTrials.gov/show/NCT03708978"
79,"NCT03452774","SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry",,"Recruiting","No Results Available","Cancer, Metastatic|Cancer|Cancer of Pancreas|Cancer of Liver|Cancer of Stomach|Cancer Liver|Cancer of Rectum|Cancer of Kidney|Cancer of Esophagus|Cancer of Cervix|Cancer of Colon|Cancer of Larynx|Cancer, Lung|Cancer, Breast|Cancer, Advanced|Cancer Prostate|Cancer of Neck|Cancer of Skin|Neuroendocrine Tumors|Carcinoma|Mismatch Repair Deficiency|BRCA Gene Rearrangement|Non Hodgkin Lymphoma|Leukemia|Non Small Cell Lung Cancer|Cholangiocarcinoma|Glioblastoma|Central Nervous System Tumor|Melanoma|Urothelial Carcinoma|Bladder Cancer|Ovarian Cancer|Endometrial Cancer|Testicular Cancer|Breast Cancer|COVID","Other: Clinical Trial Matching","Proportion of patients Eligible for CTE versus Actual CTE|Impact of CTE on Overall Survival (OS), estimated by Kaplan-Meier and Cox multivariable survival analysis|Impact of CTE on Progression-Free Survival (PFS), estimated by Kaplan-Meier and Cox multivariable survival analysis|Identification of Barriers to CTE|Real World Data Analytics|Virtual Tumor Board Utilization|Time from Intervention to Actual CTE (months)","Massive Bio, Inc.","All","Child, Adult, Older Adult",,"1500","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","SYNERGY-AI","January 1, 2018","December 2021","December 2022","March 2, 2018",,"April 28, 2020","Massive Bio, Inc, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03452774"
80,"NCT02464449","Patient-Centered Pain Care Using Artificial Intelligence and Mobile Health Tools","REACT (AI CBT)","Completed","No Results Available","Back Pain","Behavioral: Behavioral: AI-CBT|Behavioral: Behavioral: Standard Telephone CBT","pain-related disability|global pain intensity|Pain-Related Interference|depression symptom severity","VA Office of Research and Development","All","18 Years and older   (Adult, Older Adult)","Not Applicable","278","U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","IIR 13-350","July 24, 2017","April 30, 2020","April 30, 2020","June 8, 2015",,"May 15, 2020","VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven, Connecticut, United States|VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT02464449"
81,"NCT02243670","Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy",,"Completed","No Results Available","Opiate Addiction|Medication Non-adherence|Addiction|Opioid Dependence","Device: AiCure monitoring and intervention","To evaluate the feasibility and acceptability to participants and study staff in using AiCure to monitor medication adherence.|To evaluate the acceptability of using AiCure to optimize care pathways.|To measure the reliability and validity of AiCure in detecting interruptions in treatment.|The degree of participant maximum craving (during the 24 hour period prior to the study visit) for opioids as measured by the Brief Substance Craving Scale (BSCS).|The change in participant's psychosocial well being over time as measured by the seven subscales of the Addiction Severity Index (ASI).","AiCure|Orexo AB|Montefiore Medical Center","All","18 Years and older   (Adult, Older Adult)","Not Applicable","9","Industry|Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","AIC-HHSN271201300036C-01|HHSN271201300036C","August 2016","March 2017","March 2017","September 18, 2014",,"September 12, 2017","Montefiore Medical Center, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT02243670"
82,"NCT04268719","Near Focus NBI-Driven Artificial Intelligence for the Diagnosis of Gastro-Oesophageal Reflux Disease",,"Completed","No Results Available","Gastro Esophageal Reflux","Diagnostic Test: wireless pH capsule recording","To evaluate Intra-Papillary Capillary Loop (IPCL) changes secondary to oesophageal acid exposure.|To develop an accurate and reliable artificial intelligence model for the diagnosis of Gastro-Oesophageal Reflux Disease (GORD)|To explore factors that may predict response to treatment.","King's College Hospital NHS Trust","All","18 Years to 90 Years   (Adult, Older Adult)",,"76","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","227223","November 23, 2017","July 26, 2018","November 30, 2018","February 13, 2020",,"February 13, 2020","Shraddha Gulati, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04268719"
83,"NCT03973762","A Blinded, Self-control Trial to Evaluate an Artificial Intelligence Based CAD System for Diabetic Retinography",,"Recruiting","No Results Available","Diabetic Retinopathy","Device: DR Grading with CAD|Other: DR Grading by expert panel","Se and Sp under investigation target 3|Se and Sp under investigation target 1/2/4/5","Peking Union Medical College Hospital|Peking University People's Hospital|Beijing Tongren Hospital|Chinese PLA General Hospital","All","Child, Adult, Older Adult","Not Applicable","1080","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Diagnostic","GTR201-Clinical","May 31, 2019","August 15, 2020","August 15, 2020","June 4, 2019",,"April 20, 2020","Peking Union Medical College Hospital, Peking, Beijing, China",,"https://ClinicalTrials.gov/show/NCT03973762"
84,"NCT03843164","Lung Nodule Characterization by Artificial Intelligence Techniques","CARANOD-IA","Recruiting","No Results Available","Incidental Lung Nodule",,"Evaluate the performances of a novel tool based on radiomics to characterize incidental lung nodules, discovered on computed tomography.","University Hospital, Strasbourg, France","All","18 Years and older   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","7311","March 12, 2019","March 2021","March 2021","February 15, 2019",,"April 4, 2019","Service de Radiologie B - NHC, Strasbourg, France",,"https://ClinicalTrials.gov/show/NCT03843164"
85,"NCT03919370","Detection of Cerebral Ischemia With Artificial Intelligence.","TROT","Not yet recruiting","No Results Available","Ischemia, Cerebral|Ischemic Stroke|Artery Occlusion|Artery Carotid Stenosi","Other: No intervention","Heart Rate variability|Near infrared spectroscopy","Linda Block|Göteborg University|Sahlgrenska University Hospital, Sweden","All","18 Years to 100 Years   (Adult, Older Adult)",,"10","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Detection of cerebral ischemia","December 2019","December 2020","December 2022","April 18, 2019",,"September 20, 2019",,,"https://ClinicalTrials.gov/show/NCT03919370"
86,"NCT04011761","Effects of Expert Arbitration on Clinical Outcomes When Disputes Over Diagnosis Arise Between Physicians and Their Artificial Intelligence Counterparts: a Randomized, Multicenter Trial in Pediatric Outpatients",,"Not yet recruiting","No Results Available","Pediatric Outpatients Encountered in Three Specialty Clinics, i.e. Respirology, Gastroenterology, and Genito-urology","Other: expert arbitration over discordant diagnoses made by AI diagnostic system and human doctors, respectively","Hospital revisit|Hospitalization in the next 3 months after the initial visit|Average total outpatient cost|Accuracy rate of AI-based diagnosis and accuracy rate of the diagnoses made by pediatricians, using the diagnoses made by the expert arbitrator as the decisive diagnoses.|Counseling time spent with each patient","Guangzhou Women and Children's Medical Center","All","up to 18 Years   (Child, Adult)","Not Applicable","10000","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","aiwcmc","November 1, 2019","October 31, 2020","April 30, 2021","July 8, 2019",,"July 8, 2019","Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT04011761"
87,"NCT03125837","Establishment of Airway Database for Surgical Patients",,"Not yet recruiting","No Results Available","Difficult Airway|Artificial Intelligence",,"the sensitivity of artificial Intelligence to predict difficulty of facemask ventilation and endotracheal intubation","Second Affiliated Hospital, School of Medicine, Zhejiang University|Zhejiang University","All","18 Years and older   (Adult, Older Adult)",,"50000","Other","Observational","Observational Model: Other|Time Perspective: Prospective","2016-076","May 2017","May 2022","May 2022","April 24, 2017",,"April 24, 2017",,,"https://ClinicalTrials.gov/show/NCT03125837"
88,"NCT03829423","An Enhanced Artificial Intelligence Breast MRI Interpretation System","IntelliScan","Not yet recruiting","No Results Available","Breast Cancer","Diagnostic Test: Breast MRI interpretation","Sensitivity/specificity of breast interpretation algorithm|Time required for diagnosis|User-friendliness of IntelliScan system","Jamil Kanfoud|Brunel University London|First Option Software Ltd.|Teesside University","Female","20 Years and older   (Adult, Older Adult)","Not Applicable","1526","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Care Provider)|Primary Purpose: Diagnostic","4901","April 2019","January 2020","July 2020","February 4, 2019",,"February 6, 2019",,,"https://ClinicalTrials.gov/show/NCT03829423"
89,"NCT04208971","Batch Enrollment for AI-Guided Intervention to Lower Neurologic Events in Unrecognized AF",,"Not yet recruiting","No Results Available","Atrial Fibrillation","Other: AI-enabled ECG-based Screening Tool for AF","Diagnosis of Atrial Fibrillation as Detected by Patch Application","Mayo Clinic","All","18 Years and older   (Adult, Older Adult)","Not Applicable","1000","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening","19-012411","October 2020","October 2021","October 2022","December 23, 2019",,"December 23, 2019",,,"https://ClinicalTrials.gov/show/NCT04208971"
90,"NCT02454660","Improving Adherence and Outcomes by Artificial Intelligence-Adapted Text Messages","AIM@BP","Completed","No Results Available","Medication Non-adherence","Behavioral: SMS (Text messages)","Medication Adherence (Proportion Days Covered (PDC)) assessed by administrative insurance records|Self-reported medication adherence assessed via a questionnaire|Pill bottle openings (how often medication was taken) assessed by records from pill bottle caps (MEMS readers)|Medication Beliefs assessed via a questionnaire","University of Michigan|Agency for Healthcare Research and Quality (AHRQ)","All","21 Years and older   (Adult, Older Adult)","Not Applicable","49","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention","1R21HS022336-01A1","May 2015","November 4, 2016","November 4, 2016","May 27, 2015",,"April 11, 2017","University of Michigan College of Pharmacy, Ann Arbor, Michigan, United States|Spectrum Health, Grand Rapids, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT02454660"
91,"NCT03874702","Automated Diagnosis of Stroke in Computed Tomography With the Use of Artificial Intelligence",,"Enrolling by invitation","No Results Available","Stroke|Ischemic Stroke",,"Alberta Stroke Program Early Computed Tomography Score","University of Guadalajara","All","18 Years and older   (Adult, Older Adult)",,"350","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","UGuadalajara","August 15, 2019","June 1, 2022","June 1, 2022","March 14, 2019",,"September 25, 2019","Departamento de neurociencias, Guadalajara, Jalisco, Mexico",,"https://ClinicalTrials.gov/show/NCT03874702"
92,"NCT04142879","Automated Detection and Triage of Large Vessel Occlusions Using Artificial Intelligence for Early and Rapid Treatment (ALERT)","ALERT","Not yet recruiting","No Results Available","Stroke Workflow and Clinical Outcome Parameters","Device: Viz Device Software","Non-Interventional Centers|Interventional Centers|Workflow Endpoints","Providence Little Company of Mary-Torrance|Viz.ai, Inc.","All","18 Years and older   (Adult, Older Adult)",,"500","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","ALERT-VIZ-LVO-02","December 1, 2019","December 31, 2020","December 31, 2021","October 29, 2019",,"October 29, 2019","Providence Little Company of Mary Medical Center-Torrance, Torrance, California, United States",,"https://ClinicalTrials.gov/show/NCT04142879"
93,"NCT04016987","Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes",,"Not yet recruiting","No Results Available","Type 1 Diabetes","Behavioral: Automated structured education intervention based on an app and artificial intelligence","changes in serum hemoglobin A1c level|changes in Time in range (TIR)|Chinese version of Diabetes Quality of Life scale|Diabetes Self-Management Scale|Chinese version of Diabetes Self-Care Activities|Diabetes Empowerment Scale-Short Form|State-Trait Anxiety Inventory (STAI)|Beck's Depression Inventory (BDI)|Fasting blood glucose|Systolic blood pressure|Diastolic blood pressure|Total cholesterol|High-density lipoprotein (HDL) cholesterol|Low-density lipoprotein (LDL) cholesterol|Triglycerides|Height in meters|Weight in kilograms|Patients engagement with the app|Adverse events","Second Xiangya Hospital of Central South University","All","18 Years to 50 Years   (Adult)","Not Applicable","138","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","AI App-EC T1D 2019","November 2019","November 2021","November 2023","July 12, 2019",,"October 30, 2019",,,"https://ClinicalTrials.gov/show/NCT04016987"
94,"NCT03976297","Artificial Intelligence/Machine Learning Modeling on Time to Palliative Care Review in an Inpatient Hospital Population",,"Recruiting","No Results Available","Palliative Care","Other: Control Tower","Timely identification for need of palliative care|The number of inpatient palliative care consults|Timely identification for need of palliative care per unit|Transition time to hospice-designated bed|Time to hospice designation|Emergency Department visit within 30 days of discharge|Hospitalization or readmission within 30 days of discharge|ICU transfers|Ratio of inpatient hospice death to non-hospice hospital deaths|Rate of discharge to external hospice|Inpatient length of stay","Mayo Clinic","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20000","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","19-002315","August 19, 2019","August 19, 2020","October 2020","June 6, 2019",,"August 28, 2019","Mayo Clinic, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03976297"
95,"NCT03499145","Validation of the Utility of Ophthalmology Intelligent Diagnostic System",,"Completed","No Results Available","Ophthalmopathy|Artificial Intelligence","Device: Ophthalmology diagnostic system.","The proportion of accurate, mistaken and miss detection of the ophthalmology diagnostic system.","Sun Yat-sen University|Ministry of Health, China|Xidian University","All","Child, Adult, Older Adult",,"615","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CCPMOH2018-China-2","April 1, 2018","August 31, 2019","August 31, 2019","April 17, 2018",,"October 21, 2019","Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03499145"
96,"NCT04307030","Study on AI Recognition System Of Heart Sound In Congenital Heart Disease Screening",,"Not yet recruiting","No Results Available","Congenital Heart Disease in Children","Diagnostic Test: Heart Auscultation and Echocardiography","Receiver operating characteristic (ROC) of sensitivity","Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","All","up to 18 Years   (Child, Adult)",,"5000","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","XH-20-003","July 1, 2020","December 31, 2021","June 30, 2023","March 13, 2020",,"March 13, 2020","Bijie First Municipal Hospital, Bijie, China|Children's Hospital Affiliated to Chongqing Medical University, Chongqing, China|Children's Hospital Affiliated to Zhejiang Medical University, Hangzhou, China|Shandong Provincial Hospital, Jinan, China|Linhai Hospital for Women and Children, Linhai, China|Linyi Hospital for Women and Children, Linyi, China|Shanghai Children's Medical Center, Shanghai, China|Shiyan Taihe Hospital, Shiyan, China|The Second Hospital Affiliated to Wenzhou Medical University, Wenzhou, China",,"https://ClinicalTrials.gov/show/NCT04307030"
97,"NCT04278274","Post-Neoadjuvant Treatment MRI Based AI System to Predict pCR for Rectal Cancer","MR-AI-pCR","Recruiting","No Results Available","Rectal Cancer","Procedure: the artificial intelligence|Procedure: the radiologists","The prediction accuracy of AI prediction system and expert radiologists in prediction tumor response|The specificity of AI prediction system and expert radiologists in prediction tumor response|The sensitivity of AI prediction system and expert radiologists in prediction tumor response|The area under curve (AUC) of Receiver Operating Characteristic (ROC) curves of AI prediction system and expert radiologists in prediction tumor response","Sixth Affiliated Hospital, Sun Yat-sen University|Sir Run Run Shaw Hospital|The Third Affiliated Hospital of Kunming Medical College.","All","18 Years to 75 Years   (Adult, Older Adult)",,"322","Other","Observational","Observational Model: Other|Time Perspective: Prospective","MR-AI-pCR 2020","January 8, 2020","August 8, 2020","December 8, 2020","February 20, 2020",,"February 20, 2020","the Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China|The Third Affiliated Hospital of Kunming Medical College, Kunming, Yunnan, China|Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04278274"
98,"NCT04319055","AI-Assisted Facial Surgical Planning",,"Completed","No Results Available","Facial Plastic and Reconstructive Surgery|Periocular Diseases|Orbital Diseases|Artificial Intelligence",,"The model performance is evaluated by accuracy|AUC (Area Under the Curve)|ROC (Receiver Operating Characteristics) curve.|An Artificial Intelligence Approach to Identifying Facial, Periocular, and Orbital Diseases","National Taiwan University Hospital|Stanford University","All","20 Years to 65 Years   (Adult, Older Adult)",,"17932","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","201908066RIND","January 1, 2009","December 31, 2018","July 30, 2019","March 24, 2020",,"March 24, 2020","National Taiwan University Hospital, Taipei, Taiwan",,"https://ClinicalTrials.gov/show/NCT04319055"
99,"NCT04455568","Establish a Telecare Model of Acute Coronary Syndrome Patient With Heart Stent Implantation by a Non-invasive Wearable Device and Artificial Intelligence Cloud to Reducing Medical Adverse Events.",,"Not yet recruiting","No Results Available","Acute Coronary Syndrome|Percutaneous Transluminal Coronary Angioplasty","Device: use EKG Wisdom bracelet","death|Restenosis|heart failure|heart disease re-hospitalization|Stroke re-hospitalization|Arrhythmia re-hospitalization|Physician adjusts medicine|Physician arranges examination early|Medical Compliance|Medical Costs","Taipei Medical University Shuang Ho Hospital|Taipei Medical University WanFang Hospital|Taipei Medical University Hospital|Taipei Medical University|Lotung Poh-Ai Hospital","All","20 Years and older   (Adult, Older Adult)",,"400","Other","Observational","Observational Model: Other|Time Perspective: Prospective","N202004123","July 1, 2020","July 1, 2022","July 1, 2024","July 2, 2020",,"July 2, 2020",,,"https://ClinicalTrials.gov/show/NCT04455568"
100,"NCT03274908","Real-world Clinical Study and Medical Machine Intelligence Study for Traditional Chinese Internal Medicine",,"Recruiting","No Results Available","Internal Disorders","Other: regular medical treatment","internal diseases","Shanghai Tongji Hospital, Tongji University School of Medicine|Huashan Hospital|Puer Hospital of Chinese Medicine|Dangyang Hospital of Chinese Medicine|Changde Hospital affiliated to Hunan University of Chinese Medicine|Ruikang Hospital affiliated to Guanxi University of Chinese Medicine|Shandong Jining No.1 People's Hospital|People's Hospital of Dangyang","All","20 Years to 100 Years   (Adult, Older Adult)",,"2000000","Other","Observational","Observational Model: Case-Only|Time Perspective: Other","20170906","April 1, 2017","December 30, 2020","December 30, 2022","September 7, 2017",,"March 20, 2019","Huasha Hospital, Shanghai, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT03274908"
101,"NCT04354675","Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer",,"Not yet recruiting","No Results Available","Breast Cancer","Genetic: Automated program (ChatBot)|Genetic: Genetics counselor|Other: BCGCKQ Survey|Other: Satisfaction Survey|Genetic: Genetic testing","Percent of participants who took up genetic testing after not meeting NCCN guidelines for genetic testing|Mean overall patient satisfaction with decision about genetic testing: survey|Overall comprehension as assessed by BCGCKQ|Percentage of overall cohort with mutation|Number of patients who decline genetic testing|Frequencies of most common reasons for not pursuing genetic testing|Time to treatment","Case Comprehensive Cancer Center","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening","CASE12119","July 7, 2020","January 1, 2023","January 1, 2024","April 21, 2020",,"April 21, 2020","Cleveland Clinic, Cleveland, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT04354675"
102,"NCT03753724","IDEAL: Artificial Intelligence and Big Data for Early Lung Cancer Diagnosis Study","IDEAL","Recruiting","No Results Available","Pulmonary Nodule, Solitary|Pulmonary Nodule, Multiple|Lung Cancer",,"The overall diagnostic performance of a new computer aided prediction (CAP) model for malignancy in small pulmonary nodules (% diagnostic accuracy).|The health economic benefits of the CAP model.|The diagnostic performance of the CAP model for malignancy in small pulmonary nodules at a specific operating point relevant to clinical practice.","University of Oxford|Optellum Ltd.","All","18 Years and older   (Adult, Older Adult)",,"1050","Other","Observational","Observational Model: Other|Time Perspective: Prospective","13489","August 29, 2018","September 1, 2019","September 1, 2020","November 27, 2018",,"November 27, 2018","Royal Berkshire Nhs Foundation Trust, Reading, Berkshire, United Kingdom|Nottingham University Hospitals Nhs Trust, Nottingham, Nottinghamshire, United Kingdom|Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom|Leeds Teaching Hospitals Nhs Trust, Leeds, West Yorkshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03753724"
103,"NCT04326413","Artificial Intelligence Evaluation of Periodontal Health Using Selfie Intraoral Photography",,"Not yet recruiting","No Results Available","Gingivitis","Procedure: Oral hygiene instruction and simple scaling","Clinical gingival inflammation at 3 month|Photographic gingival inflammation at 3 month|Photographic gingival inflammation at baseline|Clinical gingival inflammation at baseline|Patient reported outcome on the use of smartphone selfie","The University of Hong Kong","All","18 Years and older   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","HKWC-2019-0666","January 1, 2021","December 31, 2022","June 30, 2023","March 30, 2020",,"March 31, 2020","Prince Philip Dental Hospital, Sai Ying Pun, Hong Kong",,"https://ClinicalTrials.gov/show/NCT04326413"
104,"NCT04220424","Glioma Patients Registry Based on Radiological, Histopathological and Genetic Analysis",,"Recruiting","No Results Available","Glioma","Diagnostic Test: MR and Histopathology images based prediction of molecular pathology and patient survival","AUC of Prediction performance","The First Affiliated Hospital of Zhengzhou University|Sun Yat-sen University","All","1 Year to 95 Years   (Child, Adult, Older Adult)",,"500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","GliomaAI-6","November 1, 2018","January 1, 2021","March 1, 2021","January 7, 2020",,"January 7, 2020","Department of Neurosurgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China",,"https://ClinicalTrials.gov/show/NCT04220424"
105,"NCT03401931","Artificial Intelligence Use for the Detection of Atrial Fibrillation Drivers","AI Fib","Withdrawn","No Results Available","Fibrillation, Atrial|To Evaluate the Intraoperative Efficiency of the AIFIB Software in the Detection of Atrial Fibrillation Driver During an Ablation Procedure",,"AF termination|AT termination","Hospital St. Joseph, Marseille, France","All","18 Years and older   (Adult, Older Adult)",,"0","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","HSJ_AIFIB_2017","January 9, 2018","January 9, 2018","January 9, 2018","January 17, 2018",,"April 28, 2020","Hopital d'Aix en Provence, Aix-en-Provence, France|CHU Nice, Nice, France|Isala Hospital, Zwolle, Netherland, Netherlands",,"https://ClinicalTrials.gov/show/NCT03401931"
106,"NCT03556813","Artificial Intelligence vs Physicians for Breast Cancer Patients' Information",,"Completed","No Results Available","Breast Cancer","Other: survey","Quality of Patient information","Wefight","Female","18 Years and older   (Adult, Older Adult)",,"150","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","INCASE0518","November 1, 2018","December 1, 2018","January 20, 2019","June 14, 2018",,"April 25, 2019","Wefight, Montpellier, France",,"https://ClinicalTrials.gov/show/NCT03556813"
107,"NCT02697578","Artificial Intelligence: a New Alternative to Analyse CKD-MBD in Hemodialysis",,"Completed","No Results Available","Chronic Kidney Disease Mineral and Bone Disorder",,"Change from Baseline Fibroblast growth factor 23 (pg/ml) at 24 months","Maimónides Biomedical Research Institute of Córdoba","All","18 Years to 90 Years   (Adult, Older Adult)",,"197","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","PI-0311-2014","February 1, 2016","December 19, 2018","December 19, 2018","March 3, 2016",,"December 21, 2018","Hospital Universitario Reina Sofía, Córdoba, Spain",,"https://ClinicalTrials.gov/show/NCT02697578"
108,"NCT04223934","Tailored Drug Titration Using Artificial Intelligence",,"Recruiting","No Results Available","Hypertension","Other: optima4BP","Reduction in systolic BP [SBP] (mmHg) measured remotely [Time frame: 0 - 6 months]|Incidence of Adverse Events [Time Frame: full 12 months]|Sustained remote SBP Target during observational period [Time Frame: 6 - 12 months (end of study)]","Optima Integrated Health|University of California, San Francisco","All","21 Years to 80 Years   (Adult, Older Adult)","Not Applicable","300","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","O4BP-001","February 18, 2020","September 30, 2021","March 31, 2022","January 13, 2020",,"June 9, 2020","University of California San Francisco, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT04223934"
109,"NCT04058379","Artificial Intelligence Analysis of Initial Scan Evolution of Traumatic Brain Injured Patient to Predict Neurological Outcome","RADIOMIC-TBI","Recruiting","No Results Available","Trauma, Brain","Radiation: CT scan","Clinical evolution during first 7 days in ICU with therapeutic intensity level (TILsum)|Mortality according to scan profiles|Morbidity (consequences of the trauma) according to scan profiles|Comparison and Description of correlation between early scan profiles evolution signature by AI and to clinical evolution (with TILSum)|Neurological Pupil Index","University Hospital, Grenoble","All","18 Years and older   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","38RC19.193","January 1, 2020","October 1, 2020","April 1, 2021","August 15, 2019",,"March 25, 2020","University Hospital Grenoble, Grenoble, France",,"https://ClinicalTrials.gov/show/NCT04058379"
110,"NCT02801877","IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for Depression","AIM","Completed","Has Results","Depression|Anxiety","Behavioral: IntelliCare|Behavioral: Hub App with the Recommender System|Behavioral: Coaching","Adherence to the Mobile Application Intervention|Patient Health Questionnaire - 9 (PHQ-9) - Depression Severity|GAD-7 (Generalized Anxiety Disorder Scale-7) - Anxiety Severity","Northwestern University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","301","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","R01MH100482-01-RCTIC|R01MH100482-01","July 2016","January 2018","January 2018","June 16, 2016","May 31, 2019","March 2, 2020","Northwestern University, Chicago, Illinois, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/77/NCT02801877/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02801877"
111,"NCT02176226","IntelliCare: Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM)",,"Completed","Has Results","Major Depressive Disorder|Anxiety Disorders","Behavioral: IntelliCare","Patient Health Questionnaire - 9 (PHQ-9) - Depression Severity Module|GAD-7 (Generalized Anxiety Disorder Scale-7)|Mean Number of Treatment App Use Sessions by Study Week","Northwestern University","All","19 Years and older   (Adult, Older Adult)","Not Applicable","105","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","R01MH100482-01FTIC","March 2015","June 2016","June 2016","June 27, 2014","October 29, 2018","October 29, 2018","Northwestern University, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT02176226"
112,"NCT04000087","ECG AI-Guided Screening for Low Ejection Fraction","EAGLE","Active, not recruiting","No Results Available","Asymptomatic Left Ventricular Systolic Dysfunction (Disorder)|Heart Failure","Other: AI-enabled ECG-based Screening Tool","New Diagnosis of Low Ejection Fraction (defined as ejection fraction <40%)","Mayo Clinic","All","18 Years and older   (Adult, Older Adult)","Not Applicable","358","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening","19-003137","June 26, 2019","March 31, 2020","November 1, 2020","June 27, 2019",,"May 13, 2020","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT04000087"
113,"NCT04325815","CADDIE Trial - Computer Aided Diagnosis and Detection for Intelligent Endoscopy","CADDIE","Not yet recruiting","No Results Available","Polyps|Adenoma Colon|Colorectal Polyp|Colon Polyp","Device: CADDIE- Computer Aided (AI) Device used in Endoscopy","To evaluate whether using the CADDIE system improves endoscopist detection of adenomas during colonoscopy.|Evaluate the difference in number of adenomas detected per colonoscopy between intervention and non-intervention arm|To determine whether the CADDIE artificial intelligence system improves endoscopic detection of all polyps during colonoscopy|Compare the accuracy of endoscopist optical diagnosis of diminutive polyps when using the CADDIE system (intervention arm) compared to without the CADDIE system (control arm)|Compare the accuracy of endoscopist optical diagnosis to assign colonoscopy surveillance intervals when using the CADDIE system (intervention arm) compared to without the CADDIE system (control arm)|Compare the accuracy of endoscopist optical diagnosis of diminutive rectal polyps when using the CADDIE system (intervention arm) compared to without the CADDIE system (control arm)|Evaluate the safety of the CADDIE by recording occurrence and severity of adverse events.|Assess integration of CADDIE into normal colonoscopy clinical workflow.","University College, London","All","18 Years and older   (Adult, Older Adult)",,"654","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","UCL/12/6166","May 2020","May 2023","May 2023","March 30, 2020",,"March 30, 2020",,,"https://ClinicalTrials.gov/show/NCT04325815"
114,"NCT03868813","An Artificial Intelligence Assisted Telehealth Intervention to Promote Self-Management in Patients With Type 2 Diabetes Mellitus (Qualitative Interview)",,"Recruiting","No Results Available","Diabetes Mellitus","Behavioral: Semi-structured Interview","Users' Expectation from a Health Coaching System","University of Alabama at Birmingham","All","18 Years to 80 Years   (Adult, Older Adult)",,"20","Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","UAB-DRC-2019-1","July 1, 2019","July 2020","July 2020","March 11, 2019",,"July 9, 2019","University of Alabama at Birmingham, Birmingham, Alabama, United States",,"https://ClinicalTrials.gov/show/NCT03868813"
115,"NCT04017351","Virtual Assistant for Plastic Surgery Patients",,"Recruiting","No Results Available","Surgery","Other: Artificial Intelligence Virtual Assistant","Number of phone calls|Duration of phone call|Nature of phone call","Mayo Clinic","All","18 Years and older   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","19-001980","April 10, 2020","September 1, 2022","September 1, 2023","July 12, 2019",,"April 13, 2020","Mayo Clinic in Florida, Jacksonville, Florida, United States",,"https://ClinicalTrials.gov/show/NCT04017351"
116,"NCT03214627","Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial","ANEMEX","Terminated","No Results Available","Anemia|End Stage Renal Disease","Device: Anemia Control Model (ACM)|Drug: IV iron|Drug: Erythropoiesis-Stimulating Agent (ESA)","Change in the proportion of patients with haemoglobin within the target range as compared to the historical control period (non-inferiority testing)|Change in the proportion of patients with haemoglobin within the target range as compared to historical control period (superiority testing)|Change in haemoglobin fluctuations as compared to historical control period|Change in cumulative ESA dose as compared to historical control period|Change in cumulative IV iron dose as compared to historical control period","Vifor Fresenius Medical Care Renal Pharma|Worldwide Clinical Trials|Fresenius Medical Care Deutschland GmbH","All","19 Years to 90 Years   (Adult, Older Adult)","Not Applicable","88","Industry|Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","VEN-DEV-401","December 10, 2018","May 21, 2019","May 21, 2019","July 11, 2017",,"January 7, 2020","Kings College Hospital, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03214627"
117,"NCT04418245","CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis","COVID 19-IA","Active, not recruiting","No Results Available","Covid-19","Diagnostic Test: Imaging by thoracic scanner","Vital status|Patient requiring more than 3 liters of oxygen to maintain a saturation >95% (intensive care unit or resuscitation department)|Percentage of lung affected on CT|Percentage of lung affected by ground glass opacity on scan|Percentage of lung affected by condensation on scan|Length of hospitalization|rehospitalization|Duration of intubation|Software operating time|C-reactive protein levels|lactate dehydrogenase|lymphocytemia|D Dimers level|Time until onset of symptoms|Time between RT-PCR positive results and first scan|Age|BMI> 30|Medical history of cardiovascular disease|Diabetes|Medical history of respiratory disease|Medical history of immunosuppressed condition|Current or previous history of smoking|Calculate a prognostic score from clinical, biological and CT parameters|Calculate a prognostic score from clinical and biological parameters only|Compare receiver operating curves of prognostic scores with and without CT parameters","Centre Hospitalier Universitaire de Nīmes","All","Child, Adult, Older Adult",,"1000","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","NIMAO/2020/COVID 19-IA/JF-01","March 1, 2020","June 2020","July 2020","June 5, 2020",,"June 5, 2020","CHU la Timone, Marseille, France|CHU Montpellier, Montpellier, France|CHU de Nimes, Nîmes, France|CHU Poitiers, Poitiers, France|CHU Strasbourg, Strasbourg, France|CHU Martinique, Fort-de-France, Martinique",,"https://ClinicalTrials.gov/show/NCT04418245"
118,"NCT04156880","Artificial Intelligence in Mammography-Based Breast Cancer Screening",,"Not yet recruiting","No Results Available","Breast Cancer","Other: mammography","area under curve (AUC)|accuracy|sensitivity|specificity","Chinese University of Hong Kong|IBM China/Hong Kong Limited","Female","Child, Adult, Older Adult",,"1000","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","NTEC-2019-0655","June 2020","December 2023","June 2024","November 8, 2019",,"March 17, 2020",,,"https://ClinicalTrials.gov/show/NCT04156880"
119,"NCT04400435","Detection of Heart Conditions With Single Lead ECG Using Artificial Intelligence","DAVID1","Not yet recruiting","No Results Available","Left Ventricular Dysfunction","Device: Use of Eko DUO electronic stethoscope","Single-lead ECG based algorithm development","Eko Devices, Inc.","All","18 Years and older   (Adult, Older Adult)",,"600","Industry","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","2020.4","July 2020","March 2021","March 2021","May 22, 2020",,"May 22, 2020",,,"https://ClinicalTrials.gov/show/NCT04400435"
120,"NCT02833428","Spinal Cord and Artificial Intelligence","SKY","Recruiting","No Results Available","Spinal Cord Injuries","Device: Biomedical equipment (Eclipse Nim, Medtronic®)","Assessment of change of ASIA impairment scale (American Spinal Cord Injury Association)|Assessment of change of Somatosensory Evoked Potentials (SEPs)|Assessment of change of Motor Evoked Potentials (PEM)","Groupe Hospitalier Paris Saint Joseph","All","18 Years and older   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","SKY","January 20, 2018","January 20, 2022","September 20, 2022","July 14, 2016",,"February 5, 2020","Groupe Hospitalier Paris Saint Joseph, Paris, Ile-de-France, France",,"https://ClinicalTrials.gov/show/NCT02833428"
121,"NCT04462380","AiCR : Artificial Intelligence in Cardiac aRrest","AiCR","Recruiting","No Results Available","Cardio Respiratory Arrest",,"Prediction of mortality in the intensive care unit","Centre Hospitalier Universitaire de Nice|Institut National de Recherche en Informatique et en Automatique|AIINTENSE","All","18 Years and older   (Adult, Older Adult)",,"500","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","20reamed01","February 1, 2020","December 31, 2020","December 31, 2020","July 8, 2020",,"July 8, 2020","Nice Hospital, Nice, France",,"https://ClinicalTrials.gov/show/NCT04462380"
122,"NCT02748044","Validation of the Utility of Rare Disease Intelligence Platform",,"Completed","No Results Available","Cataract|Artificial Intelligence","Device: CC-Cruiser","The proportion of accurate, mistaken and miss detection of CC-Cruiser.","Sun Yat-sen University|Ministry of Health, China|Xidian University","All","up to 80 Years   (Child, Adult, Older Adult)","Not Applicable","53","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","CCPMOH2016-China3","January 2012","April 2016","April 2016","April 22, 2016",,"April 22, 2016","Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China|Department of Ophthalmology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China|Department of Ophthalmology, First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong, China|Department of Ophthalmology, Qingyuan People's Hospital, Qingyuan, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT02748044"
123,"NCT03960710","Automatic Segmentation of Polycystic Liver","ASEPOL","Recruiting","No Results Available","Polycystic Liver Disease|Polycystic Hepatorenal Disease|Liver Injury","Other: Anonymized CT examinations|Other: Training (1)|Other: Training (2)|Other: Validation (1)|Other: Validation (2)","Test of automatic segmentation by the convolutional neural network on these group and collection of data set","Hospices Civils de Lyon","All","18 Years and older   (Adult, Older Adult)",,"120","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","ASEPOL","April 1, 2019","July 2019","September 2019","May 23, 2019",,"May 28, 2019","Service de radiologie - Pavillon B - Cellule Recherche imagerie, Hôpital Edouard Herriot (HCL), Lyon, France",,"https://ClinicalTrials.gov/show/NCT03960710"
124,"NCT04309851","A Deep Learning Approach to Submerged Teeth Classification and Detection",,"Completed","No Results Available","Artificial Intelligence|Submerging Tooth","Diagnostic Test: deep learning","Submerged Tooth Detection","Eskisehir Osmangazi University","All","5 Years to 12 Years   (Child)",,"74","Other","Observational","Observational Model: Other|Time Perspective: Retrospective","E86412-49","January 1, 2019","January 1, 2020","March 1, 2020","March 16, 2020",,"March 16, 2020","Seçil Çalışkan, Eskisehir, Turkey",,"https://ClinicalTrials.gov/show/NCT04309851"
125,"NCT04160988","A Single-center, Retrospective Study to Evaluate the Clinical Performance of Artificial Intelligence Medical Assisted Diagnostic Software (VeriSee DR) for Screening of Diabetic Retinopathy in Patients With Diabetes Mellitus",,"Completed","No Results Available","Diabetic Retinopathy",,"To evaluate the clinical performance of VeriSee DR by determining the sensitivity.|To evaluate the clinical performance of VeriSee DR by determining the specificity.|To evaluate the clinical performance of VeriSee DR by determining the positive predictive values (PPV).|To evaluate the clinical performance of VeriSee DR by determining the negative predictive values (NPV).|To determine the percentage of subjects' images with insufficient quality as judged by VeriSee DR.","Acer Being Health Inc.|National Taiwan University Hospital","All","20 Years and older   (Adult, Older Adult)",,"903","Industry|Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","QCR19002","December 16, 2019","January 31, 2020","May 11, 2020","November 13, 2019",,"July 9, 2020","National Taiwan University Hospital, Taipei, Taiwan",,"https://ClinicalTrials.gov/show/NCT04160988"
126,"NCT01696162","Conventional Home Exercise Programs Versus Electronic Home Exercise Versus Artificial Intelligence ""Virtual Therapy"" for Anterior Knee Pain",,"Completed","No Results Available","Patellofemoral Pain Syndrome","Other: Algorithm based Exercise Videos|Other: PDF Exercise Sheets|Other: Limited Exercise Videos","The 3 and 6 week survey data evaluating efficacy of the algorithm|Participant compliance|Safety","Simpletherapy","All","18 Years to 64 Years   (Adult)","Not Applicable","85","Industry","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","413","September 2012","October 2013","October 2013","September 28, 2012",,"June 17, 2014","Simpletherapy, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT01696162"
127,"NCT03362138","Artificial Intelligence-assisted Evaluation of Pigmented Skin Lesions","NNCD","Unknown status","No Results Available","Melanoma|Pigmented Skin Lesion|Dysplastic Nevi","Device: dermoscopy","Sensitivity for Classifier results as compared to biopsy|Sensitivity for MCT results as compared to biopsy|The positive predictive value of MCT|The negative predictive value of MCT","Assuta Hospital Systems","All","18 Years to 90 Years   (Adult, Older Adult)",,"80","Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","AQ16842","December 6, 2017","December 31, 2018","March 31, 2019","December 5, 2017",,"September 13, 2018","Maccabi Healthcare Clinic, Tel Aviv, Israel",,"https://ClinicalTrials.gov/show/NCT03362138"
128,"NCT04415736","Artificial Intelligence in Subarachnoid Hemorrhage",,"Completed","No Results Available","Subarachnoid Hemorrhage, Aneurysmal","Other: No intervention, observational study","HRV data analysed by artificial intelligence for detection of DCI","Göteborg University","All","16 Years to 100 Years   (Child, Adult, Older Adult)",,"64","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","AISAH","May 2015","October 2016","May 2020","June 4, 2020",,"June 4, 2020","Sahlgrenska University Hospital, Gothenburg, Sweden",,"https://ClinicalTrials.gov/show/NCT04415736"
129,"NCT04441580","Assessing the Additional Neoplasia Yield of Computer-aided Colonoscopy in a Screening Setting","GENIAL-CO","Recruiting","No Results Available","Colonic Neoplasms|Colonic Adenocarcinoma|Polyps of Colon|Rectal Neoplasms|Rectal Adenocarcinoma","Device: CADe colonoscopy using GI Genius device","Rate of advanced adenomas|Rate of patients detected with 3 or more adenomas.|Overall adenoma and polyp detection rate, flat adenoma and serrated polyps/adenomas.|Size of lesions detected|Rate of neoplasia by colonic site|Post-colonoscopy surveilance|Time of cecal intubation.|Withdrawal and total procedure time.|Learning curve.|Patient experience|Specific contribution of AI","Fondazione Poliambulanza Istituto Ospedaliero","All","50 Years to 69 Years   (Adult, Older Adult)","Not Applicable","600","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening","GENIAL-CO 2.0 del 09/01/2020","May 4, 2020","May 1, 2021","June 3, 2021","June 22, 2020",,"June 22, 2020","Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy",,"https://ClinicalTrials.gov/show/NCT04441580"
130,"NCT04022512","Accuracy of Deep-learning Algorithm for Detection and Risk Stratification of Lung Nodules",,"Recruiting","No Results Available","Osteogenic Sarcoma","Radiation: computed tomography","accuracy|sensitivity|specificity|area under curve (AUC)|average number of false positives per scan (FPs/scan)|competition performance metric (CPM)","Chinese University of Hong Kong|IBM China/Hong Kong Limited","All","up to 18 Years   (Child, Adult)",,"120","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","NTEC-2019-0445","November 6, 2019","August 2022","January 2023","July 17, 2019",,"November 7, 2019","The Chinese University of Hong Kong, Prince of Wale Hospital, Hong Kong, Shatin, Hong Kong",,"https://ClinicalTrials.gov/show/NCT04022512"
131,"NCT03908645","Development and Validation of a Deep Learning Algorithm for Bowel Preparation Quality Scoring",,"Active, not recruiting","No Results Available","Bowel Preparation","Device: Artificial intelligence assisted bowel preparation quality scoring system|Device: Conventional human scoring","The rate of patients achieving adequate bowel preparation in each group.|Adenoma Detection Rate|Polyp Detection Rate","Shandong University","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research","2019SDU-QILU-G001","December 15, 2018","December 15, 2019","April 15, 2020","April 9, 2019",,"April 9, 2019","Qilu hosipital, Jinan, Shandong, China",,"https://ClinicalTrials.gov/show/NCT03908645"
132,"NCT04216550","Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas",,"Recruiting","No Results Available","Recurrent Glioma","Drug: Apatinib","Changes of Response to Treatment|Progression-Free Survival (PFS)|Overall Survival (OS)|Incidence of treatment-related adverse events","The First Affiliated Hospital of Zhengzhou University","All","18 Years to 90 Years   (Adult, Older Adult)",,"600","Other","Observational","Observational Model: Cohort|Time Perspective: Other","GliomaAI-5","January 1, 2018","January 1, 2025","June 1, 2025","January 2, 2020",,"January 6, 2020","Department of Neurosurgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China",,"https://ClinicalTrials.gov/show/NCT04216550"
133,"NCT04313387","Efficiency of an Algorithm Derived From Corneal Tomography Parameters to Distinguish Highly Susceptible Corneas to Ectasia From Healthy",,"Completed","No Results Available","Keratoconus, Artificial Intelligence, Support Vector Machine","Diagnostic Test: Corneal tomography multivariate index derived from a support vector machine (CTMVI).","CTMVI designed to screen patients prior to refractive surgery","Gildasio Castello de Almeida Junior|Fundação de Amparo à Pesquisa do Estado de São Paulo|Sao Jose do Rio Preto Medical School","All","Child, Adult, Older Adult",,"588","Other","Observational","Observational Model: Case-Control|Time Perspective: Retrospective","37232214.1.0000.5415","January 1, 2012","January 1, 2018","January 1, 2018","March 18, 2020",,"March 18, 2020",,,"https://ClinicalTrials.gov/show/NCT04313387"
134,"NCT04395482","Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury","TAC-COVID19","Recruiting","No Results Available","covid19","Other: Lung CT scan analysis in COVID-19 patients","A qualitative analysis of parenchymal lung damage induced by COVID-19|A quantitative analysis of parenchymal lung damage induced by COVID-19|The potential impact of parenchymal morphological CT scans in patients with severe moderate respiratory failure.|Automated segmentation of lung scans of patients with COVID-19 and ARDS.|Knowledge of chest CT features in COVID-19 patients and their detail through the use of machine learning and other quantitative techniques.|The ability within which the analysis of artificial intelligence that uses deep learning models can be used to predict clinical outcomes","University of Milano Bicocca","All","18 Years and older   (Adult, Older Adult)",,"500","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","TAC-COVID19","April 15, 2020","June 15, 2020","October 15, 2020","May 20, 2020",,"May 26, 2020","Ospedale Papa Giovanni XXIII, Bergamo, Italy|Policlinico San Marco-San Donato group, Bergamo, Italy|Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy|ASST di Lecco Ospedale Alessandro Manzoni, Lecco, Italy|ASST Melegnano-Martesana, Ospedale Santa Maria delle Stelle, Melzo, Italy|ASST Monza, Monza, Italy|AUSL Romagna-Ospedale Infermi di Rimini, Rimini, Italy|Istituto per la Sicurezza Sociale-Ospedale della Repubblica di San Marino, San Marino, San Marino",,"https://ClinicalTrials.gov/show/NCT04395482"
135,"NCT04213183","Association of Eye With Hepatobiliary Disorders :Qualitative Analysis Via Deep Learning",,"Recruiting","No Results Available","Ophthalmology|Artificial Intelligence|Hepatobiliary Disease","Diagnostic Test: Hepatobiliary Disorders","area under the receiver operating characteristic curve of the deep learning system|sensitivity and specificity of the deep learning system","Sun Yat-sen University|Third Affiliated Hospital, Sun Yat-Sen University|Huadu District People's Hospital of Guangzhou|iKang Medical International","All","Child, Adult, Older Adult",,"1788","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","AEHD-2019","December 1, 2018","December 25, 2019","December 31, 2020","December 30, 2019",,"March 26, 2020","Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT04213183"
136,"NCT03840590","Adenoma Detection Rate Using AI System in China","SinoAIADR","Not yet recruiting","No Results Available","Colorectal Neoplasms|Colonic Polyp|Adenoma","Device: CSK AI system|Device: Standard Colonoscopy","Adenoma detection rate, ADR|Polyp detection rate, PDR","Changhai Hospital|Sixth Affiliated Hospital, Sun Yat-sen University|Shanghai Zhongshan Hospital|Tianjin People's Hospital|Tianjin Nankai Hospital","All","45 Years to 80 Years   (Adult, Older Adult)","Not Applicable","800","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","SINOCOLO2019B","April 1, 2019","December 1, 2019","March 1, 2020","February 15, 2019",,"February 15, 2019","Sixth affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China|Shanghai Zhongshan Hospital, Shanghai, Shanghai, China|Tianjin Nankai Hospital, Tianjin, Tianjin, China|Tianjin People's Hospital, Tianjin, Tianjin, China",,"https://ClinicalTrials.gov/show/NCT03840590"
137,"NCT04413370","Dry Eye Screening and Referral System",,"Recruiting","No Results Available","Dry Eye","Diagnostic Test: Dry eye diagnostic test","Area under the curve (referral)|Area under the curve (each group)|Accuracy, true positive rate, and true negative rate","Sun Yat-sen University","All","18 Years and older   (Adult, Older Adult)",,"300","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","Dry eye screening system","January 6, 2020","August 6, 2020","January 1, 2021","June 2, 2020",,"June 2, 2020","Zhongshan Ophthalmic Center, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT04413370"
138,"NCT04328792","Prediction Model of CP-EBUS in the Diagnosis of Lymph Nodes",,"Recruiting","No Results Available","Lymph Node Disease",,"Diagnostic efficacy of EBUS multimodal artificial intelligence prediction model based on videos|Diagnostic efficacy of traditional qualitative and quantitative methods|Diagnostic efficacy of multimodal deep learning model based on images|Comparion of prediction model based on deeping learning with traditional qualitative and quantitative methods","Shanghai Chest Hospital","All","18 Years and older   (Adult, Older Adult)",,"1300","Other","Observational","Observational Model: Cohort|Time Perspective: Other","SHCHE201906","July 1, 2018","June 30, 2020","December 31, 2020","March 31, 2020",,"April 2, 2020","Shanghai Chest Hospital, Shanghai, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT04328792"
139,"NCT04215211","MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence",,"Recruiting","No Results Available","Glioma","Diagnostic Test: Survival prediction for glioma patients","AUC of survival prediction performance","The First Affiliated Hospital of Zhengzhou University|Sun Yat-sen University","All","1 Year to 90 Years   (Child, Adult, Older Adult)",,"2500","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","GliomaAI-2","January 1, 2017","January 1, 2027","June 1, 2027","January 2, 2020",,"January 3, 2020","Department of Neurosurgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China",,"https://ClinicalTrials.gov/show/NCT04215211"
140,"NCT04217018","MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence",,"Recruiting","No Results Available","Glioma","Diagnostic Test: Prediction of molecular pathology","AUC of prediction performance","The First Affiliated Hospital of Zhengzhou University|Sun Yat-sen University","All","1 Year to 95 Years   (Child, Adult, Older Adult)",,"3000","Other","Observational","Observational Model: Cohort|Time Perspective: Other","GliomaAI-1","January 1, 2017","January 1, 2027","June 1, 2027","January 3, 2020",,"January 7, 2020","Department of Neurosurgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China",,"https://ClinicalTrials.gov/show/NCT04217018"
141,"NCT04217044","Histopathology Images Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence",,"Recruiting","No Results Available","Glioma","Diagnostic Test: Histopathology images based prediction of molecular pathology","AUC of prediction performance","The First Affiliated Hospital of Zhengzhou University|Sun Yat-sen University","All","1 Year to 95 Years   (Child, Adult, Older Adult)",,"3000","Other","Observational","Observational Model: Cohort|Time Perspective: Other","GliomaAI-3","January 1, 2017","January 1, 2027","June 1, 2027","January 3, 2020",,"January 6, 2020","Department of Neurosurgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China",,"https://ClinicalTrials.gov/show/NCT04217044"
142,"NCT04215224","Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial Intelligence",,"Recruiting","No Results Available","Glioma","Diagnostic Test: Histopathology images based survival prediction for glioma patients","AUC of survival prediction performance","The First Affiliated Hospital of Zhengzhou University|Sun Yat-sen University","All","1 Year to 90 Years   (Child, Adult, Older Adult)",,"3500","Other","Observational","Observational Model: Cohort|Time Perspective: Other","GliomaAI-4","January 1, 2017","January 1, 2027","June 1, 2027","January 2, 2020",,"January 3, 2020","Department of Neurosurgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China",,"https://ClinicalTrials.gov/show/NCT04215224"
143,"NCT04339855","AI for Colorectal Polyp Detection",,"Active, not recruiting","No Results Available","Focus of the Study is to Evaluate a New Developed Deep-learning Computer-aided Detection System in Combination With LCI for Colorectal Polyp Detection","Other: CAD with LCI for colorectal polyp detection","Colorectal polyp detection","Johannes Gutenberg University Mainz","All","18 Years and older   (Adult, Older Adult)",,"600","Other","Observational","Observational Model: Other|Time Perspective: Other","HN_01KR7Zt","February 1, 2019","August 31, 2020","September 30, 2020","April 9, 2020",,"April 9, 2020","University Hospital Mainz, Mainz, Germany",,"https://ClinicalTrials.gov/show/NCT04339855"
144,"NCT04394052","Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II","TUMOSTEO II","Not yet recruiting","No Results Available","Soft Tissue Neoplasm|Bone Neoplasm","Diagnostic Test: MR imaging","Lesion benignancy or malignancy|Sarcoma FNCLCC (fédération Nationale des Centres de Lutte Contre le Cancer) grade","Central Hospital, Nancy, France|Lorraine Cancer Institute - ICL|Emille Gallé Surgical Center - CCEG|Diagnostic and Interventional Adaptative Imaging Laboratory - IADI|Nancy's Regional University Hospital Center (CHRU-Nancy) anatomopathology department","All","18 Years and older   (Adult, Older Adult)",,"740","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CentralHNF TUMOSTEO II","June 1, 2020","June 1, 2026","June 1, 2030","May 19, 2020",,"May 19, 2020",,,"https://ClinicalTrials.gov/show/NCT04394052"
145,"NCT03865979","AI ENRICH - AI Detection of ICH",,"Recruiting","No Results Available","Intracerebral Hemorrhage","Device: Viz RECRUIT","Performance","Viz.ai, Inc.|Nico Corporation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","5000","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","VIZ-ICH-01","January 23, 2020","December 2021","December 2021","March 7, 2019",,"July 2, 2020","Cooper University Hospital, Camden, New Jersey, United States|SUNY Buffalo, Buffalo, New York, United States",,"https://ClinicalTrials.gov/show/NCT03865979"
146,"NCT04224298","Preliminary Study on Eye Features of Patients With Malignant Tumors",,"Enrolling by invitation","No Results Available","Human Characteristics",,"Model of white-eye ocular features in patients with malignant tumors","Beijing Cancer Hospital","All","18 Years to 75 Years   (Adult, Older Adult)",,"1000","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","WEIS","February 1, 2019","June 1, 2021","December 31, 2021","January 13, 2020",,"January 13, 2020","Yichen Dr. Xu, Beijing, China",,"https://ClinicalTrials.gov/show/NCT04224298"
147,"NCT04369833","Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform",,"Recruiting","No Results Available","PreDiabetes|Glucose Metabolism Disorders|Diabetes Mellitus","Device: continuous glucose monitoring system","Glucose/insulin levels pattern","Pusan National University Hospital","All","18 Years and older   (Adult, Older Adult)",,"130","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","H-2003-033-088","May 11, 2020","December 31, 2022","December 31, 2022","April 30, 2020",,"June 4, 2020","Pusan national university hospital, Busan, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT04369833"
148,"NCT04398563","Heart Failure in Norway: Clinical Characteristics, Mortality and Health Care Resource Use",,"Active, not recruiting","No Results Available","Heart Failure|Heart Failure With Preserved Ejection Fraction|Heart Failure With Reduced Ejection Fraction",,"Mortality|Readmission|Diagnostic work up according to guidelines|Treatment according to guidelines","University Hospital, Akershus|Novartis","All","18 Years and older   (Adult, Older Adult)",,"14998","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Retrospective","2019/833 (REK)","January 20, 2020","June 2021","December 2023","May 21, 2020",,"May 21, 2020","Akershus University Hospital, Lørenskog, Norway",,"https://ClinicalTrials.gov/show/NCT04398563"
149,"NCT03920995","Multi-center Database Registry to Study Thalamus Changes Using AI in MS",,"Not yet recruiting","No Results Available","Multiple Sclerosis",,"Multi-center registry of MRI scans","University at Buffalo|Celgene","All","18 Years to 85 Years   (Adult, Older Adult)",,"1000","Other|Industry","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","N/A-NI-MS-PI-13632","April 2019","September 30, 2020","March 31, 2021","April 19, 2019",,"April 22, 2019",,,"https://ClinicalTrials.gov/show/NCT03920995"
150,"NCT02511119","Application of Genomic Techniques and Image Processing Using Artificial Intelligence to Obtain a Predictor Model Risk of Melanoma",,"Unknown status","No Results Available","Melanoma",,"Number of participants with Melanoma","Maimónides Biomedical Research Institute of Córdoba|Mount Sinai Hospital, New York","All","18 Years and older   (Adult, Older Adult)",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","JRR-MEL-2015","July 2015","July 2018",,"July 29, 2015",,"July 30, 2015",,,"https://ClinicalTrials.gov/show/NCT02511119"
151,"NCT04236375","Eye Movement and Cognitive Dysfunction","EMCD","Not yet recruiting","No Results Available","Eye Movement Disorder|Cognitive Dysfunction",,"Area under the curve|Accuracy, true positive rate, and true negetive rate","Sun Yat-sen University","All","45 Years and older   (Adult, Older Adult)",,"700","Other","Observational","Observational Model: Case-Crossover|Time Perspective: Cross-Sectional","Eye movement-cognitive decline","February 1, 2020","August 1, 2020","December 1, 2020","January 22, 2020",,"January 22, 2020",,,"https://ClinicalTrials.gov/show/NCT04236375"
152,"NCT03400514","Clinical Concordance Study Between Watson for Oncology and Clinician Practice","W001","Unknown status","No Results Available","Cancer|Artificial Intelligence",,"concordance","Qingdao University","All","18 Years to 90 Years   (Adult, Older Adult)",,"350","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","XCZhang001","April 12, 2017","December 31, 2018","January 31, 2019","January 17, 2018",,"January 18, 2018","The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China",,"https://ClinicalTrials.gov/show/NCT03400514"
153,"NCT03598322","The Volume Effect of Hydrodissection for Carpal Tunnel Syndrome",,"Completed","No Results Available","Carpal Tunnel Syndrome","Procedure: Dextrose 1mL injection|Procedure: Dextrose 2mL injection|Procedure: Dextrose 4mL injection","Change of Visual analog scale (VAS)|Boston Carpal Tunnel Syndrome Questionnaire Score (BCTQ)|QuickDASH|MSK US finding","National Taiwan University Hospital","All","20 Years to 80 Years   (Adult, Older Adult)","Not Applicable","63","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","201711014RINA","June 30, 2018","July 1, 2019","July 30, 2019","July 26, 2018",,"September 6, 2019","Department of Physical Medicine & Rehabilitation , National Taiwan University Hospital, Taipei, Taiwan",,"https://ClinicalTrials.gov/show/NCT03598322"
154,"NCT04214132","Evaluation of a Virtual Counseling Application for Communication Skills Training in Nursing Education",,"Completed","No Results Available","Communication","Other: Virtual Counselling Application using Artificial Intelligence","Mean score of students' attitude towards learning communication skills|Mean score of students' perceived self-efficacy|clinical communication skills mean scores|clinical communication skills scores","National University, Singapore","All","18 Years and older   (Adult, Older Adult)","Not Applicable","434","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","NUS S-18-074","August 1, 2017","October 31, 2019","October 31, 2019","January 2, 2020",,"January 2, 2020","National University of Singapore, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT04214132"
155,"NCT03955614","Intelligent Operating Room","inOr","Recruiting","No Results Available","Surgery","Other: pedal-controlled GoSurgeryTM|Other: ML-controlled GoSurgeryTM|Other: NoGo","Does GosurgeryTM affect teamwork?|Does GoSurgeryTM affect surgical training overtime?|Does GoSurgeryTM affect delays in the operating theatre?|Does GoSUrgeryTM affect mental demand overtime when operating?|Does GoSurgeryTM affect operative timings?|Does GoSurgeryTM affect patient outcomes (the presence of complications )?|Does GoSurgeryTM affect patient outcomes (duration of hospital stay)?|How does GosurgeryTM affect team performance?|Evaluation of the Machine Learning algorithm to correctly detect operative steps of the procedures.|Does GoSurgeryTM influence cost of wasted equipment?","Imperial College London","All","18 Years and older   (Adult, Older Adult)","Not Applicable","150","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","19SM4984","October 4, 2019","October 2020","October 2020","May 20, 2019",,"October 10, 2019","Imperial College Hospitals NHS Trust, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03955614"
156,"NCT04419545","Covid Radiographic Images Data-set for A.I","CORDA","Recruiting","No Results Available","Radiology|Artificial Intelligence","Diagnostic Test: Neural network diagnosis algorithm","sensibility and specificity of neural network diagnosis","Azienda Ospedaliera Città della Salute e della Scienza di Torino|University of Turin, Italy|Azienda Ospedaliera Ordine Mauriziano di Torino","All","Child, Adult, Older Adult",,"2500","Other","Observational","Observational Model: Case-Control|Time Perspective: Retrospective","CORDA","March 24, 2020","December 31, 2020","March 31, 2021","June 5, 2020",,"June 5, 2020","Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Torino, Turin, Italy",,"https://ClinicalTrials.gov/show/NCT04419545"
157,"NCT04220242","Future of Colorectal Cancer Surgery","FOCCuS1","Recruiting","No Results Available","Colorectal Cancer|Surgery","Other: Video recordings with analysis thereafter applied|Other: Examination of microsections of tissue excised for the purposes of cancer resection|Other: Cancer organoid development and testing","Video recordings of Colorectal Cancer.|Analysis of video recordings|Biophysics visualisation software development|Biophysics model training|Validation of predictive accuracy biophysics-visualisation model|Coefficients of Variation|Microscopic Map of intratumoral fluorophore accumulation|Realtime delineation display of tumour area including margins","Mater Misericordiae University Hospital|Royal College of Surgeons, Ireland|IBM Research In Ireland","All","18 Years and older   (Adult, Older Adult)",,"250","Other","Observational","Observational Model: Cohort|Time Perspective: Other","DT 2018 0240","December 30, 2019","December 1, 2022","March 1, 2023","January 7, 2020",,"January 7, 2020","Mater Misericordiae University Hospital, Dublin, Other (Non U.s.), Ireland",,"https://ClinicalTrials.gov/show/NCT04220242"
158,"NCT02022397","Automated Assessment of Difficult Airway With Facial Recognition Techniques","PeScho","Recruiting","No Results Available","Adverse Effect of Other General Anesthetics, Sequela",,"Computerized classification of difficult intubation","University of Lausanne Hospitals|Ecole Polytechnique Fédérale de Lausanne","All","16 Years and older   (Child, Adult, Older Adult)",,"6000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","183/09|CTI","March 2012","December 23, 2020","December 23, 2020","December 27, 2013",,"September 26, 2019","Dpt of Anesthesiology, University of Lausanne CHUV, Lausanne, VD, Switzerland",,"https://ClinicalTrials.gov/show/NCT02022397"
159,"NCT02988193","Piloting Healthcare Coordination in Hypertension","PRECISION","Completed","Has Results","Hypertension","Device: optima4BP Medication Management","Clinical Adoption of a Decision Support Artificial Intelligence","Optima Integrated Health|University of California, San Francisco","All","21 Years to 90 Years   (Adult, Older Adult)","Not Applicable","28","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","15-16045","December 2015","January 2017","February 28, 2017","December 9, 2016","September 18, 2019","September 18, 2019","University of California San Francisco, San Carlos, California, United States",,"https://ClinicalTrials.gov/show/NCT02988193"
160,"NCT04313140","Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging",,"Not yet recruiting","No Results Available","Development of the Virtual Biopsy|Tumor Grade|Artificial Intelligence Algorithms|Clinical|Radiological","Diagnostic Test: Diagnostic test","Validation of the virtual biopsy in the context of gliomas through the use of statistical learning algorithms (artificial intelligence) compared to the biopsy.","Poitiers University Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","500","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic","2019-A02531-56","June 2020","June 2025","June 2025","March 18, 2020",,"March 20, 2020",,,"https://ClinicalTrials.gov/show/NCT04313140"
161,"NCT00872079","Personalized Warfarin Dosing by Genomics and Computational Intelligence",,"Terminated","Has Results","Venous Thrombosis|Atrial Fibrillation|Myocardial Infarction","Device: Genomics","Patient Genomics","US Department of Veterans Affairs|VA Office of Research and Development","All","18 Years and older   (Adult, Older Adult)","Not Applicable","175","U.S. Fed","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","CAMM-04-07S","September 2008","September 2011","September 2011","March 31, 2009","February 24, 2014","February 24, 2014","VA Medical Center, Louisville, Louisville, Kentucky, United States",,"https://ClinicalTrials.gov/show/NCT00872079"
162,"NCT04359745","Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression",,"Recruiting","No Results Available","Glioblastoma",,"Accuracy of the artificial intelligence model|Failure rate of the artificial intelligence model","Guy's and St Thomas' NHS Foundation Trust|King's College London","All","18 Years to 80 Years   (Adult, Older Adult)",,"500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","3.0 04/09/18","March 21, 2019","May 26, 2023","May 26, 2023","April 24, 2020",,"April 27, 2020","Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|King's College Hospital NHS Trust, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04359745"
163,"NCT03870581","AI-based Social Software to Manage wARfarin Therapy","AI-SMART","Not yet recruiting","No Results Available","Anticoagulant-induced Bleeding|Warfarin Sodium Causing Adverse Effects in Therapeutic Use","Behavioral: AI-based social software management model|Behavioral: Human-based social software management model","Time in therapeutic range|INR variability|Bleeding events|Thrombotic events","Wuhan Asia Heart Hospital","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","500","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","2019-P-012","May 1, 2019","April 30, 2021","May 1, 2021","March 12, 2019",,"March 12, 2019","WAHH, Wuhan, Hubei, China|Wuhan Asia Heart Hospital, Wuhan, Hubei, China",,"https://ClinicalTrials.gov/show/NCT03870581"
164,"NCT03822390","Diagnostic Performance of a Convolutional Neural Network for Diminutive Colorectal Polyp Recognition","POLAR","Recruiting","No Results Available","Artificial Intelligence|Colorectal Polyp","Device: CAD-CNN system","The accuracy of the CAD-CNN system for predicting histology of diminutive colorectal polyps (1-5mm) compared with the accuracy of the prediction of the endoscopist. Both the CAD-CNN system and the endoscopist will use NBI for their predictions.|The mean duration in seconds of the CAD-CNN system to make a per polyp diagnosis.|The mean number of attempts of the CAD-CNN to make a diagnosis per polyp|The ratio of unsuccessful diagnosis from all diagnosis of the CAD-CNN system. An unsuccessful diagnosis/failure of the CAD-CNN system is defined as more than 3 unsuccessful attempts|The number of diminutive polyps per colonoscopy that is resected and discarded without histopathological analysis with optical diagnosis strategy (the CAD-CNN system or endoscopist)|The percentage of colonoscopies in which diminutive polyps are characterized based on optical diagnosis, removed and discarded without histopathological evaluation (i.e. proportion of polyps assessed with high confidence)|The percentage of colonoscopies in which the surveillance interval is based on the optical diagnosis of the CAD-CNN system and the patient can be directly informed of the surveillance interval after colonoscopy|The percentage of colonoscopies in which diminutive hyperplastic polyps in the rectosigmoid are left in situ.|The diagnostic sensitivity for optical diagnosis of the CAD-CNN system and the endoscopists|The diagnostic sensitiviy for optical diagnosis of the CAD-CNN system and the endoscopists|The accuracy rates on a per polyp basis|Agreement between recommended surveillance intervals, based on optical diagnosis of diminutive polyps with high confidence, compared to surveillance recommendations based on histology of all polyps|The diagnostic specificity for optical diagnosis of the CAD-CNN system and the endoscopists|The diagnostic PPV for optical diagnosis of the CAD-CNN system and the endoscopists|The diagnostic NPV for optical diagnosis of the CAD-CNN system and the endoscopists|The diagnostic AUC for optical diagnosis of the CAD-CNN system and the endoscopists","Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Bergman Clinics|Medical Centre Leeuwarden","All","18 Years and older   (Adult, Older Adult)",,"292","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","W18_422","October 16, 2018","October 16, 2020","October 16, 2020","January 30, 2019",,"November 21, 2019","Academic Medical Centre, Amsterdam, Noord-Holland, Netherlands",,"https://ClinicalTrials.gov/show/NCT03822390"
165,"NCT04331015","Artificial Intelligence in Diagnosis of DFNA9","DFNA9","Completed","No Results Available","DFNA9|Sensorineural Hearing Loss","Diagnostic Test: Pure tone audiometry","hearing threshold|age|prediction gene locus","Jessa Hospital","All","18 Years and older   (Adult, Older Adult)",,"111","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","JessaH-5-ORL","February 1, 2020","March 28, 2020","March 28, 2020","April 2, 2020",,"April 3, 2020","Jessa Hospital, Hasselt, Limburg, Belgium|University of Antwerp, Antwerpen, Belgium",,"https://ClinicalTrials.gov/show/NCT04331015"
166,"NCT03773458","Validation of the Utility of an Artificial System for the Large-scale Screening of Scoliosis",,"Completed","No Results Available","Orthopedic Disorder of Spine|Artificial Intelligence|Scoliosis","Device: An artificial system for the screening of scoliosis","The proportion of accurate, mistaken and miss detection of the intelligent visual acuity diagnostic system.","Sun Yat-sen University",,"10 Years to 22 Years   (Child, Adult)","Not Applicable","500","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","CCPMOH2018-China-13","June 1, 2018","July 30, 2018","July 30, 2018","December 12, 2018",,"December 12, 2018","Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03773458"
167,"NCT03240848","Comparison of Artificial Intelligent Clinic and Normal Clinic",,"Completed","No Results Available","Cataract","Procedure: artificial intelligent clinic|Procedure: normal clinic|Procedure: experts diagnose","The accuracy of artificial intelligence diagnosis for congenital cataract|The evaluation of disease severity and treatment determination|The time consuming of diagnosis|The level of patients' satisfaction","Sun Yat-sen University","All","1 Month to 14 Years   (Child)","Not Applicable","350","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Diagnostic","CCPMOH2017-China-5","August 9, 2017","May 25, 2018","May 25, 2018","August 7, 2017",,"July 30, 2018","Zhognshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03240848"
168,"NCT04122326","Monitoring and Evaluation of Posture in Office Workstations With Artificial Intelligence",,"Active, not recruiting","No Results Available","Musculoskeletal Pain|Musculoskeletal Injury|Musculoskeletal Strain","Behavioral: Workstation Modification","Change in Pain on the Visual Analog Pain Scale from baseline|Posture on the Rapid Upper Limb Assessment","University of Southern California|U.S. National Science Foundation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20","Other|U.S. Fed","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","UP-19-00140","May 1, 2019","October 25, 2019","May 1, 2020","October 10, 2019",,"November 4, 2019","University of Southern California, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT04122326"
169,"NCT04145232","AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.",,"Recruiting","No Results Available","Non Small Cell Lung Cancer|Neoepitopes|Neoantigens|Immunotherapy|Next Generation Sequencing (NGS)|Personalized Neoantigen Cancer Vaccine","Biological: Collection of biopsy (FFPE), blood (PBMC) and stool","Number of Responders and Non-responders on immunotherapy (evaluated using RECIST 1.1 criteria)","Ardigen|Małopolskie Centre of Entrepreneurship","All","18 Years and older   (Adult, Older Adult)",,"30","Industry|Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","A.I.mmune|RPMP.01.02.01-12-0301/17","June 13, 2019","June 30, 2020","November 30, 2020","October 30, 2019",,"October 31, 2019","University Clinical Centre in Gdansk, Gdańsk, Poland",,"https://ClinicalTrials.gov/show/NCT04145232"
170,"NCT04340180","Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction",,"Not yet recruiting","No Results Available","Breast Benign Tumor|Breast Malignant Tumor","Drug: Standard of Care (SOC) gadolinium Breast MRI|Drug: reduced 1/4 dose gadolinium Breast MRI with Artificial Intelligence (AI) to aid in evaluation.","Compare lesion conspicuity on a scale of 1-4 from low-dose and SOC-dose imaging.|Compare lesion size in millimeters from low-dose to SOC-dose imaging.|Compare lesion margins on a scale from 1-4 from low-dose and SOC-dose imaging.|Compare lesion internal enhancement pattern on a scale from 1-4 from low-dose and SOC- dose imaging.|Compare the overall background enhancement (scale per standard imaging guidelines. Minimal, mild, moderate, marked).","University of Alabama at Birmingham|Bracco Corporate","Female","18 Years to 99 Years   (Adult, Older Adult)","Phase 1","20","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","R19-159","June 30, 2020","December 31, 2021","December 31, 2022","April 9, 2020",,"April 9, 2020","The Kirklin Clinic, Birmingham, Alabama, United States",,"https://ClinicalTrials.gov/show/NCT04340180"
171,"NCT04370002","Sensor-based Characterization of Depression","SENSCODE","Recruiting","No Results Available","Depression, Unipolar",,"Hamilton Depression Rating Scale (HDRS)|Patient Health Questionnaire 9 (Phq-9)","Massachusetts General Hospital|Massachusetts Institute of Technology","All","18 Years to 75 Years   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Other|Time Perspective: Prospective","2019P000997","January 28, 2020","August 31, 2023","August 31, 2024","April 30, 2020",,"April 30, 2020","Depression Clinical Research Program, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04370002"
172,"NCT03904667","Application of Watson for Oncology in Hepatocellular Carcinoma Surgery",,"Active, not recruiting","No Results Available","Liver Resection","Other: Watson on oncology surgery decision evaluation","Operative outcomes|Postoperative survival","Zhujiang Hospital","All","18 Years to 80 Years   (Adult, Older Adult)",,"150","Other","Observational","Observational Model: Cohort|Time Perspective: Other","20170101","January 1, 2017","December 31, 2021","December 31, 2021","April 5, 2019",,"April 5, 2019","Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT03904667"
173,"NCT04014725","Validation of the Utility of Myopia Intelligent Diagnostic System",,"Not yet recruiting","No Results Available","Myopia","Device: Myopia Intelligent Diagnostic System","The AUC of the Myopia Intelligent Diagnostic System|The sensitivity of the Myopia Intelligent Diagnostic System|The specificity of the Myopia Intelligent Diagnostic System","Sun Yat-sen University","All","6 Years to 18 Years   (Child, Adult)","Not Applicable","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","CCPMOH2019-China-2","July 10, 2019","August 1, 2019","August 1, 2019","July 10, 2019",,"July 10, 2019",,,"https://ClinicalTrials.gov/show/NCT04014725"
174,"NCT03973437","Development and Validation of a Deep Learning Algorithm to Evaluate Endoscopic Disease Activity of Ulcerative Colitis.",,"Not yet recruiting","No Results Available","Ulcerative Colitis","Device: Artificial inteligence associated ulcerative colitis severity scoring system|Device: Conventional human scoring","The scoring accuracy of Mayo ES in AI-associated group and conventional group.|The scoring accuracy of UCEIS in AI-associated group and conventional group.|The accuracy of mucosal healing judgements using Mayo ES in each group.|The accuracy of mucosal healing judgements using UCEIS in each group.","Shandong University","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research","2019-SDU-QILU-G002","June 1, 2019","December 31, 2019","June 1, 2020","June 4, 2019",,"June 4, 2019","Qilu hosipital, Jinan, Shandong, China",,"https://ClinicalTrials.gov/show/NCT03973437"
175,"NCT03915119","Fuzzy AI Using VR for Collision Prevention","CAT","Completed","No Results Available","Injuries","Other: GFT AI training","Pro-saccades test|Self paced saccades|Anti-saccades test","Children's Hospital Medical Center, Cincinnati","All","14 Years to 22 Years   (Child, Adult)","Not Applicable","45","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","2017-6006","January 1, 2018","February 1, 2019","September 30, 2019","April 16, 2019",,"February 7, 2020","Cincinanti Childrens Hospital Medical Center, Cincinnati, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT03915119"
176,"NCT04453956","A Single Center Study on Comparing the Different Function of EndoAngel in Improving the Quality of Colonscopy",,"Not yet recruiting","No Results Available","Adenoma","Diagnostic Test: Colonoscopy with the assistance of EndoAngel's polyp detection function.|Diagnostic Test: Colonoscopy with the assistance of EndoAngel's quality monitoring function.|Diagnostic Test: Colonoscopy without the assistance of EndoAngel's any function.","Adenoma detection rate|Polyp detection rate|The mean number of polyps per procedure|The mean number of adenomas per procedure|Detection rate of large, small and diminutive polyps|The mean number of large, small and diminutive polyps per procedure|Detection rate of large, small and diminutive adenomas|The mean number of large, small and diminutive adenomas per procedure|Detection rate of adenoma in different sites|The mean number of adenomas in different sites per procedure|Time of colonoscopic insertion|Time of colonoscopic withdrawal|Cecal intubation rate","Renmin Hospital of Wuhan University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","1076","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Diagnostic","EA-19-001","June 30, 2020","July 20, 2020","August 18, 2020","July 1, 2020",,"July 1, 2020","Renmin Hospital of Wuhan University, Wuhan, Hubei, China",,"https://ClinicalTrials.gov/show/NCT04453956"
177,"NCT04384211","QOCA®-Image Medical Platform - Smart VCF Risk Management System",,"Active, not recruiting","No Results Available","Compression Fracture","Other: Computer Assisted Detection Software For Vertebral Fractures","Concordance rate|Accuracy","Taipei Medical University WanFang Hospital|Quanta Computer Inc.","All","50 Years to 90 Years   (Adult, Older Adult)",,"1500","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","N201909056","June 1, 2019","May 31, 2020","May 31, 2020","May 12, 2020",,"June 2, 2020","Taipei Medical University WanFang Hospital, Taipei, Taiwan",,"https://ClinicalTrials.gov/show/NCT04384211"
178,"NCT04289025","Modelling and AI Using Sensor Data to Personalise REHABilitation Following Joint Replacement","MAPREHAB","Not yet recruiting","No Results Available","Arthroplasty Complications","Other: Exercise","Objective change in gait kinematics|Subjective change in gait|Quality of life changes","Norfolk and Norwich University Hospitals NHS Foundation Trust|Dynamic Metrics Ltd|University of East Anglia","All","45 Years to 75 Years   (Adult, Older Adult)","Not Applicable","100","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","Dig Health01","June 2020","January 2021","March 2021","February 28, 2020",,"February 28, 2020","Norfolk and Norwich University Hospital, Norwich, Norfolk, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04289025"
179,"NCT04270032","Using Deep Learning Methods to Analyze Automated Breast Ultrasound Images, to Establish a Diagnosis, Therapy Assessment and Prognosis Prediction Model of Breast Cancer.",,"Recruiting","No Results Available","Breast Cancer","Diagnostic Test: ABUS","sensitivity|false-positive per volume|area under curve|overall survival(OS) time|Disease-free survival (DFS) time","The First Affiliated Hospital of the Fourth Military Medical University|Seoul National University Bundang Hospital|Xidian University|Shenzhen University","Female","18 Years and older   (Adult, Older Adult)",,"10000","Other","Observational","Observational Model: Other|Time Perspective: Retrospective","AI-Breast-US","February 1, 2020","September 1, 2024","September 1, 2024","February 17, 2020",,"February 17, 2020","The First Affiliated Hospital of Fourth Military Medical University, Xi'an, Shaanxi, China",,"https://ClinicalTrials.gov/show/NCT04270032"
180,"NCT04123678","DERM Health Economics Study",,"Recruiting","No Results Available","Melanoma|Non-melanoma Skin Cancer","Device: Deep Ensemble for the Recognition of Malignancy (DERM)","Referral rate|Sensitivity of DERM on biopsied lesions|Specificity of DERM on biopsied lesions|False positive rate of DERM on biopsied lesions|False negative rate of DERM on biopsied lesions|Positive predictive value of DERM on biopsied lesions|Number needed to biopsy by DERM on biopsied lesions|Sensitivity of teledermatologists on biopsied lesions|Specificity of teledermatologists on biopsied lesions|False positive rate of teledermatologists on biopsied lesions|False negative rate of teledermatologists on biopsied lesions|Positive predictive value of teledermatologists on biopsied lesions|Negative predictive value of teledermatologists on biopsied lesions|Number needed to biopsy by teledermatologists on biopsied lesions|Sensitivity of DERM to identify benign conditions|Specificity of DERM to identify benign conditions|False positive rate of DERM to identify benign conditions|False negative rate of DERM to identify benign conditions|Positive predictive value of DERM to identify benign conditions|Negative predictive value of DERM to identify benign conditions|Number needed to refer by DERM to identify benign conditions|Concordance of DERM result with clinical diagnosis|Percent of patients attending teledermatology by referral route|Time taken from general practitioner (GP) referral to diagnosis|Estimated cost impact associated with introducing DERM into the patient pathway|Proportion of images submitted to DERM that cannot be analysed|Patient satisfaction survey","Skin Analytics Limited|Innovate UK","All","18 Years and older   (Adult, Older Adult)",,"581","Industry|Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","DERM-005","February 26, 2020","July 2020","September 2020","October 11, 2019",,"March 19, 2020","Chelsea and Westminster Hospital, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04123678"
181,"NCT03706534","Breast Ultrasound Image Reviewed With Assistance of Deep Learning Algorithms",,"Active, not recruiting","No Results Available","Breast Cancer|Breast Lesions|Breast Mass","Device: Ultrasound Image review with CADe|Device: Ultrasound Image review with CADx|Device: Ultrasound Image manual review|Procedure: Biopsy","Concordance rate|Reporting time|Consensus|Accuracy|Sensitivity|Specificity|Area Under Curve","Samsung Medison|University of Rochester","All","19 Years and older   (Adult, Older Adult)","Not Applicable","300","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Device Feasibility","300.08-2018-Samsungmedison-S","September 20, 2018","November 30, 2019","January 31, 2020","October 16, 2018",,"October 29, 2019","University of Rochester, Rochester, New York, United States",,"https://ClinicalTrials.gov/show/NCT03706534"
182,"NCT04081038","Dental Hygienists and Dentists as Providers of Oral Mucosa Screening and Brush Biopsies","mouthcancer","Recruiting","No Results Available","Oral Cancer","Diagnostic Test: Brush biopsy","Brush biopsy","Dalarna County Council, Sweden","All","18 Years and older   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Other|Time Perspective: Prospective","Oral cancer screening","August 31, 2019","December 31, 2020","June 30, 2021","September 6, 2019",,"May 21, 2020","Kristina Edman, Falun, Dalarna, Sweden|Public Dental Service, Falun, Dalarna, Sweden",,"https://ClinicalTrials.gov/show/NCT04081038"
183,"NCT04079036","Decision Support System for Anesthetists","Serenity","Not yet recruiting","No Results Available","Anesthesia",,"Heart Rate|Arterial blood pressure|Mean Arterial Pressure|Non Invasive Blood pressure|Conscience Level|Inspired anesthetic concentration|Inspired carbon dioxide concentration|Inspired Nitrous Oxide concentration|Blood oxygen saturation|Exhaled Carbon Dioxide concentration|Exhaled Anesthetic concentration|Anesthetic agent infusion rate|Analgesic agent infusion rate|Neuro-muscular Block agent infusion rate|Ventilation respiratory rate|Ventilation Tidal volume|Ventilation Minute Volume|Ventilation maximum pressure per cycle|Ventilation Plateau pressure|Ventilation PEEP|Primary anesthesia Data - related to the manual infusion of drugs|Preoperative patient medical records - General state of the patient in ASA.|Preoperative patient medical records - General state of the patient in METS.|Preoperative patient medical records - Clinical state of the patient - Age|Preoperative patient medical records - Clinical state of the patient - gender|Preoperative patient medical records - Clinical state of the patient - Weight|Preoperative patient medical records - Clinical state of the patient - Height","University of Sao Paulo General Hospital|University of Sao Paulo|Fundação de Amparo à Pesquisa do Estado de São Paulo","All","1 Month to 80 Years   (Child, Adult, Older Adult)",,"360","Other","Observational","Observational Model: Case-Crossover|Time Perspective: Prospective","CAAE 03424918.6.0000.0068","October 2019","December 2019","January 2020","September 6, 2019",,"September 6, 2019","Hospital das Clínicas - Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil",,"https://ClinicalTrials.gov/show/NCT04079036"
184,"NCT01338116","Optimal Antibiotic Treatment of Moderate to Severe Bacterial Infections","CDSS","Unknown status","No Results Available","Community-associated Infections|Health-care Acquired Infections|Nosocomial Infections","Other: antibiotic treatment of by TREAT/PCR","Clinical success defined as 30-day survival and clinical stability on day 4|Appropriate empirical antibiotic treatment|Survival|Hospital stay|Antibiotic miuse of broad spectrum antibiotics and total costs of antibiotic treatment Superfluous antibiotic treatment|Costs|Adverse events","Rabin Medical Center","All","18 Years and older   (Adult, Older Adult)","Phase 3","600","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","6036","April 2016","January 2018","January 2019","April 19, 2011",,"April 7, 2016","Rabin Medical Center, Beilinson Hospital, Petah Tikvah, Israel",,"https://ClinicalTrials.gov/show/NCT01338116"
185,"NCT04335942","Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor","Es-Alert","Not yet recruiting","No Results Available","Duchenne Muscular Dystrophy|Spinal Muscular Atrophy","Other: Alert ""AFNOR 3.6"".|Other: Alertes "" AFNOR 3.6 "" et alertes "" Guidelines "".","Evaluate the impact of a device, monitoring the wheelchair user's risk of pressure sores and issuing alerts based on international recommendations, on the support reliefs provided by the subject in an ecological situation|the differences in occupational performance at the MCRO (Mesure canadienne du rendement occupationnel) score|the impact of visual biofeedback of the pressure print on chair|Feasibility study of integrating international recommendations to reduce the risk of pressure ulcers in a medical device|the study of the acceptability by the patient of alerts in relation with international recommendations","Assistance Publique - Hôpitaux de Paris","All","18 Years and older   (Adult, Older Adult)","Not Applicable","36","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","APHP190924","April 2020","April 2020","October 2020","April 7, 2020",,"April 7, 2020",,,"https://ClinicalTrials.gov/show/NCT04335942"
186,"NCT03909685","Examining the Feasibility of the Ask RoSE Mobile Mental Health Application",,"Not yet recruiting","No Results Available","Mental Health Wellness 1|Anxiety","Behavioral: Mobile Mental Health App","Average session time when using the mobile app|Time of day the mobile app is used|Most commonly used feature within the app|Change in Short term impact on mood as assessed by the Positive and Negative Emotions Scale (PANAS)|Change in Short term impact on anxiety as assessed by the General Anxiety Disorder-7 (GAD-7) scale","Johns Hopkins University","All","21 Years to 28 Years   (Adult)","Not Applicable","45","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","IRB00206859","July 2020","March 2021","March 2021","April 10, 2019",,"April 10, 2020",,,"https://ClinicalTrials.gov/show/NCT03909685"
187,"NCT03953976","INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy",,"Recruiting","No Results Available","Head and Neck Squamous Cell Carcinoma","Radiation: Intensity modulated radiation therapy (IMRT)","Crude risk of solitary elective volume recurrence (SEVR) following INRT, according to NCI's CTCAE v4.0 toxicity criteria.|EORTC QLQ-C30 Summary score|EORTC QLQ-C30 Physical and role functioning subscales|EORTC HN35 Dry mouth and sticky saliva subscales|MDADI global, emotional, functional and physical subscales|EQ-5D global score (0-100)","University of Texas Southwestern Medical Center","All","18 Years to 99 Years   (Adult, Older Adult)","Phase 2","67","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","STU 2019-0711","July 23, 2019","July 2022","July 2022","May 17, 2019",,"March 10, 2020","University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States",,"https://ClinicalTrials.gov/show/NCT03953976"
188,"NCT03980470","Deep-Learning Image Reconstruction in CCTA",,"Recruiting","No Results Available","Coronary Artery Disease","Device: TrueFidelity","Subjective image quality as measured by Likert scale from 1 to 5, change from experimental interventional to the control intervention|Signal intensity as average hounsfield units within a region of interest in the aortic root, change from experimental interventional to the control intervention|Image noise as standard deviation of hounsfield units within a region of interest in the aortic root, change from experimental interventional to the control intervention|Signal-to-noise ratio and contrast-to-noise ratio, change from experimental interventional to the control intervention|Comparison of dose-length products and radiation exposure in mSv|Subjective analysis of plaque composition (calcified plaque, non-calcified plaque, mixed plaque) and lesion severity (below 50%, 50-70%, over 70%)","University of Zurich","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic","USZ-2019-00533","May 3, 2019","June 30, 2019","September 30, 2019","June 10, 2019",,"June 10, 2019","University Hospital, Zurich, Switzerland",,"https://ClinicalTrials.gov/show/NCT03980470"
189,"NCT03712059","National Colorectal Polyp Care","NCPC","Recruiting","No Results Available","Colorectal Polyp","Diagnostic Test: FIT test and colonoscopy|Diagnostic Test: Polypectomy and biopsy|Diagnostic Test: Classification","Detection rate of early colorectal cancers and precancerous lesions in colonoscopy and combination of FIT and APCS|Complete resection rate of polypectomy|Specificity and sensitivity of endoscopists and artificial intelligence-assisted system in classifying polyps","Changhai Hospital","All","18 Years to 75 Years   (Adult, Older Adult)",,"25000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","NCPC","November 1, 2018","April 30, 2019","June 30, 2019","October 19, 2018",,"October 25, 2018","Changhai Hospital, Second Military Medical University, Shanghai, China|Changhai Hospital, Second Military Medical University, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT03712059"
190,"NCT04055766","A Diagnostic Test on DeepDoc-an AI-based Decision Support System",,"Not yet recruiting","No Results Available","Stroke|Headache|Vertigo|Meningitis/Encephalitis","Device: DeepDoc AI-based Decision Support System","Accuracy of diagnosis by DeepDoc AI-based Decision Support System|Sensitivity of diagnosis by DeepDoc AI-based Decision Support System|Specificity of diagnosis by DeepDoc AI-based Decision Support System","Xijing Hospital","All","18 Years to 80 Years   (Adult, Older Adult)",,"4000","Other","Observational","Observational Model: Case-Crossover|Time Perspective: Prospective","DeepDoc-M5","September 1, 2020","September 9, 2020","March 1, 2021","August 14, 2019",,"December 13, 2019",,,"https://ClinicalTrials.gov/show/NCT04055766"
191,"NCT03448757","Determination of Autonomic Responses to the Exposure of Low Energy Electromagnetic Fields With Frequency Modulation in Patients With Advanced Hepatocellular Carcinoma and Healthy Individuals.",,"Recruiting","No Results Available","Hepatocellular Carcinoma","Other: measuring hemodynamic parameters heart beat to heart beat during single-frequency exposure","non-invasive hemodynamic parameter measurements during exposure AM RF EMF|Hemodynamic alteration´s comparison among advanced cancer patients and healthy controls","Hospital Sirio-Libanes","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","HSL 2016-83","February 15, 2018","April 15, 2019","February 16, 2020","February 28, 2018",,"August 6, 2018","Hospital Sírio-Libanês, São Paulo, Brazil",,"https://ClinicalTrials.gov/show/NCT03448757"
192,"NCT01850199","Intelligent and Educational System for Gestational Diabetes Management",,"Completed","No Results Available","Gestational Diabetes","Other: Smart telemedicine remote monitoring for gestational diabetes|Other: Usual management","Median blood glucose (Interquartile range)|Time from glucose criteria for insulin prescription to actual insulin starting","Corporacion Parc Tauli|CIBER-BBN: Networking Research Center for Bioengineering.|Technical University of Madrid","Female","18 Years to 46 Years   (Adult)","Not Applicable","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","SINEDiE","January 2014","September 2015","September 2015","May 9, 2013",,"July 28, 2016","Parc Tauli Sabadell University Hospital, Sabadell, Barcelona, Spain",,"https://ClinicalTrials.gov/show/NCT01850199"
193,"NCT03662802","Development of a Novel Convolution Neural Network for Arrhythmia Classification","AI-ECG","Not yet recruiting","No Results Available","Arrhythmias, Cardiac|Cardiac Arrest|Cardiac Arrythmias","Other: Neural Network Classifier","Diagnostic Accuracy","Scripps Clinic|Scripps Health","All","Child, Adult, Older Adult",,"2000","Other","Observational","Observational Model: Cohort|Time Perspective: Other","027527","October 2018","October 2019","October 2019","September 7, 2018",,"September 7, 2018","Scripps Clinic, San Diego, California, United States",,"https://ClinicalTrials.gov/show/NCT03662802"
194,"NCT04424121","CCTA, CACS and ECG Stress Testing in Patients With Suspected CAD: Precision Phenotyping and Financial Evaluation","DATASET","Not yet recruiting","No Results Available","Stable Angina|Coronary Artery Disease|Atherosclerosis|Coronary Artery Calcification","Diagnostic Test: CCTA","Major Adverse Cardiac Events (MACE)|Chest-pain rehospitalization|Frequency of angina [Seattle Angina Questionnaire (SAQ)]|Generic health status [Medical Outcomes Study 12-Item Short Form (SF-12)]","Aristotle University Of Thessaloniki|Lefkos Stavros The Athens Clinic|Affidea Kozani Cardiac Imaging Center|National and Kapodistrian University of Athens","All","18 Years and older   (Adult, Older Adult)","Not Applicable","900","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","DATASET PRECISE_01062020_03448","January 1, 2021","June 30, 2023","December 31, 2023","June 9, 2020",,"June 9, 2020","Lefkos Stavros The Athens Clinic, Athens, Greece|National and Kapodistrian University of Athens, School of Medicine, Athens, Greece|Affidea Kozani Cardiac Imaging Center, Kozáni, Greece|Aristotle University of Thessaloniki, School of Medicine, Thessaloníki, Greece",,"https://ClinicalTrials.gov/show/NCT04424121"
195,"NCT04270799","Lung Nodule Imaging Biobank for Radiomics and AI Research","LIBRA","Not yet recruiting","No Results Available","Lung Cancer|Pulmonary Nodule, Multiple|Pulmonary Nodule, Solitary|Lung Neoplasms","Diagnostic Test: Machine Learning Classification","Development of an imaging biobank|Discovery of a CT-thorax based radiomics profile to predict cancer risk.","Royal Marsden NHS Foundation Trust|Royal Marsden Partners|The Royal Brompton and Harefield NHS Foundation Trust|University College London Hospitals|Guys and St Thomas' NHS Foundation Trust|Imperial College NHS Foundation Trust|Lewisham and Greenwich NHS Trust|King's College Hospital NHS Trust|Epsom and St Helier University Hospitals NHS Trust|The Institute of Cancer Research, London|Biomedical Research Centre, London","All","18 Years and older   (Adult, Older Adult)",,"1000","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","CCR5215","April 2020","August 2021","August 2021","February 17, 2020",,"February 17, 2020",,,"https://ClinicalTrials.gov/show/NCT04270799"
196,"NCT04220437","Identification of Neoatherosclerosis in ISR Patients Based on Artifical Intelligence",,"Recruiting","No Results Available","In-stent Restenosis|Neo-atherosclerosis|Retrospective","Other: no interventin","The identification of NA|neovascularizaion|ISR segment in the CAG images|lipid‐core arc|Thin‐cap fibroatheroma‐like neointima|macrophage arc","Chinese PLA General Hospital","All","18 Years to 80 Years   (Adult, Older Adult)",,"90","Other","Observational","Observational Model: Other|Time Perspective: Retrospective","AI-301-ISR","February 1, 2019","June 30, 2020","December 30, 2020","January 7, 2020",,"January 7, 2020","The General Hospital of PLA, Beijing, China",,"https://ClinicalTrials.gov/show/NCT04220437"
197,"NCT04299919","The AI Prognostic Assessment and Pathological Basis Research of Early HCC After Minimally Invasive Treatment",,"Active, not recruiting","No Results Available","Hepatocellular Carcinoma","Procedure: Minimally invasive treatment|Procedure: Hepatectomy","Three-month recurrence|Six-month recurrence|One-year recurrence|Two-year recurrence|Three-year recurrence|Progression-free survival","The First Affiliated Hospital of Dalian Medical University","All","Child, Adult, Older Adult",,"1200","Other","Observational","Observational Model: Case-Control|Time Perspective: Retrospective","PJ-KS-KY-2019-167","April 1, 2007","June 30, 2023","June 30, 2024","March 9, 2020",,"March 9, 2020","The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China",,"https://ClinicalTrials.gov/show/NCT04299919"
198,"NCT03650686","Validity, Reliability and Feasibility of an Automated Photographic Measurement/Assessment of Food Intake in the Hospitalized Elderly","PAMPILLE","Recruiting","No Results Available","Elderly People|Food Intake Measurement","Other: Food weighing (gold standard)|Other: Automated photographic method (method to be evaluated)|Other: Semi-quantitative method (routine method)","Average percentage quantification of ingesta","Centre Hospitalier Universitaire Dijon","All","18 Years and older   (Adult, Older Adult)",,"70","Other","Observational","Observational Model: Other|Time Perspective: Prospective","Buisson PHRIP 2017 PAMPILLE","May 3, 2018","May 2019","December 2019","August 29, 2018",,"August 29, 2018","Chu Dijon Bourogne, Dijon, France",,"https://ClinicalTrials.gov/show/NCT03650686"
199,"NCT04407533","Dietary Intake and Eating Habits During the COVID-19 Pandemic","COVIDiet","Recruiting","No Results Available","COVID-19","Other: Diet tracking and survey","Dietary intake|Diet quality|Eating habits","McGill University","All","18 Years and older   (Adult, Older Adult)",,"1920","Other","Observational","Observational Model: Ecologic or Community|Time Perspective: Prospective","20-04-064","May 25, 2020","August 31, 2022","August 31, 2022","May 29, 2020",,"May 29, 2020","McGill University - School of Human Nutrition, Montréal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT04407533"
200,"NCT04447599","Conjunctival and Retinal Vascularization and Small Vessel Disease","EVACORMA","Not yet recruiting","No Results Available","Cerebral Stroke","Other: photography of conjunctival vessels","Numbers of conjunctival vascular abnormalities|Classification of different types of vascular abnormalities in different grades of small vessel disease|Absence of difference between the 2 eyes|same stade of vascular abnormalities","University Hospital, Toulouse","All","55 Years to 80 Years   (Adult, Older Adult)","Not Applicable","850","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","RC31/20/0001","September 1, 2020","September 1, 2022","September 1, 2022","June 25, 2020",,"June 25, 2020","NASR Nathalie, Toulouse, France",,"https://ClinicalTrials.gov/show/NCT04447599"
201,"NCT04332055","RCT Measuring the Effect of the ERVIN Software",,"Not yet recruiting","No Results Available","Decision Making, Shared|Arthroplasty, Replacement, Knee|Arthroplasty, Replacement, Hip|Osteoarthritis, Knee|Osteoarthritis, Hip|Artificial Intelligence","Other: ERVIN","Oxford Hip Score|Oxford Knee Score|HRQoL|SDM","Northern Orthopaedic Division, Denmark|Aalborg University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","600","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research","2015-141-ERVIN","June 1, 2020","May 30, 2021","May 30, 2025","April 2, 2020",,"April 2, 2020","Northern Orthopaedic Division, Clinic Farsø, Aalborg University Hospital, Farsø, Northern Jutland, Denmark",,"https://ClinicalTrials.gov/show/NCT04332055"
202,"NCT02837172","Diagnosis of PD and PD Progression Using DWI","K23","Completed","No Results Available","Parkinson's Disease","Other: Diffusion Weighted Imaging (DWI)","MRI and DAT scan: Accuracy of diagnosis of Parkinson's disease in a clinically relevant population|Can MRI profile risk for tremor and postural instability in PD","University of Alabama at Birmingham","All","19 Years and older   (Adult, Older Adult)",,"58","Other","Observational","Observational Model: Case-Control|Time Perspective: Other","K23NS083620","September 25, 2014","April 14, 2019","April 14, 2019","July 19, 2016",,"June 19, 2019","University of Alabama at Birmingham, Birmingham, Alabama, United States",,"https://ClinicalTrials.gov/show/NCT02837172"
203,"NCT04400513","Development of an Algorithm to Differentiate Heart Murmurs Using Electronic Stethoscopes",,"Recruiting","No Results Available","Murmur, Heart|Aortic Valve Stenosis|Tricuspid Regurgitation|Mitral Regurgitation|Innocent Murmurs|Heart Murmurs","Device: Use of Eko CORE and Eko DUO electronic stethoscopes","Murmur Timing|Systolic Murmur Type Classification|Systolic Murmur Severity Classification","Eko Devices, Inc.","All","18 Years and older   (Adult, Older Adult)",,"1145","Industry","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","2020.3","June 25, 2020","September 2021","September 2021","May 22, 2020",,"June 29, 2020","CoxHealth, Springfield, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT04400513"
204,"NCT04278196","Computer Assisted Quality-monitoring for Magnet-controlled Capsule Endoscopy: a Prospective Case-control Study.",,"Recruiting","No Results Available","Magnet Controlled Capsule Endoscopy","Other: AI-Box","The integrity of the magnet controlled capsule endoscopy|The visibilty of the gastric|The time of operation in gastric","Shandong University","All","18 Years to 75 Years   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","2020SDU-QILU-24","January 1, 2020","February 28, 2020","March 15, 2020","February 20, 2020",,"February 20, 2020","Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China",,"https://ClinicalTrials.gov/show/NCT04278196"
205,"NCT04203251","Evaluation of TTE Utilization in Medical Surgery Step-Down Unit",,"Not yet recruiting","No Results Available","Cardiac Disease","Device: Caption Health Guidance Technology","Mean time to acquire images|Percentage of attempted studies with clinically useful images","Caption Health, Inc.","All","18 Years to 99 Years   (Adult, Older Adult)",,"100","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","CHUCSF01","March 2020","May 2020","May 2020","December 18, 2019",,"December 18, 2019","University of California San Francisco, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT04203251"
206,"NCT04056663","Health-circuit Evaluation as a Digital Support for the Management of Patients at Risk of Hospitalization","Health_Circuit","Not yet recruiting","No Results Available","Multiple Chronic Conditions|Chronic Disease","Behavioral: Health-Circuit mobile application","Unplanned visits|Service utilization measures|Change in The Health Empowerment Scale|Change in the Fantastic Lifestyle questionnaire|Equipment failures|Software failures|Errors in execution|Number of errors due to the participant's temporary functions|Errors due to failures in the organization|Number of participants in the study with respect to the total of potential participants|Number of entries to the application (app) per patient|Number of contacts with clinical professionals responsible for managing the case|Number of video calls|Number of patients who have accessed the conditions of use|Change in Continuity of care within the healthcare system as measured by the Nijmegen Continuity of Care Questionnaire|Patient satisfaction with the mHealth tool assessed by the Net Promoter Score alongside three custom made general satisfaction.|Professional satisfaction with the mHealth tool assessed by the Net Promoter Score alongside three custom made general satisfaction.|Patient mHealth tool usability assessed by the System Usability Scale|Professional mHealth tool usability by the System Usability Scale|Patient mHealth experience|Professional mHealth experience|Number of clinical diagnoses in app users|Degree of severity of the symptom|Duration of the symptom|Number of professionals that the manager has contacted through the app|Number of interactions between professionals through the app|Number of solutions provided only by the manager|Number of solutions provided by the primary care professional|Number of solutions that has been a virtual visit|Number of solutions that has been a classroom visit|Number of referrals to the emergency department regarding the total number of solutions","Hospital Clinic of Barcelona","All","18 Years and older   (Adult, Older Adult)","Not Applicable","400","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research","Health-Circuit Clinic","September 12, 2019","December 31, 2019","January 15, 2020","August 14, 2019",,"September 9, 2019","Hospital Clínic, Barcelona, Spain",,"https://ClinicalTrials.gov/show/NCT04056663"
207,"NCT03901664","Lymphocyte Sub-populations and Auto Immune Diseases","SPLIT","Completed","No Results Available","Autoimmune Diseases",,"Diagnosis of autoimmune disease","University Hospital, Brest","All","Child, Adult, Older Adult",,"3500","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","SPLIT ( 29BRC17.0243)","February 1, 2018","April 1, 2018","April 1, 2018","April 3, 2019",,"April 3, 2019","CHRU de Brest, Brest, France",,"https://ClinicalTrials.gov/show/NCT03901664"
208,"NCT04412031","Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient","PredictCovid19","Completed","No Results Available","to Predict an Unfavorable Evolution of Covid-19 at the Hospital Admission of Patients","Other: non applicable","Need of mechanical ventilation, transfer to an intensive care unit or death within 21 days of admission.","Hospices Civils de Lyon","All","18 Years and older   (Adult, Older Adult)",,"802","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","20_185","November 11, 2019","May 14, 2020","May 15, 2020","June 2, 2020",,"June 2, 2020","Hôpital E Herriot - Hospices Civils de LYON, Lyon, France",,"https://ClinicalTrials.gov/show/NCT04412031"
209,"NCT04383457","Covid-19 Triage Using Camera-based AI",,"Recruiting","No Results Available","Coronavirus Infections","Device: RIA-device (Remote Investigation and Assessment)","Agreement between the new camera based method and reference standard to estimate body temperature|Agreement between the new camera based method and reference standard to estimate heart rate|Agreement between the new camera based method and reference standard to estimate blood oxygen saturation|Agreement between the new camera based method and reference standard to estimate systolic blood pressure|Agreement between the new camera based method and reference standard to estimate diastolic blood pressure|Agreement between the new camera based method and reference standard to estimate respiratory rate|Prediction of hospital admission using vital signs estimated using reference standard methods|Prediction of death using vital signs estimated using reference standard methods|Prediction of hospital admission using vital signs estimated using the new camera based method|Prediction of death using vital signs estimated using the new camera based method|Prediction of hospital admission using raw camera data|Prediction of death using raw camera data","Vastra Gotaland Region|Detectivio AB","All","18 Years and older   (Adult, Older Adult)",,"500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","U1111-1251-4114","June 15, 2020","December 2020","December 2020","May 12, 2020",,"June 18, 2020","Östra Sjukhuset, Gothenburg, Sweden",,"https://ClinicalTrials.gov/show/NCT04383457"
210,"NCT03600051","Automated Phonocardiography Analysis in Adults",,"Completed","No Results Available","Aortic Insufficiency|Aortic Stenosis|Mitral Insufficiency|Mitral Insufficiency and Aortic Stenosis|Tricuspid Regurgitation|Insufficiency, Pulmonary|Insufficiency, Tricuspid","Device: Automated Heart Murmur Detection AI","Sensitivity for pathological heart murmur detection","CSD Labs GmbH","All","18 Years and older   (Adult, Older Adult)",,"90","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","GRZ03 (PbE)","December 10, 2015","January 18, 2017","January 31, 2017","July 26, 2018",,"July 26, 2018","University Hospital, Graz, Styria, Austria",,"https://ClinicalTrials.gov/show/NCT03600051"
211,"NCT04371289","Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up","CARDICoVRISK","Not yet recruiting","No Results Available","COVID-19|Cardiovascular Risk Factor",,"Predictive modeling of in-hospital outcome|Clinical, pathophysiological and molecular mechanisms|Short -Term Sequelae","Istituto Auxologico Italiano","All","18 Years and older   (Adult, Older Adult)",,"5500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CE_2020_03_26_02","April 2020","July 10, 2020","September 10, 2020","May 1, 2020",,"May 1, 2020","Istituto Auxologico Italiano, Milan, Italy",,"https://ClinicalTrials.gov/show/NCT04371289"
212,"NCT03585660","Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy",,"Recruiting","No Results Available","Prostate Cancer","Procedure: Diagnostic MRI|Procedure: Diagnostic Prostate Biopsy|Device: Risk Map DSS tool","Rate of biopsy samples positive for prostate cancer versus those that are negative as assessed by receiver operating characteristic curve|Rate of biopsy samples positive for prostate cancer versus those that are negative as assessed by area under the curve","University of Chicago","Male","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","IRB17-1694","June 19, 2018","June 2021","June 2022","July 13, 2018",,"October 8, 2019","University of Chicago Medical Center, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT03585660"
213,"NCT03885570","Blood Transfusion Management in Patients With Mitral Valve Replacement in China",,"Recruiting","No Results Available","Mitral Valve Replacement|Transfusion Reaction|Blood Transfusion Complication","Procedure: Mitral valve replacement","Mortality|Intraoperative blood transfusion","The Third Xiangya Hospital of Central South University|Second Xiangya Hospital of Central South University|Chinese Academy of Medical Sciences, Fuwai Hospital|The Affiliated Hospital Of Southwest Medical University|Qilu Hospital of Shandong University|Zhejiang Provincial People’s Hospital|Beijing Aerospace General Hospital","All","18 Years to 75 Years   (Adult, Older Adult)",,"2000","Other","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","ThirdXiangyaHCSUJF","September 16, 2019","December 2, 2019","December 31, 2021","March 21, 2019",,"September 19, 2019","Third Xiangya Hospital, Changsha, Hunan, China",,"https://ClinicalTrials.gov/show/NCT03885570"
214,"NCT04362657","Computer Aided Diagnosis in Upper GI Endoscopy","AIOGD","Recruiting","No Results Available","Upper Gastrointestinal Disorder|OGD","Diagnostic Test: Computer Aided Diagnosis","Anatomical coverage during OGD by CAD|Procedure time|Endoscopists satisfactory score","Chinese University of Hong Kong","All","18 Years and older   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","CREC 2019.274.T","April 20, 2020","January 22, 2022","July 22, 2022","April 27, 2020",,"April 29, 2020","Combined Endoscopy Center, Prince of Wales Hospital, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT04362657"
215,"NCT04116983","DERM NMSC Validation Study",,"Not yet recruiting","No Results Available","Non-melanoma Skin Cancer","Device: Deep Ensemble for the Recognition of Malignancy (DERM)","AUROC of DERM performance when analysing images of biopsied lesions|AUROC of DERM performance when analysing images of non-biopsied lesions|The sensitivity of DERM when used to assess biopsied lesions|The specificity of DERM when used to assess biopsied lesions|The false positive rate of DERM when used to assess biopsied lesions|The false negative rate of DERM when used to assess biopsied lesions|The positive predictive value of DERM when used to assess biopsied lesions|The negative predictive value of DERM when used to assess biopsied lesions|The sensitivity of DERM when used to assess non-biopsied lesions|The specificity of DERM when used to assess non-biopsied lesions|The false positive rate of DERM when used to assess non-biopsied lesions|The false negative rate of DERM when used to assess non-biopsied lesions|The positive predictive value of DERM when used to assess non-biopsied lesions|The negative predictive value of DERM when used to assess non-biopsied lesions|Concordance of clinician assessment with histologically confirmed diagnosis|The concordance of DERM result generated using images from each camera|The proportion of skin lesions with 3 images that can be analysed by DERM;|The proportion of skin lesions with at least 1 readable image that can be analysed by DERM","Skin Analytics Limited|Innovate UK","All","18 Years and older   (Adult, Older Adult)",,"543","Industry|Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","DERM-003","March 21, 2020","July 2020","September 2020","October 7, 2019",,"March 18, 2020","Royal Free London NHS Foundation Trust, London, United Kingdom|Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom|Poole General Hospital, Poole, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04116983"
216,"NCT04314271","The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia",,"Recruiting","No Results Available","Novel Coronavirus Pneumonia",,"characteristics of cardiopulmonary ultrasound|assess the relationship between pulmonary ultrasound imaging score and National Early Warning Score(NEWS) and prognosis.","Xiangya Hospital of Central South University","All","18 Years and older   (Adult, Older Adult)",,"80","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","202003028","March 20, 2020","May 1, 2020","May 31, 2020","March 19, 2020",,"March 19, 2020","Xiangya Hospital, Central South University, Changsha, Hunan, China",,"https://ClinicalTrials.gov/show/NCT04314271"
217,"NCT04434924","The Construction of Precision Medicine in Chinese Medicine",,"Not yet recruiting","No Results Available","Hypertension",,"The correlation between TCM body constitution and genetic variation","China Medical University Hospital","All","20 Years and older   (Adult, Older Adult)",,"600","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","CMUH109-REC1-025","June 16, 2020","December 31, 2021","December 31, 2021","June 17, 2020",,"June 17, 2020",,,"https://ClinicalTrials.gov/show/NCT04434924"
218,"NCT04335318","Real Life AI in Polyp Detection","RELIANT","Recruiting","No Results Available","Colonic Polyp","Device: AI-assisted colonoscopy","Polyp detection rate comparison|Mean withdrawal time comparison|AI-Polyp bounding boxes - True Positive Evaluation|AI-Polyp bounding boxes - False Positive Quantitative Evaluation|AI-Polyp bounding boxes - False Negative Evaluation|Reaction Time Analysis","Wuerzburg University Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","230","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","AI01","May 1, 2020","August 2020","November 2020","April 6, 2020",,"May 21, 2020","Universitätsklinikum Würzburg, Würzburg, Bayern, Germany",,"https://ClinicalTrials.gov/show/NCT04335318"
219,"NCT04222439","Deep Learning Algorithm for the Diagnosis of Gastrointestinal Diseases",,"Recruiting","No Results Available","Gastrointestinal Disease","Device: AI for the Diagnosis of Gastrointestinal Diseases","The diagnostic accuracy of gastrointestinal diseases with deep learning algorithm.|The diagnostic sensitivity of gastrointestinal diseases with deep learning algorithm.|The diagnostic specificity of gastrointestinal diseases with deep learning algorithm.|The diagnostic positive predictive value of gastrointestinal diseases with deep learning algorithm.|The diagnostic negative predictive value of gastrointestinal diseases with deep learning algorithm.","Shandong University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100000","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","2019-SDU-QILU-G710","January 1, 2020","February 2020","February 2020","January 10, 2020",,"February 18, 2020","Qilu Hospital, Shandong University, Jinan, Shandong, China",,"https://ClinicalTrials.gov/show/NCT04222439"
220,"NCT04087824","Deep Learning Algorithm for Recognition of Colonic Segments.",,"Not yet recruiting","No Results Available","Colonic Diseases","Device: AI assisted recognition of colonic segments","The accuracy of each colonic segment real-time recognition with deep learning algorithm.|The accuracy of total colonic segments recognition with deep learning algorithm as compared to endoscopic experts group.","Shandong University","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","2019SDU-QILU-G003","September 15, 2019","November 15, 2019","December 15, 2019","September 12, 2019",,"September 12, 2019",,,"https://ClinicalTrials.gov/show/NCT04087824"
221,"NCT03688906","AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test",,"Completed","No Results Available","Colo-rectal Cancer|Cancer Colon|Cancer, Rectum|Neoplasms,Colorectal|Polyps|Polyp of Colon|Adenoma|Adenoma Colon",,"Diagnosis of colorectal cancer or advanced adenomas in patients undergoing routine screening colonoscopy, or post-colonoscopy","Freenome, Inc.","All","18 Years and older   (Adult, Older Adult)",,"3275","Industry","Observational","Observational Model: Other|Time Perspective: Prospective","AI-EMERGE/FRE-001","January 12, 2018","November 25, 2019","November 25, 2019","September 28, 2018",,"May 1, 2020","Clinical Research Associates, Huntsville, Alabama, United States|Del Sol Research Management, Chandler, Arizona, United States|Del Sol Research Management,, Tucson, Arizona, United States|Del Sol Research Management, Tucson, Arizona, United States|Preferred Research Partners, Little Rock, Arkansas, United States|Precision Research Institute, Chula Vista, California, United States|Diverse Research Solutions, Oxnard, California, United States|Precision Research Institute, San Diego, California, United States|Gastroenterology Associates of Fairfield County, Bridgeport, Connecticut, United States|Palmetto Research, Hialeah, Florida, United States|Clinical Research of Homestead, Homestead, Florida, United States|Advanced Gastroenterology Associates, LLC, Palm Harbor, Florida, United States|Rockford Gastroenterology, Rockford, Illinois, United States|Delta Research Partners, Bastrop, Louisiana, United States|New Orleans Research Institute, Metairie, Louisiana, United States|Louisiana Research Center, Shreveport, Louisiana, United States|Commonwealth Clinical Studies, Brockton, Massachusetts, United States|Quality Clinical Research, Omaha, Nebraska, United States|Asheville Gastroenterology Associates, Asheville, North Carolina, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Cumberland Research Associates, Fayetteville, North Carolina, United States|Wake Research Associates, Raleigh, North Carolina, United States|Trial Management Associates, Wilmington, North Carolina, United States|The Jackson Clinic, Jackson, Tennessee, United States|Advanced Research Institute, Ogden, Utah, United States|Gastroenterology Associates of Tidewater, Chesapeake, Virginia, United States|Verity Research Inc, Fairfax, Virginia, United States|Digestive and Liver Disease Specialists, Norfolk, Virginia, United States|Washington Gastroenterology, Bellevue, Washington, United States|Forzani and MacPhail Colon Cancer Screening Centre, Calgary, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT03688906"
222,"NCT03793231","fungalAi for Fungal Surveillance & Antifungal Stewardship","fungalAi","Enrolling by invitation","No Results Available","Fungal Infections","Combination Product: fungalAi platform technology","Accuracy of electronic surveillance using fungalAi natural language processing compared to active manual methods for detection of fungal pneumonia|Accuracy of disease classification of deep learning based image analysis for fungal pneumonia at scan level.|Accuracy of feature detection of fungal pneumonia using deep learning based image analysis of chest CT compared to radiologist expertise.|Accuracy of disease classification of an expert system integrating microbiology and antifungal drug prescriptions with text and image analysis compared to active manual surveillance.","Bayside Health|Monash University|Monash Health|Eastern Health|Western Sydney Local Health District|SA Health|Fremantle Hospital and Health Service|Singhealth Foundation","All","Child, Adult, Older Adult",,"1000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","43127/MonH-2018-152967|012018|2015-54","January 1, 2019","April 30, 2020","June 30, 2020","January 4, 2019",,"June 28, 2019","Alfred Health, Melbourne, Victoria, Australia",,"https://ClinicalTrials.gov/show/NCT03793231"
223,"NCT04003662","Vital Sign Comparison Between Lifelight and Standard of Care - Development","VISION-D","Recruiting","No Results Available","Vital Signs","Device: Vital Signs Measurement","Blood Pressure Readings|Oxygen Saturation Readings|Heart Rate (pulse) Readings|Respiratory Rate","Xim Limited","All","3 Years and older   (Child, Adult, Older Adult)",,"9000","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","PHT/2018/25 IRAS ID 242581","May 1, 2018","May 1, 2020","May 1, 2020","July 1, 2019",,"July 1, 2019","Portsmouth Hospitals NHS Trust, Portsmouth, England, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04003662"
224,"NCT04032444","Collecting Orthopedic Safety and Performance Data Using Surgeons Clinical Outcomes Registry (SCOR)","SCOR","Recruiting","No Results Available","Orthopedics",,"Number of device associated and procedure associated adverse events.|Rates of revision surgeries.","Tornier, Inc.","All","18 Years and older   (Adult, Older Adult)",,"5000","Industry","Observational","Observational Model: Cohort|Time Perspective: Other","19F-W-SCOR-RM","July 30, 2019","January 2040","January 2040","July 25, 2019",,"March 11, 2020","Orthopedic Surgeon, Scottsdale, Arizona, United States|Orthopedic Surgeon, Denver, Colorado, United States|Orthopedic Surgeon, Bradenton, Florida, United States|Orthopedic Surgeon, Pensacola, Florida, United States|Orthopedic Surgeon, Augusta, Georgia, United States|Orthopedic Surgeon, Orland Park, Illinois, United States|Orthopedic Surgeon, Indianapolis, Indiana, United States|Orthopedic Surgeon, Overland Park, Kansas, United States|Orthopedic Surgeon, Falmouth, Maine, United States|Orthopedic Surgeon, Peabody, Massachusetts, United States|Orthopedic Surgeon, Saint Clair Shores, Michigan, United States|Orthopedic Surgeon, Florham Park, New Jersey, United States|Orthopedic Surgeon, Sioux Falls, South Dakota, United States|Orthopedic Surgeon, Houston, Texas, United States|Orthopedic Surgeon, Woodbridge, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT04032444"
225,"NCT03967756","Impact of Automatic Polyp Detection System on Adenoma Detection Rate",,"Recruiting","No Results Available","Colonic Polyps|Colorectal Adenomas","Device: Automatic polyp detection system","adenoma detection rate(ADR)|polyp detection rate(PDR)|adenoma per colonoscopy|polyp per colonoscopy","Changhai Hospital|The First Affiliated Hospital of Dalian Medical University|Wenzhou Central Hospital|Wuhan Union Hospital, China","All","40 Years to 85 Years   (Adult, Older Adult)","Not Applicable","1118","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","AI-2","June 1, 2019","July 20, 2020","October 1, 2020","May 30, 2019",,"March 5, 2020","Changhai Hospital, Second Military Medical University, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT03967756"
226,"NCT04145609","Intensified Acute Kidney Disease Care to Reduce Chronic Kidney Disease","ISACC","Not yet recruiting","No Results Available","Acute Kidney Injury|Renal Insufficiency, Chronic|Acute Kidney Disease|Decision Support Systems, Clinical","Behavioral: Multidisciplinary team (MDT) care and Acute kidney disease (AKD) clinic","Proportion of Major adverse kidney event|Mortality|Chronic dialysis|Renal progression|Time to MAKE|Time to death|Time to chronic dialysis|Time to renal progression to CKD|Time to first ER visit|Time to first rehospitalization|Time to first recurrence of AKI|Proportion of MACE","Taipei Medical University Shuang Ho Hospital|National Health Research Institutes, Taiwan|Taipei Medical University","All","20 Years and older   (Adult, Older Adult)","Not Applicable","690","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","N201905047","January 1, 2020","December 31, 2020","December 31, 2021","October 30, 2019",,"October 30, 2019",,,"https://ClinicalTrials.gov/show/NCT04145609"
227,"NCT04414033","Bubble: A New VR-AI Way of Treatment for Hot Flashes in Women With Breast Cancer",,"Completed","No Results Available","Hot Flashes|Breast Cancer","Device: Bubble: A New VR-AI Way of Treatment for Hot Flashes","Demographic and background (disease & treatment-elated) information|HFRDIS The Hot Flash Related Daily Interference Scale|HFRS The Hot Flash Rating Scale|PSS The Perceived Stress Scale|K10 The Kessler Psychological Distress Scale|B-IPQ The Brief Illness Perception Questionnaire|PSQI The Pittsburgh Sleep Quality Index|WHOQOL-BREF The World Health Organization Quality of Life Scale","Bar-Ilan University, Israel|Hematology and Oncology Specialists","Female","28 Years to 55 Years   (Adult)","Not Applicable","37","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","22012020","February 1, 2018","February 28, 2019","February 28, 2019","June 4, 2020",,"June 4, 2020","Bar Ilan University, Ramat Gan, Israel",,"https://ClinicalTrials.gov/show/NCT04414033"
228,"NCT04347369","A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease",,"Recruiting","No Results Available","COVID-19 Disease","Other: other","discrimination|Calibration|Net benefit","Xinqiao Hospital of Chongqing","All","18 Years to 80 Years   (Adult, Older Adult)",,"1000","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","XQonc-015","January 17, 2020","April 30, 2020","May 31, 2020","April 15, 2020",,"April 15, 2020","Xinqiao Hospital of Chongqing, Chongqing, China",,"https://ClinicalTrials.gov/show/NCT04347369"
229,"NCT04256395","Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19","COVID-19","Completed","No Results Available","Susceptibility to Viral and Mycobacterial Infection","Other: mobile internet survey on self-test","positive number diagnosed by national guideline in the evaluated population|distribution map of evaluated people|Effect of medical guidance by designated feedback questionnaire|mental scale of relief the mental anxiety and avoid unnecessary outpatient","Beijing Tsinghua Chang Gung Hospital|Institute for precision medicine of Tsinghua University|Institute for artificial intelligent of Tsinghua University|Chinese Medical Doctor Association|Institute for network behavior of Tsinghua University|school of clinical medicine of Tsinghua University","All","Child, Adult, Older Adult",,"102456","Other","Observational","Observational Model: Other|Time Perspective: Prospective","RWS-BTCH-002","February 1, 2020","July 1, 2020","July 1, 2020","February 5, 2020",,"July 7, 2020","Beijing Tsinghua Changgung Hospital, Beijing, Beijing, China",,"https://ClinicalTrials.gov/show/NCT04256395"
230,"NCT00825461","Ghrelin With Anorexia Nervosa",,"Completed","No Results Available","Anorexia Nervosa",,"Concentration of ghrelin in blood.","Maastricht University Medical Center","Female","12 Years to 35 Years   (Child, Adult)",,"20","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","08-3-089","March 2009","December 2011","December 31, 2012","January 21, 2009",,"January 9, 2018","University Hospital Maastricht, Maastricht, Limburg, Netherlands",,"https://ClinicalTrials.gov/show/NCT00825461"
231,"NCT03837327","Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy","VOCAL","Recruiting","No Results Available","Adnexal Mass|Ovarian Cancer|Pelvic Mass",,"To determine the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the VOCAL test|To evaluate the association of protein and glycoprotein (GP) biomarkers with histological subtypes, stage, treatments and disease free survival (DFS) among woman with ovarian cancer","Venn Biosciences Corporation","Female","18 Years and older   (Adult, Older Adult)",,"1200","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","OVACA-001","April 16, 2019","April 2021","April 2021","February 12, 2019",,"November 22, 2019","Palo Alto Medical Foundation, Sunnyvale, California, United States|Mayo Clinic, Jacksonville, Florida, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|Dr. Sudarshan K. Sharma, Ltd. - Gynecologic Oncology, Hinsdale, Illinois, United States|Hospital Sultan Ismail, Johor Bahru, Johor, Malaysia|Hospital Seberang Jaya, Seberang Jaya, Penang, Malaysia|Hospital Raja Permaisuri Bainun, Ipoh, Perak, Malaysia|Hospital Wanita Dan Kanak-kanak Sabah, Kota Kinabalu, Sabah, Malaysia|The Medical City, Pasig City, Metro Manila, Philippines",,"https://ClinicalTrials.gov/show/NCT03837327"
232,"NCT04323137","Encouraging Flu Vaccination Among High-Risk Patients Identified by ML",,"Not yet recruiting","No Results Available","Influenza|Vaccination|Health Promotion|Health Behavior|Risk Reduction","Behavioral: Risk reduction|Behavioral: Medical records-based recommendation|Behavioral: Algorithm-based recommendation","Flu vaccination rate|Flu diagnosis rate|Flu-like symptoms rate|Flu complications rate|Change in ER visits from pre- to post-intervention|Change in hospitalizations from pre- to post-intervention|Flu vaccination among relatives|Flu diagnosis among relatives|Flu-like symptoms among relatives|Flu complications among relatives","Geisinger Clinic","All","18 Years and older   (Adult, Older Adult)","Not Applicable","16500","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Prevention","2020-0290","September 2020","May 2021","May 2021","March 26, 2020",,"March 26, 2020",,,"https://ClinicalTrials.gov/show/NCT04323137"
233,"NCT04213430","Development and Validation of a Deep Learning System for Multiple Ocular Fundus Diseases Using Retinal Images",,"Recruiting","No Results Available","Ophthalmological Disorder","Other: diagnostic","Area under the receiver operating characteristic curve of the deep learning system|Sensitivity of the deep learning system|Specificity of the deep learning system","Sun Yat-sen University","All","Child, Adult, Older Adult",,"300000","Other","Observational","Observational Model: Other|Time Perspective: Other","CCPMOH2019- China8","January 2014","February 2020","May 2020","December 30, 2019",,"December 30, 2019","Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT04213430"
234,"NCT03569176","Examining the Efficacy of a Mobile Therapy for Children With Autism Spectrum Disorder",,"Completed","No Results Available","Autism Spectrum Disorder","Device: Autism Glass","Change in socialization subscale scores of the Vineland Adaptive Behavior Scales, 2nd Edition (VABS-II) from baseline to week 6.|Change in Parent Rated Social Responsiveness Scale 2 (SRS-2) from baseline to week 6|Change in NEPSY-II, Affect Recognition subscale scores from baseline to week 6|Change in Emotion Guessing Game (EGG) scores from baseline to week 6|Change in ASD symptoms as measured by Brief Observation of Social Communication Change (BOSCC) from baseline to week 6|Change in adaptive social and personal skills as measured by Vineland Adaptive Behavior Scales, 2nd edition (VABS-II) Full Scale from baseline to week 6.|Change in child's emotional, behavioral, and social problems from Baseline (week 0) to Week 6 as measured by Child Behavior Checklist (CBCL).","Dennis Paul Wall|Stanford University","All","6 Years to 12 Years   (Child)","Not Applicable","74","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","IRB-34059","November 1, 2016","April 11, 2018","April 15, 2018","June 26, 2018",,"July 17, 2018",,,"https://ClinicalTrials.gov/show/NCT03569176"
235,"NCT04049981","Investigation of Mechanisms of Action in Superpower Glass",,"Recruiting","No Results Available","Autism Spectrum Disorder|Autism","Device: Superpower Glass","Change in socialization subscale scores of the Vineland Adaptive Behavior Scales,3rd Edition (VABS-III) from baseline to week 4.|Change in Parent Rated Social Responsiveness Scale 2 (SRS-2) from baseline to week 4|Changes in Parent Self Agency Measure scores from Baseline to Week 4|Change in ASD symptoms as measured by Brief Observation of Social Communication Change (BOSCC) from baseline to week 4","Stanford University","All","4 Years to 8 Years   (Child)","Phase 1|Phase 2","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","34059|PHIND Dream Team Award|SPARK Pilot Program","September 4, 2019","January 1, 2020","May 1, 2020","August 8, 2019",,"September 18, 2019","Stanford University, Stanford, California, United States",,"https://ClinicalTrials.gov/show/NCT04049981"
236,"NCT04410848","Symbolic Regression Model To Predict Choledocholithiasis","(SymChole)","Recruiting","No Results Available","Common Bile Duct Calculi","Other: To determine the diagnostic of Choledocholithiasis with symbolic regression model","To validate prospectively a symbolic regression model to predict choledocholithiasis","Hospital Universitario Dr. Jose E. Gonzalez","All","18 Years and older   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","GA19-00003","June 7, 2019","May 30, 2020","July 31, 2020","June 1, 2020",,"June 1, 2020","Hospital Universitario Dr. Jose E. Gonzalez, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico",,"https://ClinicalTrials.gov/show/NCT04410848"
237,"NCT04369690","The Psychological, Social, and Economic Impacts of COVID-19","C19Survey","Recruiting","No Results Available","COVID-19|Chronic Disease|Psychiatric Disorder|Cardiovascular Diseases",,"Mental health - Stress|Mental health - Anxiety|Mental health - Depression|Moral distress in healthcare workers|Moral resilience in healthcare workers|Social life|COVID-9 symptoms|Adverse health long-term outcome|Health care utilization - Inpatient|Health care utilization - ER|Health care utilization - Outpatient|Sleep","University of Ottawa|Hopital du Sacre-Coeur de Montreal|Sunnybrook Health Sciences Centre|Southlake Regional Health Centre|The Ottawa Hospital Research Institute|Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal|Centre for Addiction and Mental Health|CHEO Research Institute|Ottawa Heart Institute Research Corporation|McGill University|Johns Hopkins University|Université de Montréal|The Royal's Institute of Mental Health Research","All","12 Years and older   (Child, Adult, Older Adult)",,"1000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2131","April 3, 2020","April 3, 2021","April 3, 2021","April 30, 2020",,"April 30, 2020","Southlake Regional Health Centre, Newmarket, Ontario, Canada|CHEO Research Institute, Ottawa, Ontario, Canada|The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada|The Centre for Addiction and Mental Health, Ottawa, Ontario, Canada|The University of Ottawa Heart Institute, Ottawa, Ontario, Canada|The Royal's Institute of Mental Health Research, Ottawa, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Hôpital en santé mentale Rivière-des-Prairies (CIUSSS du Nord-de-l'Île-de-Montréal), Montréal, Quebec, Canada|McGill University, Montréal, Quebec, Canada|University of Montréal, Montréal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT04369690"
238,"NCT04445012","Cardiovascular Acoustics and an Intelligent Stethoscope","CAIS","Recruiting","No Results Available","Heart Valve Diseases",,"To assess specificity of an AI algorithm for detecting clinically significant valve disease and congenital heart disease relative to the performance of GPs","Papworth Hospital NHS Foundation Trust","All","Child, Adult, Older Adult",,"1150","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","P02087","October 24, 2019","September 30, 2021","January 31, 2022","June 24, 2020",,"June 24, 2020","University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom|Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|King's College Hospital NHS Foundation Trust, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04445012"
239,"NCT04240652","The Diabetic Retinopathy Screening, Prevention and Control Program",,"Recruiting","No Results Available","Diabetic Retinopathy",,"Diabetic retinopathy|Referable diabetic retinopathy|Vision threatening diabetic retinopathy|Diabetic macular edema|HbA1c (%)|Smoking history|Alcohol intake|Salt intake|Vegetable and fruits intake|Physical activity|Blood pressures (mmHg)|Lipids (mg/dl)|Cardiolvascular diseases|Body mass index (BMI)|Systolic blood pressure|Diastolic blood pressure|Visceral fat (cm^2)|Fasting glucose (mmol/L)|Postprandial glucose (mmol/L)|Fasting serum C peptide (ug/L)|Postprandial serum C peptide (ug/L)|Fasting serum insuline (μIU/mL)|Postprandial serum insuline (μIU/mL)|Intimal medial thikness (mm)|Pulse wave velocity (cm/s)|Albumin-creatinine-ratio (mg/mmol)","Shanghai Jiao Tong University School of Medicine","All","18 Years and older   (Adult, Older Adult)",,"500000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Ruijin-20191231","June 5, 2018","June 5, 2038","June 5, 2040","January 27, 2020",,"February 5, 2020","Ruijin hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, Shanghai, China|Shanghai Jiao-Tong University School of Medicine, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT04240652"
240,"NCT04304118","Rajaie Cardiomyopathy and Myocarditis Registry",,"Recruiting","No Results Available","Clinical Characteristics|Natural History|Long-term Outcomes|Current Therapeutic Approaches",,"Admissions to hospital|Development of chronic heart failure|Prevalence of Stroke/Transient ischemic attack|Incidence of sudden death|Incidence of heart trasplantation|response to current therapeutic approaches","Rajaie Cardiovascular Medical and Research Center","All","1 Year and older   (Child, Adult, Older Adult)",,"6000","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","registry_98118","November 11, 2019","November 11, 2020","November 11, 2025","March 11, 2020",,"March 11, 2020","Behshid Ghadrdoost, Tehran, Iran, Islamic Republic of",,"https://ClinicalTrials.gov/show/NCT04304118"
241,"NCT04126239","Validation of a Food Addiction Screening Test","FAST - FR","Recruiting","No Results Available","Food Addiction|Obesity","Other: Online survey - questionnaire","FAST score|YFAS 2.0|BES score|DEBQ score","Hospices Civils de Lyon","All","18 Years to 70 Years   (Adult, Older Adult)",,"1610","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","69HCL19_0320","October 7, 2019","October 31, 2020","June 30, 2021","October 15, 2019",,"October 15, 2019","Centre Hospitalier Lyon Sud, Pierre-Bénite, France",,"https://ClinicalTrials.gov/show/NCT04126239"
242,"NCT04420793","Voice Changes During ECT","VAPRE","Recruiting","No Results Available","Unipolar Depression|Bipolar Depression|Bipolar Disorder, Manic","Other: Questionnaire","Acoustic feature: zero crossing rate|Acoustic feature: energy and entropy|Acoustic feature: spectral centroid, spectral spread, spectral entropy, spectral flux, spectral rolloff|Acoustic feature: Mel-Frequency Cepstral Coefficients, Chroma Vectors, and Chroma Deviation|Linguistic features: question ratio, filler ratio, number ratio, type token ratio|Linguistic features: verb frequency, noun frequency, pronoun frequency, adverb frequency, adjective frequency, particle frequency, conjunction frequency, pronoun frequency|Linguistic features: standardized word entropy|Linguistic features: Brunets index|Linguistic features: Honores statistic|Linguistic features: rate of speech|Meta-features: fatigue|Meta-features: audio quality|Meta-features: sentiment|Meta-features: stress|Meta-features: gender|Meta-features: accent|Meta-features: length|Meta-features: age|Comparing the voice feature(s) with greatest statistically significant change to Patient Health Questionnaire (PHQ)-9 scores|Acoustic Feature Specific Changes within and across sessions|Linguistic Feature Specific Changes within and across sessions|Meta-Feature Specific Changes within and across sessions|Acoustic Feature Specific Changes between sessions|Linguistic Feature Specific Changes between sessions|Meta-Feature Specific Changes between sessions|Patient Chart Review Data: Age|Patient Chart Review Data: inpatient/outpatient status|Patient Chart Review Data: gender|Patient Chart Review Data: race|Patient Chart Review Data: Psychiatric diagnosis for ECT|Patient Chart Review Data: PHQ-9 score at each session|Patient Chart Review Data: Psychiatric hospitalizations|Patient Chart Review Data: Past Psychiatric Medication Trials|Patient Chart Review Data: Current Psychiatric Medication Trials|Patient Chart Review Data: Classes of Current Psychiatric Medications|Patient Chart Review Data: Suicidal Ideation at ECT consult|Patient Chart Review Data: Past Suicide Attempts|Patient Chart Review Data: Psychiatric Review of Systems|Patient Chart Review Data: Family Psychiatric History|Patient Chart Review Data: Number of non-psychiatric medical diagnoses|Patient Chart Review Data: Past non-psychiatric medication trials|Patient Chart Review Data: Current non-psychiatric Medications|Patient Chart Review Data: Tobacco use history|Patient Chart Review Data: Tobacco use pack year|Patient Chart Review Data: Prior ECT treatment|Patient Chart Review Data: total # of prior ECT treatments for response in the past|Patient Chart Review Data: Prior transcranial magnetic stimulation (TMS) treatment|Patient Chart Review Data: Prior response to ECT or TMS|Patient Chart Review Data against voice features|Generating ROC curves: stress|Generating ROC curves: fatigue|Generating ROC curves: sentiment","Medical University of South Carolina","All","18 Years to 89 Years   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","00089198","November 7, 2019","June 30, 2021","June 30, 2021","June 9, 2020",,"June 9, 2020","Medical University of South Carolina, Charleston, South Carolina, United States",,"https://ClinicalTrials.gov/show/NCT04420793"
243,"NCT04416776","Validation of the Utility of Strabismus Intelligent Diagnostic System",,"Recruiting","No Results Available","Ophthalmological Disorder|Strabismus","Drug: Strabismus diagnostic system.","The proportion of accurate, mistaken and miss detection of the diagnostic system.","Sun Yat-sen University","All","Child, Adult, Older Adult",,"323","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","SIDS-2020","September 1, 2019","June 10, 2020","June 10, 2020","June 4, 2020",,"June 4, 2020","Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT04416776"
244,"NCT03849755","Patient Empowerment Through Predictive Personalised Decision Support(PEPPER)-Validation Study.","PEPPER","Enrolling by invitation","No Results Available","Diabetes Mellitus, Type 1","Device: PEPPER system","Change in the percentage of time in glucose target range (glucose levels 3.9-10 mmol/l or 70 - 180 mg/dl)|Change in glycosylated hemoglobin (HbA1c) value|Change in the number of episodes of post-prandial hypoglycaemia (glucose level below 3,9 mmol/L or 70 mg/dl) within 4 hours|Change in the number of episodes of post-prandial hypoglycaemia (glucose level below 3,9 mmol/L or 70 mg/dl) within 6 hours|Change in the percentage of time in hyperglycaemia (glucose level above 10 mmol/l or 180 mg/dl)|Change in the percentage of time in hypoglycaemia (glucose level below 3, 9 mmol/L or 70 mg/dl)|Change in the post-prandial area under the curve (AUC) of glucose level at 4 hours|Change in the post-prandial area under the curve (AUC) of glucose level at 6 hours|Change in the post-prandial area under the curve (AUC) (< 3,9 mmol/l or <70 mg/dl) of glucose level at 4 hours|Change in the post-prandial area under the curve (AUC) (< 3,9 mmol/l or <70 mg/dl) of glucose level at 6 hours|Change in glycaemic risk measured with low blood glucose index (LBGI)|Change in glycaemic risk measured with high blood glucose index (HBGI)|Change in glycaemic variability measured with mean amplitude of glycaemic excursions (MAGE)|Change in glycaemic variability measured with continuous overall net glycemic action at 2 hours (CONGA-2)|Change in weight (kg)|Change in insulin dose requirements|Measurement of satisfaction of diabetes treatment using Diabetes Treatment Satisfaction Questionnaire (DTSQ)|Measurement of quality of life in patients with diabetes mellitus using Diabetes Quality of Life (DQOL) questionnaire|Measurement of diabetes related problems by using Problem Areas in Diabetes (PAID) questionnaire|Measurement of health-related quality of life by using EQ-5D questionnaire|Number of incidence of low glucose alarms|Number of incidence of high glucose alarms|Number of incidence of carbohydrate recommender|Number of incidence of low glucose suspend|Number of incidence of fault detection alarm|Number of technical faults of the PEPPER safety system (any of the components listed above)|Evaluation of usability of PEPPER system by conducting the usability test","Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta|Imperial College London|Oxford Brookes University|Universitat de Girona|Cellnovo Limited|Romsoft SRL","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","669/18/EC|689810","November 15, 2018","January 31, 2020","January 31, 2020","February 21, 2019",,"August 1, 2019","Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona, Spain",,"https://ClinicalTrials.gov/show/NCT03849755"
245,"NCT04208789","Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis",,"Recruiting","No Results Available","MDR Tuberculosis|Resistance to Tuberculostatic Drugs","Diagnostic Test: Rapid Molecular Drug-Resistant Tuberculosis Test|Other: Artificial Intelligent Model|Diagnostic Test: Drug Susceptibility Test","Accuracy of Artificial Intelligent Model to Drug Susceptibility Test Results|Accuracy of Rapid Molecular Drug Resistant Tuberculosis test to Drug Susceptibility Test Results","Hasanuddin University|Chulalongkorn University","All","Child, Adult, Older Adult",,"528","Other","Observational","Observational Model: Case-Control|Time Perspective: Retrospective","0111190912","June 15, 2020","September 30, 2020","December 30, 2020","December 23, 2019",,"June 25, 2020","Kanudjoso Djatiwibowo General Hospital, Balikpapan, East Kalimantan, Indonesia|Tarakan General Hospital, Tarakan, North Kalimantan, Indonesia|Labuang Baji General Hospital, Makasar, South Sulawesi, Indonesia|Balai Besar Kesehatan Paru Masyarakat, Makasar, South Sulawesi, Indonesia|Wahidin Sudirohusodo General Hospital, Makassar, South Sulawesi, Indonesia",,"https://ClinicalTrials.gov/show/NCT04208789"
246,"NCT04221100","xrAI - Improving Quality and Efficiency in Chest Radiograph Interpretation by Radiologists",,"Not yet recruiting","No Results Available","Pulmonary Disease","Device: Radiograph interpretation for pulmonary abnormalities","Number of abnormalities identified divided by number of total of images analyzed (accuracy)|Number of true abnormalities identified divided by the total of abnormalities identified (precision)|Number of true abnormalities identified divided by the sum of true abnormalities identified and abnormalities missed (recall)|Mean of radiologist accuracy (as defined in outcome 1)|Mean of radiologist precision (as defined in outcome 2)|Mean of radiologist recall (as defined in outcome 3)","1QB Information Technologies Inc.","All","Child, Adult, Older Adult","Not Applicable","12","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic","xrAI ClinicalEvaluation Rads","March 2020","May 2020","May 2020","January 9, 2020",,"January 9, 2020",,,"https://ClinicalTrials.gov/show/NCT04221100"
247,"NCT04262557","Sunrise® a New Medical Device to Diagnose Sleep Apnea Syndrome","SENSAPNEA","Recruiting","No Results Available","Sleep Apnea Syndrome, Obstructive","Diagnostic Test: Sunrise® solution|Diagnostic Test: Polysomnography","The performance of Sunrise® to detect the respiratory event index (REI)|Evaluation of the Sunrise® reproductibility on three consecutive nights|Evaluation of the sleep quality: depth of sleep|Evaluation of the sleep quality: number of wake-ups|Evaluation of the sleep quality: sleep duration","University Hospital, Grenoble|SUNRISE|Icadom|DOCAPOST","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","40","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","38RC19.358","May 18, 2020","October 31, 2020","December 31, 2020","February 10, 2020",,"June 12, 2020","University Hospital Grenoble Alpes, Grenoble, France",,"https://ClinicalTrials.gov/show/NCT04262557"
248,"NCT04153045","xrAI - Improving Quality and Efficiency in Chest Radiograph Interpretation",,"Not yet recruiting","No Results Available","Pulmonary Disease","Device: Radiograph interpretation for pulmonary abnormalities","Number of abnormalities identified divided by number of total of images analyzed (accuracy)|Number of true abnormalities identified divided by the total of abnormalities identified (precision)|Number of true abnormalities identified divided by the sum of true abnormalities identified and abnormalities missed (recall)|Mean of physician accuracy (as defined in outcome 1)|Mean of physician precision (as defined in outcome 2)|Mean of physician recall (as defined in outcome 3)","1QB Information Technologies Inc.|Saskatchewan Health Authority - Regina Area","All","Child, Adult, Older Adult","Not Applicable","36","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic","xrAI ClinicalEvaluation Stage1","February 1, 2020","March 1, 2020","March 1, 2020","November 6, 2019",,"January 27, 2020",,,"https://ClinicalTrials.gov/show/NCT04153045"
249,"NCT04357691","Effects of Different Cardiorespiratory Training Program on Endurance Performance",,"Not yet recruiting","No Results Available","Healthy","Behavioral: Conventional training|Behavioral: AI-led training","Changes in 2.4 km completion time following first cycle in phase 1|Changes in 2.4 km completion time following second cycle in phase 1|Changes in 2.4 km completion time following third cycle in phase 1|Changes in 2.4 km completion time following phase 2|Changes in VO2peak following first cycle in phase 1|Changes in VO2peak following second cycle in phase 1|Changes in VO2peak following third cycle in phase 1|Changes in VO2peak following phase 2|Resting blood lipids panel (triglycerides, cholesterols, phospholipids, sphingolipids, inflammatory lipids, testosterone, cortisol, endocannabinoids) in phase 1|Changes in blood lipids panel (triglycerides, cholesterols, phospholipids, sphingolipids, inflammatory lipids, testosterone, cortisol, endocannabinoids) pre- and post- training following first cycle in phase 1|Changes in blood lipids panel (triglycerides, cholesterols, phospholipids, sphingolipids, inflammatory lipids, testosterone, cortisol, endocannabinoids) pre- and post- training following second cycle in phase 1|Changes in blood lipids panel (triglycerides, cholesterols, phospholipids, sphingolipids, inflammatory lipids, testosterone, cortisol, endocannabinoids) pre- and post- training following third cycle in phase 1|Changes in resting blood lipids panel (triglycerides, cholesterols, phospholipids, sphingolipids, inflammatory lipids, testosterone, cortisol, endocannabinoids) in phase 2|Changes in blood lipids panel (triglycerides, cholesterols, phospholipids, sphingolipids, inflammatory lipids, testosterone, cortisol, endocannabinoids) pre- and post- training in phase 2","Wang Yongtai Raymond|The N1 Institute for Health, Singapore|National University, Singapore","Male","21 Years to 35 Years   (Adult)","Not Applicable","20","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Other","Project CURATE","May 25, 2020","December 31, 2022","December 31, 2022","April 22, 2020",,"May 4, 2020","National University of Singapore, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT04357691"
250,"NCT04068584","Evaluation of the Impact of the SMART ANGEL ™ Device on Follow-up at Home Following Major or Intermediate Outpatient Surgery","SMART ANGEL 2","Recruiting","No Results Available","Ambulatory Surgery","Other: Smart Angel","Non-scheduled hospitalization rates between groups|Number of non-scheduled consultations between groups|Rates of calls with nurses between groups|Rates of calls with doctors between groups|Rates of unplanned prescriptions between groups|Rates of unplanned exams between groups|Rate of complications between groups|Rate of readmission between groups|Date of return to work or other activity|Patient satisfaction|Patient quality of life|Difficulties in using the device|Requirement of external help in using the device|Times spent on device|Technical errors arising","Centre Hospitalier Universitaire de Nīmes|EVOLUCARE","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","1260","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care","CIVI/2018/PC-01","February 3, 2020","August 2021","August 2021","August 28, 2019",,"June 29, 2020","Polyclinique du Parc Rambot, Aix-en-Provence, France|Clinique Bonnefon, Alès, France|Centre hospitalier universitaire Amiens-Picardie, Amiens, France|Centre hospitalier D'Arles, Arles, France|Centre Hospitalier Henri Duffaut, Avignon, France|CHU Bordeaux II, Bordeaux, France|CH antoine gayraud, Carcassonne, France|Hôpital Henri-Mondor, Créteil, France|CHU Lille, Lille, France|Clinique Via Domitia, Lunel, France|Lyon Sud, Lyon, France|Hopital Nord, Marseille, France|ICM, Montpellier, France|Hopital Saint Eloi, Montpellier, France|Hôpital Lapeyronie, Montpellier, France|Clinique des Franciscaines, Nimes, France|CHU de Nimes, Nîmes, France|Clinique Kenval, Nîmes, France|Polyclinique Grand Sud, Nîmes, France|Clinique Jouvenet, Paris, France|Hôpital Universitaire Pitié Salpêtrière, Paris, France|Institut Mutualiste Montsouris, Paris, France|CHU de Rennes, Rennes, France|CHU de Saint-Etienne, Saint-Étienne, France",,"https://ClinicalTrials.gov/show/NCT04068584"
251,"NCT04463706","COVID19 Severity Prediction and Health Services Research Evaluation",,"Recruiting","No Results Available","Covid19","Other: Predictors adverse evolution|Other: Predictors of health care provide","Clinical deterioration|Relief of symptoms|Mortality|Complications at follow up|Cost","Hospital Galdakao-Usansolo|Hospital Costa del Sol|Hospital del Mar|University Hospital of the Nuestra Señora de Candelaria|Instituto de Salud Carlos III|Hospital Universitario Araba|Biocruces Bizkaia Health Reseach Institute|Hospital de Basurto|Hospital Donostia","All","Child, Adult, Older Adult",,"20000","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","COVID19_0459","June 1, 2020","June 30, 2021","December 31, 2021","July 9, 2020",,"July 9, 2020","Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain",,"https://ClinicalTrials.gov/show/NCT04463706"
252,"NCT03738982","Patient Empowerment Through Predictive Personalised Decision Support","PEPPER","Completed","No Results Available","Type1 Diabetes Mellitus","Device: PEPPER","Change in the percentage of time spent in hypoglycaemia (glucose level below 3, 9 mmol/L or 70 mg/dl)|Number of incidence of low glucose alarms|Number of incidence of high glucose alarms|Number of incidence of carbohydrate adviser|Number of incidence of low glucose suspend|Number of incidence of fault detection alarm|Change in the percentage of time in glucose target range (glucose levels 3.9-10 mmol/l or 70 - 180 mg/dl)|Change in the percentage of time in hyperglycaemia (glucose level above 10 mmol/l or 180 mg/dl)|Change in the number of episodes of post-prandial hypoglycaemia (glucose level below 3,9 mmol/L or 70 mg/dl) within 4 hours|Change in the number of episodes of post-prandial hypoglycaemia (glucose level below 3,9 mmol/L or 70 mg/dl) within 6 hours|Change in the post-prandial glucose level at 120 minutes (mg/dl)|Change in the post-prandial glucose level at 120 minutes (mmol/l)|Change in the post-prandial area under the curve (AUC) of glucose level at 4 hours (min x mg/dl)|Change in the post-prandial area under the curve (AUC) of glucose level at 4 hours (min x mmol/l)|Change in glycaemic risk measured with low blood glucose index (LBGI)|Change in glycaemic risk measured with high blood glucose index (HBGI)|Change in glycaemic variability measured with mean amplitude of glycaemic excursions (MAGE) (mg/dl)|Change in glycaemic variability measured with mean amplitude of glycaemic excursions (MAGE) (mmol/l)|Change in glycaemic variability measured with continuous overall net glycemic action at 2 hours (CONGA-2) (mg/dl)|Change in glycaemic variability measured with continuous overall net glycemic action at 2 hours (CONGA-2) (mmol/l)|Measurement of satisfaction of diabetes treatment using Diabetes Treatment Satisfaction Questionnaire (DTSQ)|Measurement of quality of life in patients with diabetes mellitus using Diabetes Quality of Life (DQOL) questionnaire.|Measurement of diabetes related problems by using Problem Areas in Diabetes (PAID) questionnaire|Evaluation of usability and the treatment satisfaction of PEPPER system by using non-validated questionnaires.","Imperial College London|Oxford Brookes University|Universitat de Girona|Cellnovo Limited|Romsoft SRL|Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta","All","18 Years and older   (Adult, Older Adult)","Not Applicable","48","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","17HH3961","January 9, 2018","November 14, 2019","November 14, 2019","November 13, 2018",,"January 10, 2020","Imperial College Clinical Research Facility, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03738982"
253,"NCT03750890","Visual Study of Molecular Genotype in Glioma Evolution",,"Recruiting","No Results Available","Glioma of Brain",,"radiomics features（the parameters of T1WI, T2WI, DWI, DKI, ASL, ESWAN, DCE, MRS and so on）|microomics molecular markers (IDH mutation, 1p/19q status, P53 mutation, TERT and ATRX mutation, EGFR amplification and mutation, MGMT methylation status, PTEN mutation, ZM fusion gene and other gene features)","Tongji Hospital","All","Child, Adult, Older Adult",,"1000","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","ZWZ2018","January 1, 2019","December 31, 2021","December 31, 2022","November 23, 2018",,"March 26, 2019","Zhenxiong Wang, Wuhan, Choose A State Or Province, China",,"https://ClinicalTrials.gov/show/NCT03750890"
254,"NCT04298866","White Matter Hyperintensities Subtypes in Cerebral Small Vessel Disease : 7 Tesla Ultra-high Resolution Imaging MRI","SV7","Not yet recruiting","No Results Available","Cerebral Small Vessel Diseases","Other: Experimental Arm","Percentage of patients with a different form of white matter hyperintensities (WMH)|Frequency of different WMH subtypes in different types of small cerebral vessel disease|Frequency of large tract involvement|Global cognitive function|Language|Spatial exploration|Spatial memory|Visual memory|Episodic verbal memory|Working memory|Executive function|Attentional Performances status|Depression and Anxiety status|Apathy status|Pulse wave Velocity count","Assistance Publique - Hôpitaux de Paris","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","APHP180445","March 4, 2020","June 4, 2023","June 4, 2023","March 6, 2020",,"March 6, 2020",,,"https://ClinicalTrials.gov/show/NCT04298866"
255,"NCT03186300","Patient Empowerment Through Predictive Personalised Decision Support (PEPPER)","PEPPER","Completed","No Results Available","Diabetes Mellitus, Type 1","Device: PEPPER system","Change in the percentage of time spent in hypoglycaemia (glucose level below 3, 9 mmol/L or 70 mg/dl)|Number of incidence of low glucose alarms|Number of incidence of high glucose alarms|Number of incidence of carbohydrate adviser|Number of incidence of low glucose suspend|Number of incidence of fault detection alarm|Change in the percentage of time in glucose target range (glucose levels 3.9-10 mmol/l or 70 - 180 mg/dl)|Change in the percentage of time in hyperglycaemia (glucose level above 10 mmol/l or 180 mg/dl)|Change in the number of episodes of post-prandial hypoglycaemia (glucose level below 3,9 mmol/L or 70 mg/dl) within 4 hours|Change in the number of episodes of post-prandial hypoglycaemia (glucose level below 3,9 mmol/L or 70 mg/dl) within 6 hours|Change in the post-prandial glucose level at 120 minutes (mg/dl)|Change in the post-prandial glucose level at 120 minutes (mmol/l)|Change in the post-prandial area under the curve (AUC) of glucose level at 4 hours (min x mg/dl)|Change in the post-prandial area under the curve (AUC) of glucose level at 4 hours (min x mmol/l)|Change in glycaemic risk measured with low blood glucose index (LBGI)|Change in glycaemic risk measured with high blood glucose index (HBGI)|Change in glycaemic variability measured with mean amplitude of glycaemic excursions (MAGE) (mg/dl)|Change in glycaemic variability measured with mean amplitude of glycaemic excursions (MAGE) (mmol/l)|Change in glycaemic variability measured with continuous overall net glycemic action at 2 hours (CONGA-2) (mg/dl)|Change in glycaemic variability measured with continuous overall net glycemic action at 2 hours (CONGA-2) (mmol/l)|Measurement of satisfaction of diabetes treatment using Diabetes Treatment Satisfaction Questionnaire (DTSQ)|Measurement of quality of life in patients with diabetes mellitus using Diabetes Quality of Life (DQOL) questionnaire.|Measurement of diabetes related problems by using Problem Areas in Diabetes (PAID) questionnaire|Evaluation of usability and the treatment satisfaction of PEPPER system by using non-validated questionnaires.","Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta|Imperial College London|Oxford Brookes University|Universitat de Girona|Cellnovo Limited|Romsoft SRL","All","18 Years and older   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility","599/16/EC|689810","September 1, 2017","December 12, 2018","December 12, 2018","June 14, 2017",,"March 5, 2019","Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona, Spain",,"https://ClinicalTrials.gov/show/NCT03186300"
256,"NCT00600717","Clinical Applications of High-Frequency Oscillations","HFOs","Enrolling by invitation","No Results Available","Healthy|Epilepsy|Migraine|Headache|Pain|Autism|Cerebral Palsy",,,"Children's Hospital Medical Center, Cincinnati|University of Cincinnati","All","6 Years to 18 Years   (Child, Adult)",,"120","Other","Observational","Observational Model: Other|Time Perspective: Prospective","IRB 06-04-23; 2012-0866|2008-1439","November 1, 2006","July 1, 2020","July 1, 2022","January 25, 2008",,"February 18, 2019","MEG, Cincinnati, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT00600717"
257,"NCT03925337","Computer Aided Detection of Polyps in the Colon",,"Recruiting","No Results Available","Polyp, Adenomatous|Colo-rectal Cancer","Device: Computer Aided Diagnostic Software","Adenoma Miss Rate (AMR)|Polyp Miss Rate (PMR)|Amplified adenoma detection rate|Advanced adenoma miss rate determination|Colonoscope segmental withdrawal time determination|Total procedure time determination|Rate of adverse event determination","Beth Israel Deaconess Medical Center","All","22 Years and older   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","2018P000564","May 7, 2019","December 2020","December 2020","April 24, 2019",,"June 22, 2020","University of Chicago, Chicago, Illinois, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|NYU Langone, New York, New York, United States|Baylor College of Medicine, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT03925337"
258,"NCT04174287","Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease",,"Recruiting","No Results Available","Alzheimer's Disease","Drug: F-18-AV45","Amyloid Distribution Among Normal, Prodromal AD and AD Dementia Subjects Measured by Standardized Uptake Value Ratio (SUVR) as Assessed by 18F-AV45 amyloid PET Scan.","Chang Gung Memorial Hospital","All","55 Years to 80 Years   (Adult, Older Adult)","Phase 2","300","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","201801833A0","March 28, 2019","March 27, 2023","September 27, 2023","November 22, 2019",,"November 22, 2019","Chang Gung Memorial Hospital,Linkou, Taoyuan City, Guishan Dist, Taiwan",,"https://ClinicalTrials.gov/show/NCT04174287"
259,"NCT03905226","Development of a Predictive Algorithm for the Risk of Rehospitalization of Patients With Heart Failure",,"Active, not recruiting","No Results Available","Heart Failure",,"Number of readmissions","Groupe Hospitalier Paris Saint Joseph","All","18 Years and older   (Adult, Older Adult)",,"1600","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","PREDIC","January 12, 2019","December 31, 2019","March 30, 2020","April 5, 2019",,"April 5, 2019","Groupe Hospitalier Paris Saint-Joseph, Paris, France",,"https://ClinicalTrials.gov/show/NCT03905226"
260,"NCT02016092","Biomarker Discovery in Parkinson's Disease","DISCOVERY-PD","Unknown status","No Results Available","Parkinson's Disease",,"Biological markers of Parkinson's disease|Correlation between biologic markers and clinical features of PD","The Parkinson's Institute","All","18 Years to 90 Years   (Adult, Older Adult)",,"400","Other","Observational","Observational Model: Case Control|Time Perspective: Cross-Sectional","ECH-13-24|5258","December 2013","March 2016","June 2016","December 19, 2013",,"March 14, 2016","The Parkinson's Institute and Clinical Center, Sunnyvale, California, United States",,"https://ClinicalTrials.gov/show/NCT02016092"
261,"NCT04200170","Examining the Feasibility of a Mobile Mental Health Application in Psychotherapy",,"Active, not recruiting","No Results Available","Mental Health Wellness 1|Depression","Device: Rose","Average weekly completion rate for Mood check-in|Average weekly completion rate for Anxiety check-in|Average weekly completion rate for online journaling|Adherence to Patient Health Questionnaire-9 (PHQ-9) survey completion at Baseline|Adherence to Patient Health Questionnaire-9 (PHQ-9) survey completion at Week 2|Adherence to General Anxiety Disorder-7 (GAD-7) survey completion at Week 4|Adherence to General Anxiety Disorder-7 (GAD-7) survey completion at Baseline|Adherence to General Anxiety Disorder-7 (GAD-7) survey completion at Week 2|Assess objective and subjective quality of mobile app used|Change in Short term impact on anxiety as assessed by the GAD-7|Change in Short term impact on anxiety as assessed by the PHQ-9","Ask Rose","All","18 Years and older   (Adult, Older Adult)","Not Applicable","45","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","rose001","August 1, 2019","November 29, 2019","December 27, 2019","December 16, 2019",,"December 16, 2019","Key Point Health Services, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT04200170"
262,"NCT03538223","Music Listening in Radiotherapy Treatment","MuLi_RT","Recruiting","No Results Available","Breast Cancer","Other: Music Listening|Radiation: Radiotherapy","Anxiety reduction|Stress reduction","Istituti Clinici Scientifici Maugeri SpA|University of Pavia","Female","Child, Adult, Older Adult","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care","2179 CE","March 5, 2018","March 1, 2019","June 30, 2019","May 29, 2018",,"December 3, 2018","Istituti Clinici Scientifici Maugeri SpA, Pavia, Lombardy, Italy",,"https://ClinicalTrials.gov/show/NCT03538223"
263,"NCT02872454","Psychotherapeutic Text Messaging for Depression Pilot Study","TEXT4U","Completed","No Results Available","Major Depression","Behavioral: Text Messaging","Intervention Feasibility|Perceived Helpfulness of Messages|Change in Depression Symptoms","University of Michigan","All","18 Years and older   (Adult, Older Adult)","Not Applicable","190","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","HUM00090058","April 2015","April 2016","April 2016","August 19, 2016",,"August 19, 2016","University of Michigan Inpatient Psychiatry Unit, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT02872454"
264,"NCT04457505","One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19",,"Recruiting","No Results Available","Acute Respiratory Distress Syndrome|Severe Pneumonia|Respiratory Failure",,"One year mortality|Six month mortality","Consorcio Centro de Investigación Biomédica en Red, M.P.|Barcelona Supercomputing Center|Carlos III Health Institute","All","Child, Adult, Older Adult",,"5000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CIBERESUCICOVID","May 8, 2020","May 31, 2021","May 31, 2021","July 7, 2020",,"July 7, 2020","Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital de Mataró, Mataró, Barcelona, Spain|Hospital General de Cataluña, Sant Cugat Del Vallès, Barcelona, Spain|Hospital Infanta Margarita de Cabra, Cabra, Córdoba, Spain|Hospital Universitario Lucus Augusti, Lugo, Galicia, Spain|Hospital Son Llatzer, Palma De Mallorca, Mallorca, Spain|Hospital Álvaro Cunqueiro, Vigo, Pontevedra, Spain|Hospital Verge de la Cinta, Tortosa, Tarragona, Spain|Hospital Universitario Sant Joan d'Alacant, Alicante, Spain|Clínica Sagrada Família, Barcelona, Spain|Hospital Sagrat Cor, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Vall d'Hebron University Hospital, Barcelona, Barcelona, Spain|Hospital Clinic, Barcelona, Spain|Hospital Burgos, Burgos, Spain|Hospital San Pedro de Alcantara, Cáceres, Spain|Hospital de León, León, Spain|Hospital Arnau de Vilanova Lleida, Lleida, Spain|Hospital Infanta Leonor de Madrid, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Complexo Hospitalario Universitario de Ourense, Ourense, Spain|Complejo Asistencial Universitario de Palencia, Palencia, Spain|Hospital Montecelo, Pontevedra, Spain|Hospital Universitario Salamanca, Salamanca, Spain|Hospital Universitari Virgen de Valme, Sevilla, Spain|Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain|Hospital Clínic Universitari de València, Valencia, Spain|Hospital Universitari i Politècnic La Fe, Valencia, Spain|Hospital Universitario Valladolid, Valladolid, Spain|Hospital Nuestra Señora de Gracia, Zaragoza, Spain",,"https://ClinicalTrials.gov/show/NCT04457505"
265,"NCT04209166","A Study of Individualized Diagnosis and Treatment for Major Depressive Disorder With Atypical Features",,"Recruiting","No Results Available","Major Depressive Disorder","Drug: SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors)|Drug: SSRIs/SNRIs+Mood Stabilizer|Drug: SSRIs/SNRIs+Quetiapine|Drug: Usual Treatment","remission of acute phase|switch rate","Shanghai Mental Health Center|Fourth Military Medical University|Guangzhou Psychiatric Hospital|Dalian Seventh People's Hospital|Wuhan Union Hospital, China|Shanghai Jiao Tong University School of Medicine","All","16 Years to 60 Years   (Child, Adult)","Not Applicable","780","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment","CRC2018ZD05","August 12, 2019","October 31, 2022","October 31, 2022","December 23, 2019",,"December 23, 2019","Guangzhou Psychiatric Hospital, Guanzhou, Guangdong, China|Wuhan Mental Health Center, Wuhan, Hubei, China|Dalian Seventh People's Hospital, Dalian, Liaoning, China|Shanghai Mental Health Center, Shanghai, Shanghai, China|Fourth Military Medical University, Xian, Shanxi, China",,"https://ClinicalTrials.gov/show/NCT04209166"
266,"NCT04437914","Accuracy of Cardiac Arrhythmias and Conduction Disorders Diagnosis Using a Smartwatch",,"Not yet recruiting","No Results Available","Cardiovascular Diseases|Cardiac Arrhythmia|Conduction Disturbance","Diagnostic Test: Electrocardiogram diagnosis","Positive diagnostic correlation|Diagnostic accuracy 1|Diagnostic accuracy 2","Federal University of Piaui","All","18 Years and older   (Adult, Older Adult)",,"110","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","FUPiaui","August 1, 2020","February 28, 2021","August 31, 2021","June 18, 2020",,"June 19, 2020",,,"https://ClinicalTrials.gov/show/NCT04437914"
267,"NCT04061642","A Feasibility Study of an AI-Powered Clinical Decision Aid for Personalized Depression Treatment Selection",,"Recruiting","No Results Available","Depression","Device: Clinical Decision Aid","Subjective length of outpatient visits|Objective length of outpatient visits|Physician retention rates|Patient retention rates|Patient self-rated experience using the study software","Aifred Health Inc.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","10","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility","IUSMD-19-08","December 16, 2019","March 31, 2020","March 31, 2020","August 20, 2019",,"January 14, 2020","Douglas Mental Health University Institute, Verdun, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT04061642"
268,"NCT03214783","A Case-control Study to Assess the Association Between Facial Characteristics and Coronary Artery Diseases",,"Completed","No Results Available","Coronary Artery Disease","Other: Facial characteristics","The association between facial factors and increased risk of coronary artery diseases","China National Center for Cardiovascular Diseases","All","Child, Adult, Older Adult",,"2300","Other","Observational","Observational Model: Case-Control|Time Perspective: Retrospective","2017-907","July 10, 2017","October 31, 2018","October 31, 2018","July 12, 2017",,"November 6, 2018","Fuwai Hospital Chinese Academay of Medical Science and National Center for Cardiovascular Diseases, Beijing, Beijing, China",,"https://ClinicalTrials.gov/show/NCT03214783"
269,"NCT04045951","Effect of Using Myopia Prediction Algorithm on Myopia School-aged Children",,"Recruiting","No Results Available","Myopia","Other: Myopia prediction algorithm","Incidence of SER development of at least -1.0 dioptres (D)|Incidence of SER development of at least -0.5 dioptres (D)|Changes in SER \ and AL|Changes in proportion of children using atropine|Changes in proportion of children using orthokeratology lenses|Changes in proportion of children using spectacles|Changes in child's average outdoor activity time per day|Changes in child's average screen time per day","Sun Yat-sen University","All","8 Years to 10 Years   (Child)","Not Applicable","2138","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other","CCPMOH2019-China-4","August 3, 2019","November 30, 2021","November 30, 2021","August 6, 2019",,"August 7, 2019","Zhongshan Ophthalmic Centre, Guangzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT04045951"
270,"NCT03954548","CB-17-08 Augmented Endoscopy System for Mucosal Lesion Detection During Colonoscopy for Colon Rectal Cancer.",,"Recruiting","No Results Available","Colorectal Cancer","Device: CB-17-08 CADe","Adenoma per colonoscopy [APC]|Positive Predictive Value [PPV]|Adenoma miss rate [AMR]|Adenoma Detection Rate [ADR]","Cosmo Artificial Intelligence-AI Ltd|Cosmo Pharmaceuticals NV","All","45 Years and older   (Adult, Older Adult)","Not Applicable","1120","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","CB-17-08/03","February 17, 2020","June 2020","August 2020","May 17, 2019",,"February 25, 2020","Mayo Clinic, Jacksonville, Florida, United States",,"https://ClinicalTrials.gov/show/NCT03954548"
271,"NCT04015466","Advanced GC Multi-omic Characterization in EU and CELAC Populations","LEGACY-2","Recruiting","No Results Available","Gastric Cancer",,"Development of a new diagnostic algorithm for gastric cancer that includes molecular landscape, patient history, histopathological and environmental factors, personal microbiome and immune landscape|Proteomic analysis of gastric cancer tissue|Genomics (tumour next-generation sequencing)|Transcriptomics (Nanostring immune gene expression panel)|Microbiota sequencing (including level of Epstein-Barr virus [EBV] DNA)|Dietary habits as assessed by a new study-specific questionnaire|Biological risk factors as assessed through medical chart review|Daily routines as assessed by a new study-specific questionnaire","Fundación para la Investigación del Hospital Clínico de Valencia|Instituto Nacional de Cancerologia de Mexico|VU University Medical Center|Pontificia Universidad Catolica de Chile|Vall d'Hebron Institute of Oncology|INSTITUTO ALEXANDER FLEMING|Hospital Central del IPS|INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO PCUP","All","18 Years to 90 Years   (Adult, Older Adult)",,"800","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","LEGACY-2","June 12, 2019","December 31, 2021","December 31, 2021","July 11, 2019",,"February 5, 2020","Instituto Alexander Fleming, Buenos Aires, Argentina|Pontificia Universidad Católica de Chile, Santiago, Chile|Instituto Nacional de Cancerología de México, Mexico, Mexico|VU Medical Centre, Amsterdam, Netherlands|GenPat, Asunción, Paraguay|Institute of Pathology and Immunology of University of Porto, Porto, Portugal|Vall d'Hebron Institut d'Oncologia, Barcelona, Spain|Hospital Clínico Univeristario de Valencia, Valencia, Spain",,"https://ClinicalTrials.gov/show/NCT04015466"
272,"NCT03777098","Pilot Study of Strepic® Device for the Diagnosis of Group A Streptococcal Pharyngitis",,"Recruiting","No Results Available","Group A Streptococcal Infection","Device: Strepic® Device","Strepic Device Image|Throat culture or PCR result","David A. Talan|Light AI, Inc.|Olive View-UCLA Education & Research Institute","All","7 Years to 64 Years   (Child, Adult)",,"1000","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","01-2018","January 2, 2019","November 30, 2020","December 30, 2020","December 17, 2018",,"March 13, 2020","Olive View-UCLA Medical Center, Sylmar, California, United States",,"https://ClinicalTrials.gov/show/NCT03777098"
273,"NCT03972787","Effects of a Proactive Social Robot for Older Adults in Reducing Loneliness and Social Isolation",,"Recruiting","No Results Available","Loneliness|Mood|Quality of Life","Device: Proactive social robot","University of California, Los Angeles Loneliness (UCLA) V3 Scale - Change is Being Assessed","Baycrest|Jewish Senior Living Group|Intuition Robotics","All","70 Years and older   (Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","REB #18-54","March 5, 2019","December 2019","December 2019","June 4, 2019",,"June 4, 2019","Jewish Senior Living Group, San Francisco, California, United States|Baycrest, Toronto, Ontario, Canada","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/87/NCT03972787/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03972787"
274,"NCT02781012","Project Survival-Prospective Biomarker Discovery",,"Active, not recruiting","No Results Available","Pancreatic Neoplasms|Pancreatic Cancer|Pancreatitis|Pancreatic Adenocarcinoma|Metastatic Pancreatic Cancer",,"Berg's Interrogative Biology® Platform","Pancreatic Cancer Research Team|Berg, LLC","All","18 Years and older   (Adult, Older Adult)",,"436","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","PCRT 15-001","March 2016","February 2022","February 2022","May 24, 2016",,"April 16, 2019","Banner Health - MD Anderson Cancer Center, Gilbert, Arizona, United States|Mayo Clinic - Arizona, Phoenix, Arizona, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Mercy Health - St. Mary's, Grand Rapids, Michigan, United States|Virginia Piper Cancer Institute - Allina Health, Minneapolis, Minnesota, United States|Washington University School of Medicine, Saint Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT02781012"
275,"NCT04457908","The Effectiveness and Cost Effectiveness of Intelligent Assessment of Gait Disorder in Silent Cerebrovascular Disease","ACCURATE-1","Not yet recruiting","No Results Available","Silent Stroke","Diagnostic Test: intelligent assessment","Sensitivity|Specificity|Coincidence|Yoden index|Positive predictive value and negative predictive value|Cost and cost-effectiveness","Shanghai Zhongshan Hospital|Fudan University|The Affiliated Hospital Of Guizhou Medical University","All","60 Years to 85 Years   (Adult, Older Adult)","Not Applicable","1000","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Diagnostic","2018YFC1312900-05","July 1, 2020","October 31, 2020","December 31, 2020","July 7, 2020",,"July 7, 2020",,,"https://ClinicalTrials.gov/show/NCT04457908"
276,"NCT03901326","Role of On-site CT-derived FFR in the Management of Suspect CAD Patients","TARGET","Recruiting","No Results Available","Coronary Artery Disease","Diagnostic Test: CT-FFR","Rate of ICA without obstructive CAD or intervention|Major adverse cardiovascular event|Medical expenditure|Quality of life score|Cumulative radiation exposure","Chinese PLA General Hospital|Anzhen Hospital, Capital Medical University, Beijing|First Affiliated Hospital of Xinjiang Medical University|Qilu Hospital of Shandong University|Second Affiliated Hospital, School of Medicine, Zhejiang University|Tongji Hospital","All","40 Years to 75 Years   (Adult, Older Adult)","Not Applicable","1216","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","S2019-025-01","May 10, 2019","December 2020","December 2021","April 3, 2019",,"August 21, 2019","Chinese PLA General Hospital, Beijing, Beijing, China",,"https://ClinicalTrials.gov/show/NCT03901326"
277,"NCT04420156","Clinical and Genetic Analysis of ROP","(ROP)","Recruiting","No Results Available","Retinopathy of Prematurity","Other: No intervention administered.","Evaluate diagnostic accuracy of an AI system for ROP diagnosis","Oregon Health and Science University|National Institutes of Health (NIH)|U.S. National Science Foundation|Massachusetts General Hospital|Northeastern University|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|William Beaumont Hospitals|University of Illinois at Chicago|Stanford University|University of Utah|National Eye Institute (NEI)","All","up to 1 Year   (Child)",,"2000","Other|NIH|U.S. Fed","Observational","Observational Model: Cohort|Time Perspective: Prospective","IRB00007167|R01EY019474","July 1, 2011","May 31, 2024","May 31, 2030","June 9, 2020",,"June 9, 2020","Stanford University, Palo Alto, California, United States|University of Illinois Chicago, Chicago, Illinois, United States|William Beaumont Hospital, Royal Oak, Michigan, United States|Oregon Health & Science University, Portland, Oregon, United States|University of Utah, Salt Lake City, Utah, United States",,"https://ClinicalTrials.gov/show/NCT04420156"
278,"NCT04288011","Validation of the BeCare Multiple Sclerosis Assessment App",,"Enrolling by invitation","No Results Available","Multiple Sclerosis",,"Clinical EDSS score vs MLA EDSS score comparison|Disease Progression Measured by Change in EDSS score|Development of a novel application to measure change in MS","BeCare Link LLC|Yale University","All","18 Years to 75 Years   (Adult, Older Adult)",,"30","Industry|Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2000023992","February 26, 2020","August 26, 2021","December 26, 2021","February 27, 2020",,"July 9, 2020","Yale University School of Medicine, New Haven, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT04288011"
279,"NCT04380844","Effects of an Activity Control System in Patients With Diabetes: a Randomized Controlled Trial",,"Not yet recruiting","No Results Available","Diabetes Mellitus, Type 2","Other: Beprevent","Diabetes Knowledge Questionnaire","Universidad Católica San Antonio de Murcia","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","orcid.org/0000-0002-869","September 1, 2020","March 1, 2021","September 1, 2021","May 8, 2020",,"May 11, 2020",,,"https://ClinicalTrials.gov/show/NCT04380844"
280,"NCT04355507","Computed Tomography for COVID-19 Diagnosis","STOIC","Not yet recruiting","No Results Available","COVID-19","Diagnostic Test: Chest computed tomography (CT)|Diagnostic Test: Reverse-transcription polymerase chain reaction (RT-PCR)","Predictive values of CT criteria|Accuracy of CT composite severity score|Accuracy of deep-learning based score|Predictive values of deep-learning based diagnostic algorithms|Dice similarity coefficient between manual and automated segmentation of lung disease abnormalities","Assistance Publique - Hôpitaux de Paris|Institut National de la Santé Et de la Recherche Médicale, France|GE Healthcare|Orange healthcare|TheraPanacea","All","18 Years and older   (Adult, Older Adult)",,"10000","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Retrospective","APHP200434","April 2020","May 2020","July 2020","April 21, 2020",,"April 22, 2020","Cochin Hospital, Paris, France",,"https://ClinicalTrials.gov/show/NCT04355507"
281,"NCT03883035","Quality Control of Esophagogastroduodenoscopy Using Real-time EGD Auxiliary System",,"Completed","No Results Available","Esophagogastroduodenoscopy","Other: automatic quality-control system","detection rate of gastric neoplasms|mean number of gastric neoplasms detected|mean inspection completeness|mean inspection time|errors of EAS","Yanqing Li|Shandong University","All","40 Years to 80 Years   (Adult, Older Adult)","Not Applicable","1060","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Other","2019SDU-QILU-02","March 20, 2019","October 31, 2019","October 31, 2019","March 20, 2019",,"January 30, 2020","Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China",,"https://ClinicalTrials.gov/show/NCT03883035"
282,"NCT04252170","Arm Motor Rehabilitation, Entertainment and Cognition System for the Elderly",,"Completed","No Results Available","Stroke","Device: Rehabilitation Therapy, Experimental on the BrightArm Compact device","Artificial Intelligence-determined game difficulty level|Game Score (baseline and performance)|Participants' feedback using 5-point Likert scale|Therapist subjective evaluation using 5-point Likert scale|Arm Range of Motion|Finger Range of Motion|Grasp Strength with Jamar Dynamo-meter|Pinch strength with pinch meter|Shoulder strength|Fugl-Meyer Assessment (Upper Extremity sub-scale) score|Upper extremity functional index (UEFI) score|CAHAI 9 Score|Jebsen Test of Hand Function|Beck Depression Inventory II (BDI II) score|Verbal attention|Verbal fluency|Verbal memory|Brief Visuospatial Memory Test-Revised|Executive Function Module|Cognitive executive function|Visual attention","Bright Cloud International Corp|National Institute on Aging (NIA)|Genesis HealthCare System","All","50 Years to 85 Years   (Adult, Older Adult)","Not Applicable","2","Industry|NIH|Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility","BCI-10-001|5R44AG044639-05","September 15, 2018","December 31, 2018","January 31, 2019","February 5, 2020",,"February 5, 2020","PowerBack Rehabilitation, Piscataway, New Jersey, United States","""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/70/NCT04252170/ICF_000.pdf|""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/70/NCT04252170/Prot_001.pdf","https://ClinicalTrials.gov/show/NCT04252170"
283,"NCT04461210","Vulvodynia Pain Thresholds",,"Not yet recruiting","No Results Available","Vulvodynia","Diagnostic Test: Thermographic Imaging and Mechanical Pain Assessment","Annotated Pain Mapping|Change in pain map after clinical intervention|Database Development","State University of New York at Buffalo","Female","18 Years to 50 Years   (Adult)","Not Applicable","60","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","00004558","August 2020","July 2022","July 2022","July 8, 2020",,"July 8, 2020",,,"https://ClinicalTrials.gov/show/NCT04461210"
284,"NCT03857438","Correlation of Audiovisual Features With Clinical Variables and Neurocognitive Functions in Bipolar Disorder, Mania",,"Completed","No Results Available","Bipolar Disorder, Manic|Artificial Intelligence|Neurocognition|Treatment Resistant Disorders|Affective Computing|Multi- Modal Analysis","Drug: Ongoing treatment for bipolar mania|Diagnostic Test: Audiovisual recording during guided presentation","Treatment response|Changes in visual features|Changes in audio features|in Stop Signal Test|Changes in Rapid Visual Processing|in Cambridge Gambling Task|Changes in Emotion Recognition Test","Istanbul Saglik Bilimleri University|Namik Kemal University|Bosphorus University","All","18 Years to 65 Years   (Adult, Older Adult)",,"89","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","BipolarAI","September 30, 2016","February 20, 2017","July 8, 2017","February 28, 2019",,"February 28, 2019","SBU Erenkoy Mental State Hospital, Istanbul, Turkey","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/38/NCT03857438/Prot_000.pdf|""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/38/NCT03857438/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT03857438"
285,"NCT04161170","Digital Integrated Healthcare Platform in Patients With Type 2 Diabetes",,"Recruiting","No Results Available","Type 2 Diabetes","Device: Digital integrated healthcare platform","Change of HbA1c (glycated hemoglobin) at 6months from baseline|HbA1c|number of intervention for education in interventinal group C|hypoglycemic events|adverse events|patient satisfaction questionnaire score|body weight|BMI (body mass index)|body fat (%)|step count|burned calories|walking distances|intake calories|fasting glucose level|total cholesterol level|HDL cholesterol level|Triglycerides level|LDL cholesterol level|mean glucose level by CGMS (continuous glucose monitoring system) in interventional group C|glycemic variability by CGMS in interventional group C|standard deviation by CGMS in interventional group C|average applying time of CGMS in interventional group C|time in range of <54mg/dL by CGMS in interventional group C|time in range of <70mg/dL by CGMS in interventional group C|time in range of 70-180 mg/dL by CGMS in interventional group C|time in range of >180 mg/dL by CGMS in interventional group C|time in range of >250 mg/dL by CGMS in interventional group C","Samsung Medical Center","All","19 Years to 70 Years   (Adult, Older Adult)","Not Applicable","294","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2019-05-028-007","November 20, 2019","August 31, 2021","December 31, 2021","November 13, 2019",,"January 18, 2020","Samsung Medical Center, Seoul, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT04161170"
286,"NCT04349787","Improving Optical Diagnosis of Colorectal Polyps Using CADx and BASIC.",,"Completed","No Results Available","Colorectal Cancer|Colorectal Polyp","Other: Computer-aided diagnosis (CADx)|Other: BLI Adenoma Serrated International Classification (BASIC)","Diagnostic accuracy of CADx versus endoscopists|Diagnostic accuracy of BASIC versus intuition|Diagnostic metrics of CADx|AUC of CADx|Diagnostic metrics of endoscopists|Diagnostic metrics of endoscopists for high confidence diagnosis|Interobserver agreement|Computation time of CADx","Maastricht University Medical Center|Catharina Ziekenhuis Eindhoven|Eindhoven University of Technology","All","18 Years and older   (Adult, Older Adult)",,"60","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","METC 2019-1231","November 26, 2019","March 8, 2020","March 8, 2020","April 16, 2020",,"April 16, 2020","Maastricht University Medical Center, Maastricht, Limburg, Netherlands",,"https://ClinicalTrials.gov/show/NCT04349787"
287,"NCT04408703","PRognOstiC valuE of rEd Density in Ulcerative Colitis","PROCEED-UC","Not yet recruiting","No Results Available","Ulcerative Colitis","Diagnostic Test: Red Density","sustained clinical remission|endoscopic remission Mayo|endoscopic remission UCEIS","Universitaire Ziekenhuizen Leuven|Sapporo Medical University|Imelda GI Clinical Research Center","All","16 Years and older   (Child, Adult, Older Adult)",,"243","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","s63012","June 2020","June 2021","June 2022","May 29, 2020",,"May 29, 2020","Imelda GI clinical research center, Bonheiden, Belgium|UZ Leuven, Leuven, Belgium",,"https://ClinicalTrials.gov/show/NCT04408703"
288,"NCT00564122","The Accuracy of an Artificially-intelligent Stethoscope",,"Completed","No Results Available","Heart Murmurs|Congenital Heart Disease|Structural Heart Disease","Device: Artificially-Intelligent Stethoscope|Other: Physical Examination","Sensitivity of the Artificially-Intelligent Stethoscope as compared with that of Pediatric Cardiologists in determining which patients needed echocardiograms because they have congenital structural heart disease|Specificity of the Artificially-Intelligent Stethoscope as compared with that of Pediatric Cardiologists in determining which patients needed echocardiograms because they have congenital structural heart disease.","Akron Children's Hospital|Thomas C. Dispenza, M.D.|John R. Bockoven, M.D. M.B.A.","All","Child, Adult, Older Adult",,"300","Other","Observational","Observational Model: Case-Crossover|Time Perspective: Prospective","070904","December 2007",,"June 2008","November 27, 2007",,"November 1, 2011","Akron Children's Hospital's Heart Center, Akron, Ohio, United States|Akron Children's Hospital's Heart Center, Beachwood, Ohio, United States|Akron Children's Hospital's Heart Center, Boardman, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT00564122"
289,"NCT03354416","Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer",,"Recruiting","No Results Available","Prostatic Cancer|Prostatic Neoplams|Prostatic Hyperplasia|Prostate Cancer|Cancer Of Prostate",,"Associations between imaging features and clinicopathological factors","National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)","Male","18 Years and older   (Adult, Older Adult)",,"10000","NIH","Observational","Observational Model: Cohort|Time Perspective: Other","180017|18-C-0017","February 26, 2018","December 31, 2027","December 31, 2030","November 28, 2017",,"April 20, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT03354416"
290,"NCT04449380","Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients","INTERCOP","Not yet recruiting","No Results Available","COVID-19 Virus Infection","Drug: Interferon-ß-1a|Combination Product: Standard of Care (SOC)","Time to negative conversion of SARS-CoV-2 nasopharyngeal swab|Improvement in clinical severity score (a)|Improvement in clinical severity score (b)|Incidence of new oxygen use, non-invasive ventilation, or high flow oxygen devices during the trial|Oxygenation free days in the first 28 days|Ventilator free days in the first 28 days|Incidence of new mechanical ventilation use during the trial|Number of patients transferred to Intensive Care Unit (ICU)|Mortality rate|Changes from baseline in pulmonary computed tomography (CT) imaging severity score|Duration of hospital stay expressed in days|Viral load measured on plasma with RT-PCR","IRCCS San Raffaele","All","18 Years and older   (Adult, Older Adult)","Phase 2","126","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","INTERCOP","July 2020","February 2021","April 2021","June 26, 2020",,"June 30, 2020","IRCCS Ospedale San Raffaele, Milano, Italy",,"https://ClinicalTrials.gov/show/NCT04449380"
291,"NCT03775811","In Vivo Computer-aided Prediction of Polyp Histology on White Light Colonoscopy",,"Recruiting","No Results Available","Colonoscopy|Histology|Computer|Artificial Intelligence|Colorectal Polyp|Adenoma Colon Polyp|Hyperplastic Polyp","Other: Computer-assisted histological prediction of colon polyps","Accuracy of the computer-aided system for predicting polyps histology in real clinical practice","Hospital Clinic of Barcelona|Instituto de Salud Carlos III","All","18 Years and older   (Adult, Older Adult)",,"165","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","HISINVIA|PI17/00894","April 10, 2019","June 23, 2020","June 23, 2020","December 14, 2018",,"March 3, 2020","Hospital Clínic de Barcelona, Barcelona, Spain",,"https://ClinicalTrials.gov/show/NCT03775811"
292,"NCT04219306","Machine Learning Assisted Recognition of Out-of-Hospital Cardiac Arrest During Emergency Calls.",,"Completed","No Results Available","Out-Of-Hospital Cardiac Arrest","Other: Alert on dispatchers screen 'Suspect cardiac arrest'","Dispatcher recognition of cardiac arrest|Time to recognition|Dispatcher assisted telephone CPR|Time to T-CPR","Emergency Medical Services, Capital Region, Denmark","All","Child, Adult, Older Adult","Not Applicable","5242","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Diagnostic","F-35101-01","September 1, 2018","April 1, 2020","April 2, 2020","January 7, 2020",,"April 16, 2020","Emergency Medical Services Copenhagen, Ballerup, Danmark, Denmark","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/06/NCT04219306/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT04219306"
293,"NCT04357834","WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories","WAVE","Not yet recruiting","No Results Available","COVID|COVID 19|SARS-CoV 2","Other: Equipment with smartwatch throughout hospital stay on the general ward","Diagnostic accuracy of smartwatch data in predicting ICU requirement in COVID-19 contracted inpatients quantified as the area under the receiver operator characteristics curve (AUC ROC > 0.85).|Diagnostic accuracy of routine physiological data in predicting ICU requirement in COVID-19 contracted in-patients quantified as the area under the receiver operator characteristics curve (AUC ROC > 0.85).|Diagnostic accuracy of predicting hospital discharge without ICU admission in COVID-19 contracted in-patients quantified as area under the receiver operator characteristics curve|Change of heart rate from baseline (hospitalization) to ICU admission|Change of heart rate variability from baseline (hospitalization) to ICU admission|Change of skin temperature from baseline (hospitalization) to ICU admission|Change of blood oxygen saturation from baseline (hospitalization) to ICU admission|Change of respiration rate from baseline (hospitalization) to ICU admission|Change of physical activity from baseline (hospitalization) to ICU admission|Change of stress level from baseline (hospitalization) to ICU admission|Change of sleep pattern from baseline (hospitalization) to ICU admission|Change of steps per day from baseline (hospitalization) to ICU admission|Change of systolic blood pressure from baseline (hospitalization) to ICU admission|Change of diastolic blood pressure from baseline (hospitalization) to ICU admission|Change of body temperature from baseline (hospitalization) to ICU admission|Change of oxygen partial pressure (pO2) from baseline (hospitalization) to ICU admission|Change of CO2 partial pressure (pCO2) from baseline (hospitalization) to ICU admission|Change of blood pH from baseline (hospitalization) to ICU admission|Change of bicarbonate from baseline (hospitalization) to ICU admission|Change of base excess from baseline (hospitalization) to ICU admission|Change of oxygen flow rate from baseline (hospitalization) to ICU admission","University Hospital Inselspital, Berne|ETH Zurich","All","18 Years to 120 Years   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Other|Time Perspective: Prospective","WAVE","May 1, 2020","July 31, 2020","July 31, 2020","April 22, 2020",,"April 24, 2020","Emergency Department, University Hospital Bern, Inselspital, Bern, Switzerland",,"https://ClinicalTrials.gov/show/NCT04357834"
294,"NCT04407325","Tuberculosis Screening in Paraguayan Prisons","Prinose","Not yet recruiting","No Results Available","Volatile Organic Compounds|Radiography","Device: electronic nose device|Device: dig chest Xray with automated readings","Volatile organic compound signal as measured with the AeoNose™|Tuberculosis probablity score using Computed Automated detection software CAD4TB® on chest Xrays|Positive mycobacterial sputum test|Comparison of predictive value of volatile organic compound signal with Tuberculosis Probability Score|added value of the use of AeoNose and Cad4TB as a TB screening algorithm in vulnerable populations","Radboud University|European Union|ISPUP|VHIR|University Medical Center Groningen|Laboratorio central de salud publica, Paraguay|Instituto Nacional de Enfermedades Respiratorias y del Ambiente Juan Max Boetner|National TB program Paraguay|IICS Paraguay","All","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","5000","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","823890-EUSAT-RCS","July 2020","December 2021","March 2022","May 29, 2020",,"May 29, 2020",,"""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/25/NCT04407325/Prot_000.pdf|""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/25/NCT04407325/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT04407325"
295,"NCT03707275","Personalized Voice Activated Wellness Assistants for Patients With Heart Failure",,"Completed","No Results Available","Heart Failure|Congestive Heart Failure","Device: Alexa+|Other: Standard of Care Arm","Change in comfort level using Alexa+ technology as measured by the pre and post-test technology comfort survey|Change in number of hospitalizations as measured by hospitalization data extracted from the EHR|Change in medication adherence as measured by number of prescriptions filled extracted from the EHR","Medstar Health Research Institute|National Institutes of Health (NIH)|Georgetown-Howard Universities Center for Clinical and Translational Science|ObEN Artificial Intelligence","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","Alexa+ Study|UL1TR001409","December 10, 2018","October 31, 2019","October 31, 2019","October 16, 2018",,"June 19, 2020","MedStar Washington Hospital Center, Washington, District of Columbia, United States",,"https://ClinicalTrials.gov/show/NCT03707275"
296,"NCT00039585","Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor",,"Completed","No Results Available","Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer","Drug: imatinib mesylate","Clinical response in patients with epithelial ovarian cancer as measured by CT scan of chest, abdomen, and pelvis every 8 weeks|Corr. of biochem. modulation of signal transduction pathways downstream of platelet-derived growth factor receptor (PDGFR) and c-kit tyrosine kinase by tumor lysate microarray analysis in biopsy tissue with patient outcome at baseline and at 4 wks|Correlation of PDGFR and c-kit expression with response and outcome in patients with epithelial ovarian cancer as measured by tumor microarray analysis on biopsy tissue at baseline and at 4 weeks|Antiangiogenic activity as measured by tumor lysate microarray on biopsy tissue at baseline and at 4 weeks|Collateral receptor tyrosine kinase inhibition as measured by tumor lysate microarray on biopsy tissue at baseline and at 4 weeks|Prediction of response and/or toxicity as measured by Surface-Enhanced Laser Desorption/Ionization Time-Of-Flight (SELDI-TOF) proteomics and Artificial Intelligence bioinformatics on serum samples at baseline and every 4 wks","National Cancer Institute (NCI)","Female","Child, Adult, Older Adult","Phase 2",,"NIH","Interventional","Masking: None (Open Label)|Primary Purpose: Treatment","CDR0000069403|NCI-02-C-0190|NCI-5672A","May 2002","February 2006",,"January 27, 2003",,"April 30, 2015","Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States|NCI - Center for Cancer Research, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT00039585"
297,"NCT04369053","Prevention of Colorectal Cancer Through Multiomics Blood Testing","PREEMPT CRC","Recruiting","No Results Available","Colon Cancer|Rectal Cancer|Colon Neoplasm|Colon Diseases|Colon Lesion|Colon Polyp|Colorectal Cancer|Polyp|Adenoma|Rectal Diseases|Gastrointestinal Tract Cancers","Diagnostic Test: Freenome test","Sensitivity for CRC of the Freenome test|Specificity of the Freenome test","Freenome, Inc.","All","45 Years to 85 Years   (Adult, Older Adult)",,"14000","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","FRNM-004","May 20, 2020","July 30, 2021","July 30, 2021","April 30, 2020",,"July 8, 2020","IACT Health, Columbus, Georgia, United States|Quincy Medical Group, Quincy, Illinois, United States|American Health Network of Indiana, LLC, Muncie, Indiana, United States",,"https://ClinicalTrials.gov/show/NCT04369053"
298,"NCT03833804","Data-driven Identification for Substance Misuse",,"Not yet recruiting","No Results Available","Substance Use|Substance Abuse|Substance-Related Disorders","Other: Processing of clinical notes in the EHR data collected during routine care","Proportion of patients that had a universal screen positive and received SBIRT (screening, brief intervention, or referral to treatment)|All-cause re-hospitalizations following 6-months from the Index hospital encounter","Loyola University|Rush University Medical Center","All","18 Years to 89 Years   (Adult, Older Adult)",,"34800","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","211165","September 2021","September 2023","November 2023","February 7, 2019",,"September 9, 2019",,,"https://ClinicalTrials.gov/show/NCT03833804"
299,"NCT03858738","A Pilot Study on Use of Liquid Crystal Contact Thermography to Detect Early Breast Cancer",,"Completed","No Results Available","Breast Cancer","Device: Thermographic breast examination performed by Braster device","Diagnostic efficacy of liquid crystal contact thermography using a manual assessment algorithm as compared with ultrasound and/or mammography and breast biopsy.","Braster S.A.|Clinmark Clinical Research","Female","25 Years and older   (Adult, Older Adult)",,"274","Industry|Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","ThermaAlg","April 20, 2015","June 8, 2016","August 19, 2016","March 1, 2019",,"March 4, 2019",,,"https://ClinicalTrials.gov/show/NCT03858738"
300,"NCT03787433","Assisted Rehabilitation Care During Post-stroke mANaGement: fEasibiLity Assessment","ARCANGEL","Completed","No Results Available","Stroke","Device: ARC - Assisted Rehabilitation Care","Number of patients successfully completing the study|Ratio between the total number of subjects refusing to participate before training and the total number of subjects screened|Ratio between the total number of subjects refusing to participate after training and the total number of subjects screened|Number of training sessions|Overall training period duration|Assisted Rehabilitation Care (ARC) questionnaire score|Assisted Rehabilitation Care (ARC) questionnaire change|ARC global satisfaction score|Modified version of Adult Carer Quality of Life Questionnaire (AC-QoL) total score|Device-related adverse effects|Modified Rankin Score change (N.Ireland)|Barthel Index change (Italy)|Euro Quality of Life - 5 Dimension (EQ-5D) Health Questionnaire summary index|Euro Quality of Life - 5 Dimension (EQ-5D) Health Questionnaire summary index change|Signs of Depression Scale (SODS, N.Ireland)|Zung Self-Rating Depression Scale (SDS, Italy)|Resource consumption","Camlin Ltd|Northern Health and Social Care Trust|Azienda Sanitaria Locale 3, Torino","All","18 Years and older   (Adult, Older Adult)",,"41","Industry|Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","ARCANGEL","November 23, 2018","June 12, 2020","June 12, 2020","December 26, 2018",,"June 16, 2020","Azienda Sanitaria Locale 3, Torino, Pinerolo, Italy|Northern Health and Social Care Trust, Antrim, Northern Ireland, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03787433"
301,"NCT04086849","Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers",,"Recruiting","No Results Available","Head and Neck Neoplasm|Squamous Cell Carcinoma of Head and Neck","Diagnostic Test: Radiomic, pathomic, and clinical markers","Time to locoregional recurrence|Time to distant metastasis|Time to death","Sunnybrook Health Sciences Centre","All","18 Years and older   (Adult, Older Adult)",,"450","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","087-2019","July 30, 2019","December 30, 2024","June 30, 2025","September 12, 2019",,"September 13, 2019","Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04086849"
302,"NCT04366765","COVID-19 Survival - The COVIVA Study","COVIVA","Recruiting","No Results Available","COVID-19|SARS-CoV 2",,"short-term prognosis|Admission to the intensive care unit (ICU)|Invasive ventilation (Intubation)|Need for extracorporal membrane oxygenation (ECMO)|Hemodynamic support|Length of ICU stay|Acute respiratory distress Syndrome (ARDS)|Myocardial injury|ST-segment elevation myocardial infarction|In-hospital resource use|EQ-5D questionnaire","University Hospital, Basel, Switzerland","All","18 Years and older   (Adult, Older Adult)",,"1500","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","UHospital Switz","March 19, 2020","June 30, 2021","June 30, 2021","April 29, 2020",,"May 4, 2020","University Hospital Basel, Basel, Switzerland",,"https://ClinicalTrials.gov/show/NCT04366765"
303,"NCT04249895","Comprehensive Digital Archive of Cancer Imaging-Radiation Oncology( CHAVI-RO )",,"Recruiting","No Results Available","All Cancer",,"Number of patients with complete data safe.","Tata Medical Center","All","Child, Adult, Older Adult",,"500","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","EC/GOVT/24/IRB23","August 31, 2018","February 28, 2021","April 29, 2022","January 31, 2020",,"January 31, 2020","Sanjoy Chatterjee, Kolkata, West Bengal, India",,"https://ClinicalTrials.gov/show/NCT04249895"
304,"NCT03674255","Echocardiography: Value and Accuracy at REst and STress","EVAREST","Enrolling by invitation","No Results Available","Coronary Artery Disease|Ischaemic Heart Disease|Angina Pectoris",,"Assessment of Prognostically Significant CAD|Examination of Medical Records|Quantification of Extracellular Vesicles (obtained from blood samples) by Flow Cytometry|Assessment of Time to Diagnosis|Analysis of Potential Cost Savings Through the Use of Novel Biomarkers By the Reduction in Unnecessary Procedures|Investigation into the use of stress echocardiography as a clinical procedure in the UK.","University of Oxford|Oxford University Hospitals NHS Trust|Royal United Hospital Bath NHS Trust|Tameside Hospital NHS Foundation Trust|Royal Berkshire NHS Foundation Trust|East Lancashire Hospitals NHS Trust|Bradford Teaching Hospitals NHS Foundation Trust|Calderdale and Huddersfield NHS Foundation Trust|Great Western Hospital NHS Foundation Trust|Mid Essex Hospital NHS Trust|Buckinghamshire Healthcare NHS Trust|Wrightington, Wigan and Leigh NHS Foundation Trust|Chelsea and Westminster Hospital NHS Foundation Trust|Milton Keynes University Hospital NHS Foundation Trust|University Hospitals Bristol NHS Foundation Trust|North Middlesex University Hospital|Northumbria Healthcare NHS Foundation Trust|London North West Healthcare NHS Trust|St George's University Hospitals NHS Foundation Trust|Ultromics Ltd|National Institute for Health Research, United Kingdom|King's College Hospital NHS Trust|Guy's and St Thomas' NHS Foundation Trust|Poole Hospital NHS Foundation Trust|Blackpool Teaching Hospitals NHS Foundation Trust|Mid Yorkshire Hospitals NHS Trust|Northampton General Hospital NHS Trust|North West Anglia NHS Foundation Trust|Yeovil District Hospital NHS Foundation Trust|East Suffolk and North Essex NHS Foundation Trust|Nottingham University Hospitals NHS Trust|Hampshire Hospitals NHS Foundation Trust|Lantheus Medical Imaging","All","18 Years and older   (Adult, Older Adult)",,"23000","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","18100","March 2015","March 2020","January 2032","September 17, 2018",,"March 10, 2020",,,"https://ClinicalTrials.gov/show/NCT03674255"
305,"NCT03713333","Implementing Digital Health in a Learning Health System","ASE-INNOVATE","Not yet recruiting","No Results Available","Cardiovascular Diseases|Hypertension|Heart Failure|Atrial Fibrillation|Metabolic Syndrome|Genetic Disease","Diagnostic Test: Digital Health Device Diagnostics","Patient-Reported Outcome Measures|Patient-Reported Experience Measures|Health Economic Outcomes|Mobile Cardiac Telemetry|Diagnostic Imaging|Heart Failure|Atrial Fibrillation|Emergency Department Visitations|Hospitalization|Clinic Visitations|Medical Therapy","Scripps Health|West Virginia University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","500","Other","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Screening","Pro00029622","October 20, 2018","October 20, 2019","October 20, 2019","October 19, 2018",,"October 19, 2018",,,"https://ClinicalTrials.gov/show/NCT03713333"
306,"NCT03931083","Screening Test Accuracy of Gynocular™, HR-HPV Testing, VIA for Detection of Cervical Neoplastic Lesions, in Women Living With HIV",,"Recruiting","No Results Available","Uterine Cervical Neoplasms|HIV/AIDS","Diagnostic Test: Screening for CIN2+/HSIL","Test accuracy (sensitivity, specificity) of the Gynocular™ when used as stand-alone tests to detect CIN2+|Test accuracy (sensitivity, specificity) of HR-HPV when used as stand-alone tests to detect CIN2+|Test accuracy (sensitivity, specificity) of VIA when used as stand-alone tests to detect CIN2+|Diagnostic test accuracy of the Gynocular™to detect CIN2+/HSIL: other estimates, stand alone|Diagnostic test accuracy of HR-HPV testing to detect CIN2+/HSIL: other estimates, stand alone|Diagnostic test accuracy of VIA to detect CIN2+/HSIL: other estimates, stand alone|Diagnostic test accuracy of HR-HPV testing followed by Gynocular™ to detect CIN2+/HSIL: test combination|Diagnostic test accuracy of HR-HPV testing followed by Gynocular™ to detect CIN2+/HSIL: test combination - subgroup analyses|Diagnostic test accuracy of the Gynocular™ followed by HR-HPV testing to detect CIN2+/HSIL: test combination|Diagnostic test accuracy of the Gynocular™ followed by HR-HPV testing to detect CIN2+/HSIL: test combination subgroup analyses|Diagnostic test accuracy VIA followed by Gynocular™ to detect CIN2+/HSIL: test combination|Diagnostic test accuracy VIA followed by Gynocular™ to detect CIN2+/HSIL: test combination - subgroup analyses|Diagnostic test accuracy of the Gynocular™ followed by VIA to detect CIN2+/HSIL: test combination|Diagnostic test accuracy of the Gynocular™ followed by VIA to detect CIN2+/HSIL: test combination - subgroup analyses|Diagnostic test accuracy of the HR-HPV followed by VIA to detect CIN2+/HSIL: test combination|Diagnostic test accuracy of the HR-HPV followed by VIA to detect CIN2+/HSIL: test combination - subgroup analyses|Diagnostic test accuracy of the VIA followed by HR-HPV to detect CIN2+/HSIL: test combination|Diagnostic test accuracy of the VIA followed by HR-HPV to detect CIN2+/HSIL: test combination subgroup analyses|Subgroup analyses for the diagnostic test accuracy of Gynocular™: stand alone test|Subgroup analyses for the diagnostic test accuracy of VIA: stand alone test|Subgroup analyses for the diagnostic test accuracy of HR-HPV testing: stand alone test|Subgroup analyses for the diagnostic test accuracy of VIA, HR-HPV testing and Gynocular™: Combined tests|Investigation of Swede Score in WLHIV|Investigation of co-infections of premalignant and malignant disease (STIs/HR-HPV)|Investigation of Trichomonas vaginalis prevalence and persistence in association with menstrual hygiene practices|Investigations to inform telemedicine capacity: Comparison of image quality|Investigations to inform telemedicine capacity: use of static images|Investigations to inform telemedicine capacity: ROC curve for Swede score|Investigations to inform telemedicine capacity: Live versus static assessors|Artificial Intelligence (AI) for improving the detection of precancerous cervical lesions: testing AI algorithm|Artificial Intelligence for improving the detection of precancerous cervical lesions: improve AI algorithm|Diagnostic test accuracy of AI tool to detect CIN2+/HSIL: other estimates, stand alone|Diagnostic test accuracy of HR-HPV testing followed by AI tool to detect CIN2+/HSIL: test combination","University of Bern|Centre for Infectious Disease Research in Zambia|Cervical Cancer Prevention Program in Zambia|International Agency for Research on Cancer","Female","18 Years to 65 Years   (Adult, Older Adult)",,"450","Other","Observational","Observational Model: Other|Time Perspective: Prospective","GYNOCULAR|KFS-4156-02-2017|Esther17G9|U01AI069924","May 8, 2019","January 1, 2021","December 1, 2022","April 30, 2019",,"May 28, 2020","Centre for Infectious Disease Research in Zambia, Lusaka, Zambia",,"https://ClinicalTrials.gov/show/NCT03931083"
307,"NCT04001972","Interactive Communication Technologies and Nicotine Replacement Therapy Sampling for Smokers",,"Recruiting","No Results Available","Smoking Cessation|Tobacco Use Cessation","Behavioral: Brief advice (AWARD model)|Drug: NRT-S|Behavioral: IM Apps and Chatbot|Behavioral: Regular SMS message","Biochemically validated abstinence of NRT-S +IM Apps and Chatbot vs. regular SMS|Self-reported 7-day point prevalence abstinence|Self-reported past 24-week continuous abstinence|Planned quit day|Change in number of quit attempts from baseline|Change in smoking reduction rate from baseline|Change in micotine addiction level from baseline|Any access to a smoking cessation service|Any use of nicotine replacement therapy|Change in quality-adjusted life year (QALY)","The University of Hong Kong|Food and Health Bureau, Hong Kong","All","18 Years and older   (Adult, Older Adult)","Not Applicable","664","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","ICTNRT","August 19, 2019","March 31, 2021","December 31, 2021","June 28, 2019",,"September 26, 2019","School of Nursing, The University of Hong Kong, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT04001972"
308,"NCT03612583","Lung and Diaphragm-Protective Ventilation by Means of Assessing Respiratory Work","LANDMARK","Recruiting","No Results Available","Diaphragm Injury|Lung Injury|Respiratory Insufficiency|Mechanical Ventilation Complication","Procedure: Lung- and Diaphragm-Protective Ventilation","Rate of patients achieving and maintaining LDPV targets|Inspiratory effort at lower and higher PEEP levels|Expiratory diaphragmatic effort at lower and higher PEEP levels|Lung stress and strain at low and high sweep gas flow rates|Inspiratory effort at low and high sweep gas flow rates|Sedative infusion rate at low and high sweep gas flow rates|Accuracy of artificial intelligence model in predicting patient outcomes","University Health Network, Toronto","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","18-5644","February 1, 2019","October 30, 2020","December 30, 2020","August 2, 2018",,"March 28, 2019","University Health Network, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03612583"
309,"NCT02858752","Memory and Attention in Healthy Children","MASK","Recruiting","No Results Available","Healthy Volunteers","Other: Experience 1 : Auditory and Visual Discrimination|Other: Experience 2 : Passive and Active Auditory Perception|Other: Experience 3 : Visual Attention Training|Other: Experience 4 : Attention and Distractibility|Other: Experience 5 : Sustained Visual Attention","Neuropsychological tests: Proportion of accurate answers|Neuropsychological tests: reaction time of answers (seconds)|Neurophysiological tests: Event-related potentials in response to auditory and visual stimulations|Proportion of accurate answers according to age range of children|reaction time of answers (seconds) according to age range of children|Event-related potentials in response to auditory and visual stimulations according to age range of children","Hospices Civils de Lyon","All","5 Years to 17 Years   (Child)","Not Applicable","400","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","69HCL15_0711","October 6, 2016","October 6, 2020","October 6, 2020","August 8, 2016",,"August 9, 2017","Hopital Femme Mère Enfant, Lyon, France",,"https://ClinicalTrials.gov/show/NCT02858752"
310,"NCT04376853","CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch","CoronaWatch","Recruiting","No Results Available","COVID-19","Device: Apple Watch Series 5","Biomarker|Protective factors|SmartWatch compliance|Arrhythmias|QT time changes|Longitudinal risk models","University Hospital Heidelberg|The German Heart Foundation|Klaus Tschira Stiftung|Freunde und Förderer der Kardiologie Heidelberg","All","18 Years and older   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CoronaWatch","April 15, 2020","June 2020","July 2020","May 6, 2020",,"May 6, 2020","Department III of Internal Medicine, University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany",,"https://ClinicalTrials.gov/show/NCT04376853"
311,"NCT00049556","Gefitinib in Treating Patients With Cervical Cancer",,"Completed","No Results Available","Cervical Cancer|Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer","Drug: gefitinib|Other: immunohistochemistry staining method|Other: surface-enhanced laser desorption/ionization-time of flight mass spectrometry|Procedure: biopsy|Procedure: sentinel lymph node biopsy","Biochem. modulation of EGFR signal transduction pathways in tumor by tissue lysate array reduction in phosphorylation of EGFR , AKT, and ERK in tumor biopsies at baseline and at 4 weeks during therapy|Biochem. modulation of EGFR signal transduction pathways in skin biopsy tissue by tissue lysate array reduction in phosphorylation of EGFR , AKT, and ERK in skin biopsies at baseline and at 4 weeks during therapy|Clinical activity of gefitinib as measured by CT scan of chest/abdomen/pelvis every 8 weeks|Toxicity as measured by laboratory testing, history, physical exam, and patient diary every 4 weeks|Skin as a surrogate site for study of EGFR modulation and correlation with outcome and toxicity as measured by tissue lysate arrays at baseline and 4 weeks after the start of study therapy|Potential collateral activation of other signal pathways in tumor and skin as measured by tissue lysate arrays at baseline and 4 weeks after the start of study therapy|Expression of EGFR and phosphorylated-EGFR (pY-EGFR) as measured by tissue lysate arrays at baseline and 4 weeks after the start of study therapy|Prediction of response and/or toxicity by serially obtained serum samples using surface-enhanced laser desorption and ionization with time-of-flight detection (SELDI-TOF) and artificial intelligence bioinformatics at baseline and then monthly","National Cancer Institute (NCI)","Female","18 Years and older   (Adult, Older Adult)","Phase 2",,"NIH","Interventional","Primary Purpose: Treatment","CDR0000258117|NCI-02-C-0303|NCI-5561","October 2002",,"August 2006","January 27, 2003",,"June 20, 2013","Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States|NCI - Center for Cancer Research, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT00049556"
312,"NCT04407780","Cardio-Oncology Registry","CONFUCIUS","Recruiting","No Results Available","Cancer|Cardiac Disease|Metabolic Syndrome|Arrhythmia|Heart Diseases","Other: No interventions are planned","Incidence of cardio-toxicty|Analysis of cardiotoxicity|Analysis of cardioprotective strategies|Analysis of underlying cardiovacsular profile|Analysis of arrhythmias|Precision medicine|Oncology|Cardiovascular outcomes|Any advserse event|Behaviour|Metabolic","European Georges Pompidou Hospital","All","18 Years and older   (Adult, Older Adult)",,"5000","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","00011928","January 1, 2017","June 1, 2022","June 1, 2027","May 29, 2020",,"May 29, 2020","Assistance Publique Hôpitaux de Paris - Centre Université de Paris, Paris, France",,"https://ClinicalTrials.gov/show/NCT04407780"
313,"NCT03834220","Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)",,"Active, not recruiting","No Results Available","Solid Tumor","Drug: Debio 1347","Objective Response Rate (ORR)|Duration of Response (DOR)|Disease Control Rate (DCR)|Progression-Free Survival (PFS)|Overall Survival (OS)|Percentage of Participants with Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)|Trough Concentration (Ctrough) of Debio 1347|Area Under the Plasma Concentration-Time Curve Over the Dosing Interval (AUCt) of Debio 1347|Correlation of Debio 1347 plasma concentration and QTcF","Debiopharm International SA|Caris Life Sciences|Optimal Research (Just In Time sites) - other USA study locations can be available on demand, please contact optimalcommunity@optimaljit.com","All","18 Years and older   (Adult, Older Adult)","Phase 2","58","Industry|Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Debio 1347-201|2018-003584-53","March 1, 2019","August 31, 2020","August 31, 2022","February 7, 2019",,"July 1, 2020","Ironwood Cancer & Research Centers - Scottsdale, Scottsdale, Arizona, United States|University of Arizona Cancer Center, Tucson, Arizona, United States|Moores UCSD Cancer Center, La Jolla, California, United States|University of California San Francisco, San Francisco, California, United States|Sarcoma Oncology Center, Santa Monica, California, United States|H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa, Florida, United States|James Graham Brown Cancer Center, Louisville, Kentucky, United States|Tulane University Cancer Center, New Orleans, Louisiana, United States|The John Hopkins Hospital, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Memorial Sloan Kettering Cancer Center, Middletown, New Jersey, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Memorial Sloan Kettering Cancer Center, Harrison, New York, United States|Memorial Sloan-Kettering Hospital, New York, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|UC Health, LLC., Cincinnati, Ohio, United States|The Ohio State University Wexner Medical Center - James Cancer Hospital, Columbus, Ohio, United States|CTCA Cancer Treatment Centers, Tulsa, Oklahoma, United States|West Penn - Allegheny Oncology Network, Pittsburgh, Pennsylvania, United States|MD Anderson Cancer Center, Houston, Texas, United States|University of Utah Hospitals & Clinics, Salt Lake City, Utah, United States|Fred Hutchinson/Seattle Care Alliance, Seattle, Washington, United States|University of Wisconsin, Madison, Wisconsin, United States|Southern Highlands Private Hospital, Bowral, Australia|Peninsula and Southeast Oncology (PASO), Frankston, Australia|Linear Clinical Research, B Block Sir Charles Gairdner Hospital, Nedlands, Australia|John Flynn Private Hospital, Tugun, Australia|LKH - Universitätsklinikum der PMU Salzburg, Salzburg, Austria|Landesklinikum Wiener Neustadt, Wiener Neustadt, Austria|Hospital de Caridade de Ijuí, Avenida David J Martins, Ijuí, Brazil|Hospital de Clínicas de Porto Alegre, Rio Grande, Brazil|CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia, Santo André, Brazil|ICESP - Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira, Avenida Doutor Arnaldo, São Paulo, Brazil|MHAT - Dobrich, Dobrich, Bulgaria|Complex Oncological Center - Plovdiv, EOOD, Plovdiv, Bulgaria|MHAT ""Serdika"", EOOD, Sofia, Bulgaria|General Hospital Varazdin, Varaždin, Croatia|University Hospital Centre, Sestre Milosrdnice, Zagreb, Croatia|Fakultni nemocnice u sv. Anny v Brne, Brno, Czechia|Fakultni nemocnice Hradec Kralove, Hradec Králové, Czechia|Fakultni nemocnice Olomouc, Olomouc, Czechia|Thomayerova nemocnice, Prague, Czechia|Fakultni nemocnice Kralovske Vinohrady, Praha, Czechia|Ålborg Universitets Hospital, Aalborg, Denmark|Herlev Hospital, Herlev, Denmark|Odense Universitetshospital, Odense, Denmark|Docrates Syöpäsairaala, Helsinki, Finland|Helsinki University Hospital, Helsinki, Finland|ICO - Site Paul Papin, Angers, France|CHU Bordeaux - Hôpital Saint André, Groupe Hospitalier Sud - Hôpital Haut-Lévêque, Bordeaux, France|Centre Oscar Lambret, Lille, France|Groupe Hospitalier Sud - Hôpital Haut Lévêque, Pessac, France|ICO - Site René Gauducheau, Saint-Herblain, France|Institut Gustave Roussy, Villejuif, France|General Hospital of Athens Laiko, Athens, Greece|General Hospital of Athens of Chest Diseases ""SOTIRIA"", Athens, Greece|General Hospital of Athens ""Alexandra"", Athens, Greece|University General Hospital of Ioannina, Ioánnina, Greece|Seoul National University Bundang Hospital, Department of Oncology Medical office, Gyeonggi-do, Korea, Republic of|The Catholic University of Korea, St. Vincent's Hospital, CRC Room, 3F, Gyeonggi-do, Korea, Republic of|Gachon University Gil Medical Center, CRC Room, 18F, Artificial intelligence hospital, Incheon, Korea, Republic of|Korea University Anam Hospital, Seoul, Korea, Republic of|Seoul National University Hospital (SNUH), CRC Room, 2F, Cancer Center, Seoul, Korea, Republic of|Ajou University Hospital, CRC room, Clinical Trial Center, Suwon, Korea, Republic of|VU Medisch Centrum, Amsterdam, Netherlands|Haga Ziekenhuis, Den Haag, Netherlands|Akershus University Hospital, Lørenskog, Norway|Radiumhospitalet, Montebello, Oslo, Norway|Cebu Doctors' University Hospital (CDUH), Research Office, Cebu City, Philippines|Philippine General Hospital, Clinical Trial Unit Room 5, Medical Research Laboratory, Ermita, Philippines|St. Luke's Medical Center, Human Cancer Biobank Research Center, Quezon City, Philippines|Szpital Kliniczny im.Heliodora Swiecickiego Uniwersytetu Medycznego im.K. Marcinkowskiego w Poznaniu, Poznań, Poland|MTZ Clinical Research, Warszawa, Poland|Centrum Onkologii-Instytut im.M.Sklodowskiej Curie, Warszawa, Poland|S.C Delta Health Care S.R.L, Bucuresti, Romania|S.C Medisprof S.R.L., Cluj-Napoca, Romania|S.C Centrul de Oncologie Sf. Nectarie S.R.L., Craiova, Romania|S.C Oncocenter Oncologie Clinica S.R.L., Timişoara, Romania|SBIH of Arkhangelsk region ""Arkhangelsk Clinical Oncological Dispensary"", Arkhangel'sk, Russian Federation|TSBHI ""Altai Territorial oncological dispensary"", Barnaul, Russian Federation|LLC Evimed, Chelyabinsk, Russian Federation|FSBSI ""Russian Oncological Scientific Center n.a. N.N. Blokhin"", Moscow, Russian Federation|BHI of Omsk region ""Clinical Oncology Dispensary"", Omsk, Russian Federation|Tomsk Research Instutite of Oncology, Tomsk, Russian Federation|Singapore National Cancer Center (SNCC), Singapore, Singapore|Tan Tock Seng Hospital, Communicable Disease Centre, Singapore, Singapore|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Centro Integral Oncologico Clara Campal, Madrid, Spain|Hospital Clinico Universitario de Valencia, Valencia, Spain|Shuang Ho Hospital, New Taipei City, Taiwan|Taichung Veterans General Hospital, The Radiation Oncology Department, Taichung, Taiwan|National Cheng Kung University Hospital, Tainan, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Taipei Medical University Hospital (TMUH), Taipei, Taiwan|Taipei Veterans General Hospital, Medical Science & Technology Building, Taipei, Taiwan|Linkou Chang-Gung Memorial Hospital, Taoyuan, Taiwan|CI Dnipropetrovsk CMCH #4 of Dnipropetrovsk RC Dept of Chemotherapy SI Dnipropetrovsk MA of MOHU, Dnipro, Ukraine|SI V.T. Zaycev Institute of general & urgent surgery of National academy medical sciences of Ukraine, Department of purulent surgery, Kharkiv, Ukraine|Communal Non-profit Enterprise Regional Center of Oncology, Kharkiv, Ukraine|Ninewells Hospital, Dundee, United Kingdom|Guy's Hospital, London, United Kingdom|Hammersmith Hospital, London, United Kingdom|The Christie, Manchester, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03834220"
